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Our ability to engineer and domesticate microbes to give them useful properties 
promises grand rewards in the energy, agriculture, chemical and health industries. Yet, 
synthetic biologists often struggle to engineer bacterial genomes despite ever-improving 
genome-scale models of how they function. Often, they are stymied by the sheer 
complexity of the cell’s underlying systems biology and by how these continue to evolve 
rapidly after they are engineered. Recent advances in genome stabilization and genome 
simplification promise to overcome these barriers and profoundly extend our 
understanding of basic molecular biology and cellular life. Both the natural instability of 
bacterial genomes and their unexplored complexity (e.g., the presence of many genes 
with unknown functions) underlie major challenges to be reckoned with that often lead 
synthetic biologists to rely on extensive experimental trial and error. 
The construction of cells with minimal genomes to make microbiology more 
predictable is riddled with difficulties. There are sometimes advantages and sometimes 
disadvantages for removing more and more genes to simplify a bacterial cell. Similarly, 
evolution is a process that may both frustrate or enable synthetic biology. It can be 
slowed down by removing selfish DNA elements from a genome or it can be applied to 
compensate for suboptimal designs. The work in this thesis explores these interactions 
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between genome design and evolution. It asserts that rational engineering and 
simplification principles can lay stronger foundations for engineering microbial cells so 
that more complex and ambitious designs can be successfully built, but that evolution is 
also a necessary tool to achieve extreme simplification of a living cell to make it robust 
enough for research and industrial demands to achieve the potential of synthetic biology. 
Our model organism is Acinetobacter baylyi ADP1, a highly naturally 
transformable and metabolically versatile soil bacterium.  
Chapter 1 provides an introduction to A. baylyi genetic engineering and the 
current state-of-the-art in bacterial genome stabilizing and streamlining projects. Chapter 
2 describes our rational engineering efforts to reduce A. baylyi ADP1 genome instability–
mainly by deleting all transposable elements from its genome–and the beneficial 
phenotypes in the ADP1-ISx strain that resulted from this work. Chapter 3 describes 
improved A. baylyi genome engineering methods and how they were used in the first 
stage of a genome streamlining project. We also describe a “Golden Transformation” 
protocol that speeds up and simplifies the steps needed to make precise edits to the A. 
baylyi genome and also show that the native CRISPR-Cas system is functional and can be 
reprogrammed using this method. Chapter 4 describes how we begin to test how 
compensatory evolution of reduced genomes can open new pathways to more extreme 
genome minimization by restoring fitness that is lost after deleting many dispensable 
genes from a genome. Chapter 5 discusses future directions for making improvements 
that further stabilize and streamline the A. baylyi genome. 
Together, the work presented in this dissertation presents concepts, tools, and 
insights into strategies that were successful and unsuccessful for building a better and 
simpler Acinetobacter baylyi ADP1 genome. These approaches can also be applied to 
other bacterial species to propel the goals of synthetic biology forward. 
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Chapter 1: Introduction 
 
Acinetobacter baylyi ADP1 as a platform for biotech applications  
A. baylyi ADP1 is a non-pathogenic, strictly aerobic, soil γ-proteobacterium that 
is notable for its high natural transformability, metabolic versatility, and genetic 
tractability 1,2. It has a truly remarkable ability to indiscriminately uptake and incorporate 
diverse sources of DNA into its genome during normal laboratory growth 3–9. This ability 
makes it straightforward to edit its genome sequence 10. ADP1 also has a well-developed 
set of resources, including a single-gene knockout collection and genome-scale metabolic 
models, to guide engineering its capabilities 11–14. ADP1 offers broad opportunities for 
metabolic engineering 15, sensor development 9, and asking fundamental questions about 
competence mechanisms 6,16 and genome evolution 17–22.  
Broad metabolic versatility is fueling ever more studies dedicated to metabolic 
rewiring of A. baylyi ADP1 23. Deletion of genes for competing metabolic pathways has 
been used to optimize ADP1 for the production of compounds with applications in the 
food, cosmetics, and biofuel industries, such as alkanes 24,25, triacylglycerol 26 and wax 
esters 27 28 . In one case, where metabolic reprogramming shifted the carbon source from 
succinate to quinate, an engineered ADP1 strain produced dozens of unidentified, and 
possibly novel, compounds 13. Similarly, a single-gene knockout that prevents 
sugar/glucose metabolism in ADP1 makes it an effective biodetoxification tool for the 
removal of oxygen that would otherwise inhibit anaerobic fermentations 29. Beyond this 
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sort of “reductive” metabolic engineering, construction of synthetic pathways in ADP1 
has been equivalently fruitful, recently exemplified by work increasing production of 
fatty aldehydes 30.   
Early on, it was shown that ADP1 bioreporters could be designed and employed 
for detection of a wide range of compounds, for example, salicylates 31–33, alkanes 24,34 
and toxic compounds 35,36. In one of these cases, twin-layer biosensor cells were 
developed that could detect both degradation and biosynthesis of alkanes 24. This is 
possible because ADP1 is responsive to alkanes as signal molecules to direct 
transcriptional regulatory proteins (e.g.,  AlkR) 37. Due to its high competence, ADP1 has 
also been engineered as a DNA biosensor to detect marker genes from transgenic plants 5. 
Its high natural transformability and propensity for evolving gene amplifications 
in its genome, yield unique opportunities for the directed evolution of useful pathways in 
A. baylyi. Transformation-facilitated PCR mutagenesis in ADP1 can generate useful 
locus-specific mutation libraries for structure-function studies and improving protein 
properties 38,39, as has been shown in the case of the transcriptional activator (pobR) of 
the pobA gene. Purposeful emplacement and amplification of heterologous genes 
involved in lignin degradation in the genome have provided opportunities for the 
evolution of improved enzymes, including the generation of protein chimeras with 
improved catalytic dynamics 40. These capabilities enhance the usefulness of ADP1 as a 
study system for metabolic engineering, genome evolution, and synthetic biology. 
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Evolutionary challenges for synthetic biology 
Synthetic biologists have long sought to create useful genetic circuitry to exploit 
the metabolic, signaling, and sensing capabilities of cells; their progress has immense 
potential for products and breakthroughs that improve human lives 41 42 43. One challenge 
with making these a reality is that many of these devices are evolutionarily short-lived. 
They often mutate rapidly and these mutations can quickly dominate cell populations. 
This failure mode constrains attempts to develop better and more complex biological 
systems. For example, populations that highly express fluorescent proteins mutate this 
burdensome function within a relatively small number of cell divisions 44. The natural 
evolvability of genomes makes it difficult to sustain burdensome and complex genetic 
circuitry that is non-native to a host cell. Point mutations, deletions, and insertions – in 
addition to mutations caused by selfish DNA elements such as transposons and prophages 
– can frustrate synthetic biology efforts 45.  
Another stumbling block to synthetic biology is the sheer complexity of the 
cellular milieu in which an engineered circuit or pathway is deployed. An ideal chassis 
organism would be one that is thoroughly understood, such that when engineered circuits 
are added, these encounter no surprise interactions with host functions 46 47. Natural 
organisms have evolved to thrive in many different environments and survive many 
different stresses. Much of this machinery (e.g., accessory genes, genes involved in non-
central metabolism and certain membrane components) may not be necessary in an 
application in an industrial fermenter (Fig. 1.1). They may even waste energy or interact 
in unpredictable ways with engineered components. These notions, along with the 
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realization that organisms with severely reduced genomes can be found living stably in 
natural—highly static—environments (e.g., M. genitalium with a < 580 kb genome) 
(reviewed in 48), fueled a growing interest in the concept of streamlined and engineered 
“minimal” genomes. Soon, researchers began to employ genome-engineering techniques 
to build such minimal organisms using either bottom-up assembly (i.e., genomes built 
from scratch, implanted in a cell, and “booted up”) 49 or top-down approaches (i.e., the 
step-wise elimination of portions of a natural genome) 50 51. Although the effects of 
genome reduction on the metabolic capacity, stress tolerance, and transcriptomic profile 
remain largely unknown, these approaches offered an unprecedented opportunity to 








        




Benefits of clean-genome and minimal-genome strains 
  In principle, a reduced-genome bacterial chassis could be instrumental to unravel 
the basic genetics or minimal components necessary to maintain cellular life and provide 
unprecedented understanding and control of cellular molecular processes 50 51. To date, a 
range of reduced genomes have been engineered from multiple research and industrially 
relevant strains, most notably, Escherichia coli, Bacillus subtilis and Mycobacterium 
mycoides, with reductions up to 38.9 % 52, 36.0% 53, and 51.0% 54, respectively (Fig. 
1.2). “Clean-genomes”, as they are sometimes called, remove selfish DNA elements such 
as transposons (e.g., IS-elements) and prophages 55 56 57. This typically provides greater 
genome stability and reduced mutation rates 58 59. Streamlined genomes further remove 
nonessential accessory functions, such as genes involved in antibiotic resistance 53, 
sporulation 53, motility 53, stress resistance 56, and restriction modification systems 60 57. 
Examples like these illustrate how deleting many genes from genomes can provide 







    Figure 1.2. Reduced Genome Strains of E. coli (blue bars), B. subtilis (green bars), 
and M. mycoides (Syn 3.0)   
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  Interestingly, streamlined genomes have exhibited several desirable traits, such as 
the ability to overexpress ‘difficult proteins’, improved competence, robust plasmid 
maintenance, and better tolerance to oxidative stress 61. It is also possible to pursue 
genome streamlining to attain other desirable stability features such as reduced autolysis 
62 63 64. Non-detrimental large genome reductions can be superimposed, and in several 
cases, an improved growth profile has emerged 52,56,65. Another factor of industrial 
relevance is the increased biomass or final cell density often observed, even when growth 
rate was negatively impacted 64 62.  
  Increased recombinant protein expression is both an objective and attainable 
outcome of genome reduction efforts 66 56 67 68 69 62 70. In certain cases, increased 
productivity is the result of improved plasmid maintenance in reduced genome strains 55 
66 58 71 60 64. In other cases, it is the direct result of the removal of restriction-modification 
systems or lower mutation rates due to removal of IS-elements and error-prone 
polymerases 72 73 58. 
It is currently debated whether genome reduction positively impacts metabolism 
in a generalizable way as opposed to idiosyncratic ways that depend on the effects of 
specific gene deletions. In effect, some reduced-genome strains support improved 
metabolic efficiency 66 68 62 74 63 64. Others report no change or even lower performance 
for reduced-genome cells 62,71. The changes observed can sometimes be attributed to 
changes in metabolic capacity, which refers broadly to the availability of precursors (e.g., 
amino acids), reductive power (e.g., NADPH), energy requirements (e.g., ATP), and gene 
expression machinery (e.g., ribosomes and RNA polymerases) that are withdrawn from 
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pools of cellular resources 63 75–77. Non-essential gene products and secondary 
metabolites can impose translational or metabolic demands. For example, certain cellular 
features, such as flagella, impose heavy metabolic burden and thus their removal can free 
up energy (ATP) and/or reducing power (NADPH) that the deleted strain can now 
allocate for other functions 63,78. In fact, evidence suggests that the systematic removal of 
secondary metabolite producing sequences (e.g., antibiotic biosynthesis operons) and 
non-essential genes can improve properties over wild-type strains 62.  
Obstacles to effective genome streamlining 
  Genome streamlining remains both time-consuming and challenging. Systematic 
genome reduction is often accompanied by growth defects, at least in part due to the loss 
of quasi-essential genes, which are required for robust growth 79–84. In fact, analysis of 
the current literature on reduced genomes, reveals that genome reduction most often 
results in moderate to severe growth impairments. Only in a few cases has increased 
growth in rich or minimal media been observed: for E. coli 85 and P. putida 78. Yet, the 
general trend is that growth impairments or no significant changes are to be more 
expected than improved growth phenotypes as a result of minimal genome construction. 
Most recently, detrimental effects of genome reduction have been suggested to be the 
result of lack of knowledge of the underlying systems biology 86. 
  In addition to experimental evidence, comparative genomics and essential gene 
databases typically guide the selection of deletion targets for genome reduction. One 
caveat is that essential genes – genes whose deletion causes severe growth impairment or 
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complete inviability – are not only context-dependent and evolvable, but the fact that a 
priori knowledge of all essential genes in a cell – its essentialome - does not guarantee the 
successful engineering of genome-reduced strains 87. One reason is that deletion of 
certain gene pairs can be lethal, a phenomena known as “synthetic lethality”. Synthetic 
lethal combinations are difficult to predict during minimal genome construction, 
particularly when so many gene functions remain unknown. Nonetheless, the 
combination of modeling and experimental examination can greatly refine the true limits 
of genome reduction. As an example, an in silico tool that integrates genome-scale 
metabolic and transcriptional models alongside gene essentiality has been shown able to 
predict the largest “deletable” regions in an E. coli genome 88. Surprisingly, the work 
suggested a somewhat larger genome dispensability landscape than experimentally tested. 
In practice, the design trajectory of genome streamlining can dramatically change the 
outcome or lead to unexpected dead ends. That is, the effect of a adding a new deletion to 
a cell is contingent on previous deletions. Careful consideration of phenotypic 
perturbations in reduced-genome cells and how they can be repaired has ameliorated 
growth defects and resulted in promising streamlined bacterial platforms 79 52,89–91.  
  The work in this dissertation examines tools and approaches that enable simpler 
design and engineering of A. baylyi. These tools are used to develop and test the effects 
of genome cleanup and streamlining strategies on this useful microbial “chassis”. 
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Chapter 2: Reduced mutation rate and increased transformability of 
transposon-free Acinetobacter baylyi ADP1-ISx 
This chapter is reproduced (with minor modifications) from its initial publication: 
 
Suárez, G.A., Renda, B.A., Dasgupta, A., Barrick, J.E.^ (2017) Reduced mutation rate 
and increased transformability of transposon-free Acinetobacter baylyi ADP1-ISx. Appl. 
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The genomes of most bacteria contain mobile DNA elements that can contribute 
to undesirable genetic instability in engineered cells. In particular, transposable insertion 
sequence (IS) elements can rapidly inactivate genes that are important for a designed 
function. We deleted all six copies of IS1236 from the genome of the naturally 
transformable bacterium Acinetobacter baylyi ADP1. The natural competence of ADP1 
made it possible to rapidly repair deleterious point mutations that arose during strain 
construction. In the resulting ADP1-ISx strain, the rates of mutations inactivating a 
reporter gene were reduced by 7- to 21-fold. This reduction was higher than expected 
from the incidence of new IS1236 insertions found during a 300-day mutation 
accumulation experiment with wild-type ADP1 that was used to estimate spontaneous 
mutation rates in this strain. The extra improvement appears to be due in part to 
eliminating large deletions caused by IS1236 activity, as the point mutation rate was 
unchanged in ADP1-ISx. Deletion of an error prone polymerase (dinP) and a DNA 
damage response regulator (umuDAb) from the ADP1-ISx genome did not further reduce 
mutation rates. Surprisingly, ADP1-ISx exhibited increased transformability. This 
improvement may be due to less autolysis and aggregation of the engineered cells 
compared to wild type. Thus, deleting IS elements from the ADP1 genome led to a 
greater than expected increase in evolutionary reliability and unexpectedly enhanced 
other key strain properties, as has been observed for other clean-genome bacterial strains. 
ADP1-ISx is an improved chassis for metabolic engineering and other applications.	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IMPORTANCE 
Acinetobacter baylyi ADP1 has been proposed as a next-generation bacterial host for 
synthetic biology and genome engineering due to its ability to efficiently uptake DNA 
from its environment during normal growth. We deleted transposable elements from the 
ADP1 genome that are capable of copying themselves, inserting into other genes, and 
thereby inactivating them. The resulting ‘clean-genome’ ADP1-ISx strain exhibited 
larger reductions in the rates of inactivating mutations than expected from spontaneous 
mutation rates measured via whole-genome sequencing of lineages evolved under relaxed 
selection. Surprisingly, we also found that IS element activity reduces transformability 
and is a major cause of cell aggregation and death in wild-type ADP1 grown under 
normal laboratory conditions. More generally, our results demonstrate that domesticating 
a bacterial genome by removing mobile DNA elements that have accumulated during 
evolution in the wild can have unanticipated benefits.  
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INTRODUCTION 
Acinetobacter baylyi ADP1 is a nonpathogenic Gram-negative soil bacterium that 
has been used as a platform for metabolic engineering and synthetic biology due to its 
high natural transformability 92–95. ADP1 naturally catabolizes aromatic compounds and 
can detoxify inhibitory molecules that are liberated during degradation of lignocellulosic 
feedstocks 29,96; and it can be engineered for the production of biofuel components and 
high-value compounds, including wax esters and triacylglycerides 26,28. ADP1 has also 
been used to construct cell-based biosensors for salicylate and components of crude oil 
31,97. Facile engineering of the ADP1 genome to edit and add to metabolic and sensing 
pathways is made possible by its constitutive expression of a competence apparatus that 
enables it to efficiently uptake DNA from its environment in a non-sequence-specific 
manner 21. ADP1 can also transform fragmented and damaged DNA or mutagenized PCR 
products to introduce sequence variation at specific sites in its genome for optimizing 
engineered functions 8,98.  
 Insertion sequence (IS) elements are minimal transposons that are widespread in 
bacteria 99. They contribute to mutagenesis by encoding transposases that move or copy 
their DNA sequences to new locations in a genome and by acting as long repeated 
sequences that can mediate homologous recombination events that lead to deletions and 
other large-scale genome rearrangements 100,101. IS elements can be significant sources of 
genetic instability in engineered bacterial cells. For example, they are often the dominant 
 13 
source of spontaneous mutations that rapidly inactivate the heterologous expression of 
costly recombinant proteins from plasmids 44,58. 
  The genome of A. baylyi ADP1 contains a total of six IS elements, all of the same 
IS1236 type 102,103. IS1236 elements are members of the IS3 family 104. They operate by a 
copy-paste mechanism and insert randomly without any strong target site sequence bias. 
Five of the six IS1236 copies have identical sequences. Two of these are located in close 
proximity on the chromosome, forming a composite transposon (Tn5613) that can also 
mobilize two hypothetical genes located between the IS copies 105. The sixth copy 
(IS1236ψ) has evolved to be non-autonomous. It shares only 82% nucleotide identity 
with the other copies and has a frameshift mutation in its transposase gene 106.  
 We and others have observed that a considerable proportion of the mutations that 
occur in A. baylyi ADP1 are due to IS1236 activity. This transposable element family was 
initially characterized due to the prevalence of IS1236 insertions among mutations 
inactivating certain protocatechuate catabolism genes 103. IS1236 elements constitute 25-
40% of all new mutations that accumulate during long-term adaptive laboratory evolution 
experiments with ADP1 107,108, including mutations in competence genes that often arise 
during laboratory culture and reduce or eliminate the transformability of this strain 108,109. 
The DNA cleavage activity associated with IS1236 elements may also contribute to 
certain gene amplification events 106,110. 
 In this study, we sequenced the genomes of Acinetobacter baylyi ADP1 that had 
been evolved under relaxed selection for 300 days and found that IS1236 elements were 
directly responsible for 26% of all spontaneous mutations. Therefore, to improve the 
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genetic stability of ADP1, we engineered an IS-less version of this strain (ADP1-ISx) by 
deleting all six IS1236 copies. Characterization of the final strain revealed that ADP1-ISx 
exhibited a much larger reduction in mutation rates than expected, and also significantly 
greater cell yields and transformation frequencies. These improved traits in the ‘clean-
genome’ ADP1-ISx strain make it an improved platform for bioengineering applications 
that take advantage of its metabolic versatility and high naturally transformability. 
MATERIALS AND METHODS 
Strains and culture conditions  
Acinetobacter baylyi ADP1 cultures were grown in LB or minimal succinate 
(MS) media at 30°C with orbital shaking, as previously described 19. Media were 
supplemented with  µg/ml kanamycin (Kan), 60 µg/ml spectinomycin (Spec), or 200 
µg/ml 3′-azido-2′,3′-dideoxythymidine (AZT) as specified. Engineered ADP1 strains 
were archived at –80°C in 15-20% (v/v) glycerol. Prior to all experiments, cell stocks 
were thawed on ice, diluted 1:1000 into the appropriate media, and grown overnight. 
Then, these revived cultures were diluted 1:1000 and grown for an additional 24±1 h for 
preconditioning to the culture conditions of an experiment. Cell dilutions for plating on 
agar were made in sterile saline (0.85% w/v NaCl). 
Mutation accumulation (MA) experiment 
The MA lines were generated in prior work 19. Briefly, 18 ADP1 lineages were 
passaged through 300 daily single-cell bottlenecks by picking an arbitrary colony from 
LB agar, streaking out to single colonies, and allowing regrowth for 24 h before selecting 
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the next colony to transfer. This procedure gives ~25 cell divisions (generations of 
regrowth) each day for an estimated total of ~7,500 generations of evolution over the 
course of the entire MA experiment.  
Genome sequencing 
DNA was isolated from evolved clones from the MA experiment and genome-
edited clones from the construction of ADP1-ISx and then prepared for sequencing as 
described previously 108. These samples were sequenced to >100× coverage using the 
Illumina HiSeq 2500 platform at the University of Texas at Austin Genome Analysis and 
Sequencing Facility (GSAF). Read files were analyzed by using the breseq computational 
pipeline (v0.28.0) 111,112 to predict mutations, including IS element insertions and other 
types of structural variation, relative to the ADP1 reference genome (GenBank: 
NC_005966.1) 23. FASTQ files for each sequenced strain have been deposited in the 
NCBI Sequence Read Archive (accession SRP074541). When counting mutations in the 
MA experiment we removed genome differences that we previously identified as being in 
our original lab strain 19, and we also did not include an insertion of a single G that was 
present in 15 of the 17 sequenced genomes at a site 74 base pairs upstream of the atpI 
gene because it was most likely already present in the original culture that was used to 
found these lineages. Statistical tests were performed in R (v3.3.2) 113. The final mutation 
predictions are provided in Table S1. 
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Genome modification 
Enzymes were purchased from New England Biolabs (Ipswich, MA). Phusion 
polymerase was used for all PCRs. Primer sequences are provided in Table 2.1. The 
tdk/KanR dual-selection cassette was PCR amplified from the per gene knockout strain 
from the ADP1 single-gene deletion collection 114 using primers P1-F and P2-R. For each 
IS or gene deletion, ~1000 base pairs of flanking sequence on each side of the deleted 
region were amplified in two additional PCR reactions. Primers P3-F and P1′P4-R were 
used for the upstream region, and primers P2′P5-F and P6-R were used for the 
downstream region. PCR products were cleaned up using the GeneJET Purification Kit 
(Thermo Scientific). The two flanking region products and the tdk/KanR cassette were 
joined by overlap PCR to create the ‘knockout cassette’. Two PCR products for the 
flanking regions were joined in a separate overlap PCR reaction to produce the ‘rescue 
cassette’ used for scarless tdk/KanR cassette removal. To add overlap in this case, the 
upstream region was amplified with primers P3-F and P5′P4-R, and the downstream 
region was amplified with primers P4′P5-F and P6-R. Each type of overlap PCR 
amplification began with 15 temperature cycles with only the templates present (no 
primer addition), followed by 20 further cycles with the external primers P3-F and P6-R. 
The final amplified cassettes were digested with 40 U DpnI by adding 2 µL of enzyme 
into each 50 µL PCR reaction and incubating for 1 h at 37°C. Then, they were purified 
again using the GeneJET PCR Purification Kit before transformation. 
 Each genome modification involved two transformation steps. First, 70 µL of 
ADP1 cells from a preconditioned LB culture of the strain being edited were added to 1 
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ml of LB containing 100 ng of knockout cassette DNA. After overnight growth (16-24 h), 
100 µL of the transformation culture and 100 µL of a 1:10 dilution were plated on LB-
Kan plates and 100 µL of a 106 dilution were plated on LB to monitor transformation 
frequencies. In most cases, plating 100 µL from a 1:10 dilution of a transformation 
culture resulted in ~30 colonies on LB-Kan. In the second step, the integrated tdk/KanR 
cassette was replaced using the corresponding rescue cassette PCR product with the same 
transformation procedure, except plating on LB-AZT plates to select for removal of the 
tdk/KanR cassette. Each step was typically carried out with three or more replicates so 
that independently derived clones could be screened for success. Whole-cell PCR was 
used to confirm successful integration and loss of the tdk/KanR cassette at each step.  
 Each IS element was deleted one at a time using this procedure, except for the two 
IS1236 elements in Tn5613 (#2 and #3), which were deleted simultaneously. This double 
IS deletion also removed two putative genes of unknown function (ACIAD0955 and 
ACIAD0956) located between the IS elements and was designed to preserve a stop codon 
in an adjacent gene of unknown function (ACIAD0959) that overlaps IS1236 #3. 
The dinP and umuCDAb deletions were constructed in the repaired ADP1-ISx 
strain background. The double mutant was made by adding the umuDAb deletion to the 
ΔdinP strain. The ΔumuDAb single mutant produced small colonies on LB agar and did 
not reach saturation in LB liquid after 24 h of growth. Its growth defect appears to be due 
to a secondary mutation that occurred during our strain construction as ΔumuDAb strains 
constructed by others have been reported to exhibit normal growth 115. The ΔdinP and 
ΔdinP ΔumuDAb strains that we constructed grew normally. 
 18 
qPCR monitoring of IS deletion 
 We used quantitative PCR (qPCR) to monitor the relative copy number of 
IS1236 elements during ADP1-ISx strain construction. Genomic DNA (gDNA) was 
purified from at least three of the clones confirmed by PCR to have a successful deletion 
of each targeted IS copy. The Qubit dsDNA BR Assay Kit (Invitrogen) was used to 
determine DNA concentrations in these samples.  
qPCR reactions were set up with gDNA (1.1 ng/µL), IS-F and IS-R primers (0.5 
µM each), and SYBR Green Dye Real-Time PCR Master Mix (Applied Biosystems). 
These primers amplify a 119-bp product common to all six IS1236 elements (Table 2.1). 
More cycles of PCR amplification (Rn) were required to surpass an arbitrary signal 
threshold in each successive strain that removed additional IS1236 elements from the 
ADP1 genome. Clones with a higher Rn value were used to continue the deletion 
procedure.  
Growth curves 
Growth curves for wild-type ADP1 and ADP1-ISx were initiated by making 
1:1000 dilutions of cultures preconditioned in LB or MS into 50 mL of the same medium 
in 250 mL Erlenmeyer flasks. The optical density of samples removed from these 
cultures was measured at 600 nm (OD600) to monitor growth. These assays were carried 
out in triplicate. Time points at which the mean of the OD600 values across replicates 
was less than 0.25 were used for nonlinear least-squared fitting to a model with 
exponential growth rate and lag time parameters using R (v3.3.2) 113. Differences in 
growth rates or lag times between two strains were evaluated by simultaneously fitting 
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the OD600 data for both strains to a model that had allowed just one global value for this 
parameter for both strains and then examining the significance of an added offset that 
allowed for per-strain variation in that parameter. 
Reversion of cyoB and rpoD mutations  
Regions of the wild-type ADP1 genome consisting of ~1,000 base pairs upstream 
and ~1,000 base pairs downstream of the cyoB or rpoD mutations were amplified by 
PCR. These PCR products were DpnI digested and gel purified. Then, 250 ng of each 
PCR product were transformed into the same culture of ADP1-ISx using standard 
conditions. After 12 h of growth, 100 µL of this culture was transferred into 10 ml fresh 
LB. After 6 h of growth, 100 µL was transferred again into 10 ml LB. After a final 6 h of 
growth, 100 µL of a 106 dilution was plated on LB agar. PCR and Sanger sequencing 
showed that all twelve of the large colonies picked from this LB plate had reverted to 
wild-type sequences for both genes. After whole-genome sequencing to confirm that it 
had not accumulated any new secondary mutations, one of these clones was designated 
ADP1-ISx and used in all further experiments. 
Gene inactivation mutation rate assays 
Three pairs of strains derived from ADP1-ISx and wild-type ADP1 were 
constructed, each with the KanR/tdk cassette inserted at a different genomic site using the 
methods described above. For each of these strains, thirty independent 40 µl LB cultures, 
each containing ~500 colony-forming units (CFUs) from a dilution of a preconditioned 
culture, were started in 96-well microplates. These plates were sealed with adhesive foil 
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and incubated at 30°C with orbital shaking at 250 r.p.m. Following overnight growth, the 
entire volume of twenty-four of the cultures for each of the six strains were independently 
plated on LB-AZT plates. A 106 dilution of the remaining six 40 µL cultures of each 
strain was plated on nonselective LB plates. After incubation at 30°C for 30 h, colonies 
on selective and non-selective plates were counted. Mutation rates were calculated from 
these counts using FALCOR 116. 
 To compare the types of mutations leading to AZT-resistance in each strain, one 
colony was picked from each selective plate in the fluctuation tests and grown overnight 
in liquid LB. We then used PCR with primers P1-F and tdk-R to amplify the tdk portion 
of the KanR/tdk cassette from the genome of each of these mutants. 
Point mutation rate assays 
We utilized a spectinomycin resistance gene in which the eighth codon was 
mutated from GAA to the TAA stop codon to measure point mutation rates. To create 
this SpecR-E8* mutational reporter, we amplified the spectinomycin resistance gene from 
pIM1463 117 in two halves with primers that introduced the G to T mutation in a region 
common to each PCR product, and then we stitched the two pieces together in a round of 
overlap PCR. We inserted this marker into the A. baylyi genome in ‘region 1’, a site 
where we had inserted a KanR cassette in a previous study 19. Specifically, strains ADP1-
SpecR-E8* and ADP1-ISx- SpecR-E8* were created by first integrating a KanR/tdk 
cassette in region 1 and then using the mutant SpecR-E8* DNA assembled with regions of 
flanking homology as a rescue cassette. 
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 The point mutation rate was assessed for ADP1-SpecR-E8* and ADP1-ISx-SpecR-
E8* using Luria-Delbrück fluctuation tests in LB. Preconditioned cultures were diluted 
and used to inoculate 1 mL test tube cultures with ~30-50 cells. After growth for ~18-24 
h, cells from 24 of the tubes for each strain were pelleted via centrifugation and the entire 
amount was plated on LB-Spec agar. These selective plates were incubated at 30°C for 4 
days before counting colonies. The other six replicates were diluted 106 in sterile saline 
plated on nonselective LB agar and incubated overnight before counting. Point mutation 
rates were calculated and compared using the rSalvador R package (version 1.7) 118,119. 
Transformation frequency 
Six replicate 0.5 mL transformation reactions were prepared with 250 ng/mL of 
DNA consisting of the KanR/tdk cassette PCR amplified with ~1000-bp flanking 
homologies targeting site 2 or the unmutated SpecR cassette amplified with ~1000-bp 
flanking homologies targeting site 4. At the same time, dilutions from every 0.5 mL 
transformation mix were plated onto LB agar to acquire CFU counts corresponding to 
each. Negative controls with DNA but no cells were included to rule out possible 
contamination issues. All samples and transformation mixes were incubated for 16 h. 
Dilutions of each transformation were plated on LB-Kan and LB agar, and transformation 
frequencies were calculated by taking the ratios of CFUs after overnight incubation at 
30°C on selective versus nonselective plates. 
 22 
Extracellular DNA (eDNA) concentration 
Eight 5 mL cultures in MS medium were inoculated with a 1:1000 dilution of 
preconditioned cells and grown for 48 h. eDNA measurements were made using the 
Qubit high-sensitivity (HS) kit on the supernatant from 1 mL samples from these cultures 
after centrifuging for 10 min at 21,130 r.c.f. 
Live/dead staining 
Cells from preconditioned cultures grown for 24 h in MS medium were analyzed 
using the Live/Dead® BacLight™ Bacterial Viability and Counting Kit (Molecular 
Probes). For each biological replicate, 10,000 events were captured on a BD LSRFortessa 
Flow Cytometer and analyzed with FlowJo (v10.1). We analyzed five biological 
replicates in LB and three biological replicates in MS media for each strain. Live/dead 
gating was determined using dead cell controls prepared by incubating cultures with 70% 
(v/v) isopropanol for 1 h at room temperature.  
RESULTS AND DISCUSSION 
Spontaneous mutation rates in A. baylyi ADP1 
We measured genome-wide spontaneous mutation rates in ADP1 by sequencing 
17 strains from a previous mutation accumulation (MA) experiment 19. Each of these 
clonal isolates represents the endpoint of a lineage that evolved for ~7,500 generations 
(cell doublings) over 300 days of passaging colonies on LB agar. The filtering effect of 
natural selection is greatly reduced in MA experiments because every lineage experiences 
a single-cell bottleneck when a random colony is selected each day for propagation. This 
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design enables genetic drift to dominate over selection and causes the rates at which 
mutations appear in MA lineages to be very close to the rates at which they 
spontaneously arise in a genome 120.  
We found a total of 66 mutations across all 17 clones, with zero to nine mutations 
in each individual clone (Fig. 2.1A). Despite this wide range, the distribution of mutation 
counts across these independent lineages was still compatible with no difference in the 
underlying genomic mutation rate that each experienced (P = 0.45, Kruskal-Wallis test). 
The overall estimated mutation rate for ADP1 is 0.52 mutations per genome per 1000 
generations (0.40–0.66, Poisson 95% confidence interval). 
A majority of the mutations observed in the MA lines were base substitutions (n = 
36). The estimated total base substitution mutation rate is 0.79×10–10 per base pair per 
generation (0.55–1.09×10–10, Poisson 95% confidence interval). This value is similar to 
that found in other γ-proteobacteria, including Escherichia coli 121, Vibrio species 122, and 
Pseudomonas aeruginosa 123, for which estimates from MA experiments range from 0.7 
to 2.1×10–10 substitutions per base pair per generation. Other mutational signatures in 
ADP1 were also similar to those observed in other bacterial species. Transitions were 
more common than transversions, and G:C→A:T base pair substitutions were the 
dominant type of point mutation (Fig. 2.1B). 
Of the 29 base substitutions in protein coding regions, 8 were synonymous. If 
these mutations were redistributed purely by chance in coding portions of the ADP1 
genome while preserving the observed number of each type of base pair substitution (e.g., 
20 G:C→ A:T mutations), then 13.8% to 37.9% of these mutations would be expected to 
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be synonymous (95% confidence interval). Thus, the observation of 27.6% synonymous 
mutations is compatible with greatly reduced selection for fitness during the experiment.  
Of the 66 total mutations, 7 were insertions of IS1236 elements at new locations 
in the genome and 10 were deletions with at least one end adjacent to an IS1236 element 
(Fig. 2.1A). These 17 IS-mediated mutations were spread throughout 12 of the 17 
sequenced clones, with a single event per genome except that one clone had five of these 
mutations and another had two. This proportion of IS-mediated mutations (17/66) was 
not significantly different from that observed for a set of largely beneficial mutations 
(30/75) found in a previous adaptive evolution experiment 19 (two-tailed Fisher’s exact 
test, p = 0.073), implying that, when considered together, IS element mediated mutations 
are not systematically much more or less beneficial than other types of mutations in A. 
baylyi. Four of the IS1236 mediated deletions were recombination events between the 
two IS elements flanking Tn5613 that eliminated its two cargo genes of unknown 
function. These deletions were also commonly observed in the adaptive evolution 
experiment 108. The remaining 13 non-point mutations included 6 indels of 50 or fewer 
base pairs, 5 larger deletions, and two larger duplications (Fig. 2.1A). 
ADP1-ISx strain construction 
To eliminate IS elements as a source of mutations that could inactivate engineered 
DNA constructs, we deleted all six of the IS1236 elements in the ADP1 genome in five 
sequential cycles of genome editing to create strain ADP1-ISx (Fig. 2.2A). To avoid the 
unwanted spread of new IS1236 copies into unknown regions of the genome during strain 
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construction, we used qPCR to verify that IS1236 copy number in the genome decreased 
after each deletion (Fig. 2.2B). 
Whole-genome sequencing of candidate ADP1-ISx strains revealed that they were 
free of IS1236 elements but had all accumulated two secondary mutations (Table S1). 
The altered genes were rpoD, which sustained an in-frame deletion of three base pairs in 
a (AAG)3 repeat, and cyoB, which acquired a nonsynonymous point mutation. RpoD is 
the ADP1 homolog of σ70, the major housekeeping sigma factor 124. CyoB is a subunit of 
the cytochrome bo terminal oxidase complex that is involved in respiration 125.  
The ADP1 genome editing procedure involves repeated transformations, growth 
of liquid cultures in LB, and growth of colonies on LB agar in the presence of kanamycin 
or azidothymidine 92. Secondary mutations can accumulate by chance if they happen 
alongside the desired edits whenever a single colony is picked during this procedure 
(much like in the MA experiment). Alternatively, given the important roles of rpoD and 
cyoB in aerobic growth, it is possible that one or both of these mutations might have been 
favored during some or all of these culture conditions. In particular, the cyoB mutation 
may have been beneficial in response to repeated kanamycin exposure 126.	  
Under normal laboratory conditions an ADP1-ISx candidate strain with these two 
mutations exhibited greatly compromised growth (Fig. 2.3). It had significantly longer 
lag times and doubling times in liquid cultures compared to wild-type ADP1 in both LB 
broth and MS defined medium (P < 10–6, for two-tailed tests on each parameter in both 
media as described in the Methods). For example, the doubling time of the ADP1-ISx-
rpoD-cyoB strain was 65 minutes in LB compared to 35 minutes for wild-type ADP1. 
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Therefore, we reasoned that it might be possible to repair one or both of these mutations 
by transforming PCR products containing the wild-type versions of these two genes to an 
ADP1 culture and then passaging these cells. After <30 generations of serial transfer and 
regrowth in LB we found that every large colony that we sequenced had reverted to wild-
type versions of both genes. Whole-genome sequencing verified that one of these 
colonies now had no mutations in its genome aside from the five planned deletions of 
IS1236 elements. Growth curves of this final ADP1-ISx strain (Fig. 2.3) showed that its 
doubling time during exponential growth was now indistinguishable from wild-type 
ADP1 in both LB and MS (P = 0.94 and P = 0.82, respectively). Interestingly, ADP1-ISx 
was able to grow to saturation more rapidly because it had a significantly shorter lag time 
than wild-type ADP1 in both LB and MS (P = 0.011 and P < 10–6, respectively). 
Reduced rate of inactivating mutations in ADP1-ISx 
We next used a forward mutation assay to determine if mutation rates were 
reduced in the engineered ADP1-ISx strain. Specifically, we measured the rates of loss-
of-function mutations in a tdk reporter gene when it was integrated at several different 
chromosomal locations in each strain background (Fig. 2.4A). Loss of function of this 
gene gives resistance to killing by azidothymidine (AZTR). We found ~21-fold (Site 1), 
~7-fold (Site 2) and ~13-fold (Site 3) reduced mutation rates in ADP1-ISx compared to 
wild-type ADP1 (Fig. 2.4A).  
Variation among the mutation rates measured at each of these three sites is 
consistent with greater stabilization of the ADP1-ISx chromosome at locations that are 
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nearer to active IS1236 elements in wild-type ADP1. The largest mutation rate reduction 
was found at Site 1, which is only 1.3 kb away from Tn5613. Site 3 is located 76.9 kb 
from the nearest IS element and has an intermediate level of reduction in mutation rates. 
Site 2, which exhibited the smallest mutation rate reduction, is also located very near an 
IS element, but it is the mutated IS1236φ copy. Therefore, this result provides further 
evidence that this element is inactive. Taking this into account, Site 2 is actually the 
furthest of the three sites from the nearest active IS element, which is 910.4 kb away.  
Overall, the rates of inactivating mutations in wild-type ADP1 at different sites in 
the chromosome varied by around 3-fold, and these mutation rates were highest at the 
two sites that were within 100 kb of active IS-elements. This range of variation is broadly 
consistent with previous studies that have looked at the proportion of inactivating 
mutations caused by insertions of IS1236 and Tn5613 at various genetic loci in ADP1 
103,105. However, all of the measurements comparing ADP1-ISx to wild-type ADP1 found 
much larger decreases in mutation rates than the ~1.3-fold expected from the overall 
contribution of IS elements to mutagenesis found in the MA experiment where they 
accounted for just 26% of all spontaneous mutations. Even considering that IS insertions 
are more likely to disrupt a gene than point mutations, inactivating mutations were much 
rarer than we expected in ADP1-ISx. 
Unchanged point mutation rate in ADP1-ISx 
In order to understand if lower rates of point mutations in ADP1-ISx contributed 
to the greater than expected improvement in its genetic stability compared to wild-type 
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ADP1, we next performed a reverse mutation assay (Fig. 2.4B). Specifically we inserted 
a spectinomycin resistance gene with a stop codon introduced near the beginning of its 
reading frame into the chromosome of each strain at Site 4 (Fig. 2.2A). Selecting for 
spectinomycin resistant mutants is expected to be specific for measuring the rates of base 
substitutions that restore gene expression by changing the stop codon to a sense codon. 
The mutation rate estimated for ADP1-ISx (3.8 × 10–9 per cell per generation) for this 
assay was slightly higher than that found for wild-type ADP1 (2.7 × 10–9 per cell per 
generation), but this difference in mutation rates was not statistically significant (P = 
0.054, likelihood ratio test) 118. Thus, point mutation rates appear to be unchanged or, if 
anything, slightly higher in ADP1-ISx. 
Altered mutational spectrum in ADP1-ISx 
Next, we compared the types of inactivating mutations that occurred in ADP1-ISx 
versus wild-type ADP1 (Fig. 2.4C). For each of the six test strains, we analyzed 24 
independent AZTR mutants isolated during the fluctuation assays by attempting to 
amplify a 767-bp PCR product containing the tdk gene from their genomes. Insertion of a 
new IS1236 copy within the tdk gene would increase the size of this PCR product to 
~2,000 bp. Point mutations and small insertions or deletions in the tdk gene would lead to 
no visible change in PCR product size. Larger deletions that removed a portion of the tdk 
gene and adjacent genome regions extending past the primer binding sites would lead to 
no amplification product. To corroborate these PCR results, we further tested for whether 
function of the KanR gene located adjacent to tdk in the reporter cassette was maintained 
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in each mutant. If a strain with no PCR product was also kanamycin sensitive, then it was 
further evidence that a larger deletion that overlapped both the tdk gene and the adjacent 
KanR marker gene had occurred. If, on the other hand, a strain with no PCR product 
remained kanamycin resistance, then we classified the mutation as an “ambiguous” 
diagnosis of the mutation. This situation could indicate that there was a deletion 
overlapping the tdk gene but not the KanR marker gene, or it could be the result of a PCR 
reaction that failed for some other reason. 
 As expected, we found no evidence of IS insertions in the ADP-ISx strains, 
though they were responsible for 12.5% to 29.2% of the mutations in wild-type ADP1 
depending on where the reporter gene was integrated into the chromosome. For Site 1 
and Site 2, a large fraction of the inactivating mutations in wild-type ADP1 resulted in no 
PCR band: 58.3% for Site 1 and 70.8% for Site 2. A majority of these mutants were also 
kanamycin sensitive (10/14 for Site 1 and 12/17 for Site 2), which is consistent with these 
mutants having large deletions that overlap both the tdk and KanR genes. The spectrum of 
mutations shifted markedly in ADP1-ISx. Only point mutations were found at Site 2 in 
ADP1-ISx and 87.5% of mutations at Site 1 were point mutations. Thus, deletion of IS 
elements from ADP1 resulted in a lower rate of IS insertions, as expected, but also fewer 
large deletions, which are apparently mediated by the action of IS elements. This result 
could potentially explain the greater-than-expected reduction in mutation rates in ADP1-
ISx. 
 Site 3 exhibited a different change in mutational signature. Here, there were fewer 
mutants with no PCR band in wild-type ADP1 (41.7%), and the proportion of these 
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mutants was similar in ADP1-ISx (54.2%). Again, these mutants were mostly kanamycin 
sensitive, 7/10 for wild-type ADP1 and 10/13 for ADP1-ISx. These results are consistent 
with large deletions occurring at this site via a mechanism that is not directly dependent 
on IS activity. We found a 14/15 bp match for a sequence within the aph (KanR) gene to a 
region 3,108 bp upstream of the tdk/KanR cassette insertion site that is a candidate for 
homology that might mediate a deletion hotspot here 127. However, it remains unclear 
why there is an overall decrease in the mutation rate at Site 3 without a commensurate 
shift in the mutational spectrum away from IS-related mutations. 
Increased transformability with reduced autolysis in ADP1-ISx 
As we constructed strains for testing mutation rates by transforming reporter 
cassettes, we noticed that this process appeared to be more efficient in ADP1-ISx. 
Directly testing for a change showed that ADP1-ISx exhibited significantly increased 
transformation frequencies for PCR products containing the KanR/tdk cassette (into Site 
2) or a SpecR gene (into Site 4) (Fig. 2.5A). ADP1-ISx was 7.6-fold and 3.3-fold more 
transformable than wild-type ADP1 in the Site 2 and Site 4 assays, respectively. 
We also observed a slight but significant increase in the final optical density (OD) 
of cultures of ADP1-ISx (Fig. 2.5B) in both LB and MS media (P = 0.00098 and P = 
0.0028, two-tailed Welch’s t-tests comparing ODs after 18 h in LB and MS, 
respectively). In further exploring this difference, we found that there were ~4 times as 
many colony-forming units (CFUs) in saturated LB cultures of ADP1-ISx as there were 
for wild-type ADP1 (Fig. 2.5B). Additionally, when these cultures were left unshaken on 
 31 
a bench, wild-type ADP1 settled to a pellet in the bottom while ADP1-ISx cells remained 
in suspension for days (Fig. 2.5C). We have seen differences in cellular aggregation in 
evolved ADP1 strains previously, though it was increased aggregation in this case 19. 
Taken together, these observations seemed to indicate that there were either more viable 
cells, less aggregation of those cells (leading to more CFUs per cell), or both in ADP1-
ISx cultures. 
 One possible explanation for the reduced viable cell counts and transformability 
of wild-type ADP1 compared to ADP1-ISx could be that deleting IS1236 elements 
decreases autolysis. Genomic DNA released from dead cells would be expected to 
compete with the exogenous DNA added in transformation assays for uptake into cells. In 
line with this hypothesis, we found that the concentrations of extracellular DNA that 
accumulated in cultures grown in MS medium were higher for wild-type ADP1 (154 
ng/mL) than they were in ADP1-ISx (63.2 ng/mL) at 24 h, and this difference became 
even more pronounced after 48 h (Fig. 2.5D). Live/dead staining found high amounts of 
autolysis in normal cultures of wild-type ADP1 grown in LB broth while ADP1-ISx 
cultures exhibited much less cell death (Fig. 2.5E). The same trend was found in MS 
medium, though the fraction of cells staining as dead was lower for both strains in these 
conditions: 6.4 ± 4.6% for wild-type ADP1 and 1.8 ± 1.4% for ADP-ISx (95% CI). Thus, 
reduced autolysis of ADP1-ISx may contribute to its improved transformability. 
It is also possible that the improved transformability of ADP1-ISx is due to other 
factors. For example, the activity of IS1236 elements could inhibit successful 
transformation after exogenous DNA is inside a cell. This effect could be direct, if the 
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IS1236 transposase interacts with or inactivates DNA structures that are intermediates 
involved in successful integration into the chromosome. Alternatively, IS1236 activity 
could indirectly modulate DNA repair pathways that are also required for transformation 
128, by drawing the necessary factors away to sites of transposition, for example. 
Increased aggregation of cells in a wild-type ADP1 culture compared to an ADP1-ISx 
culture related to the settling phenotype might also reduce transformability by restricting 
the surface area of ADP1 cells that is accessible to added DNA for uptake.  
Importantly, increased aggregation might complicate our measurements of 
transformation frequencies and mutation rates if one CFU contains multiple (and more) 
cells for wild-type ADP1 compared to ADP1-ISx. Only one cell in an aggregate needs to 
be transformed or mutated for it to form a colony on a selective plate, yet it is counted as 
a single CFU on a nonselective plate regardless of the number of cells in the aggregate. 
The consequence is that what are normally assumed to be “per-cell” transformation and 
mutation rates will be overestimated for a strain exhibiting more aggregation because 
they actually reflect “per-aggregate” rates. Essentially, there are multiple chances (one 
for each cell) for the aggregate as a whole to give a signal of transformation or mutation. 
Considering the potential effect of aggregation on our measurements, it is clear 
that it could not explain our finding that ADP1-ISx is more transformable than wild-type 
ADP1. The opposite relationship, with ADP1 appearing to be more transformable, would 
be expected if aggregation were the only factor. By contrast, an aggregation artifact could 
potentially explain why there was a larger decrease in the apparent per-cell inactivating 
mutation rates estimated for ADP1-ISx relative to wild-type ADP1 than was expected 
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from the overall contribution of IS1236 to mutagenesis (Fig. 2.4A), including the large 
decrease at Site 3 without much change in the mutational spectrum (Fig. 2.4C). However, 
we would also expect to find a commensurate difference in our measurements of point 
mutation rates between wild-type ADP1 and ADP1-IS, and we do not (Fig. 2.4B). 
Therefore, we conclude that any change in aggregation between wild-type ADP1 and 
ADP1-ISx does not explain the dominant trends we see in these measurements. 
Deleting error-prone polymerases does not further reduce the mutation rate 
Deletion of the three stress-induced error-prone polymerases Pol II, Pol IV, and 
Pol V, from IS-less E. coli strain MDS42 has been shown to reduce its inactivating 
mutation rate by approximately 50% 129. We investigated whether a similar improvement 
was possible in ADP1-ISx. ADP1 encodes homologs of two of these E. coli polymerases: 
Pol IV (dinP) and Pol V (umuDC). However, the polymerase function of the umuDC 
complex is no longer intact. ADP1 umuC is a pseudogene interrupted by a transposase 
fragment derived from an ISEhe3-like element 115. The size and regulation of the ADP1 
umuD gene differs from E. coli, and this distinct protein subfamily (designated umuDAb) 
acts as a regulator of the DNA damage response in Acinetobacter species 115,130,131.	  	  
We created ADP1-ISx strains with dinP and umuDAb deleted, singly and in 
combination. No significant difference in the rate of inactivating mutations in the tdk 
gene integrated into the chromosome at Site 2 was found among these three deletion 
strains (Fig. 6). To test whether there was a difference in mutagenesis under conditions in 
which error prone polymerases expression might be induced to a higher level, we 
repeated this assay in the presence of subinhibitory concentrations of nalidixic acid. 
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Nalidixic acid causes double-strand breaks and thereby induces the expression of error-
prone polymerases via the SOS response in E. coli and other bacteria 132. We found that 
nalidixic acid increased the rate of mutations in the ΔumuDAb mutant and ADP1-ISx to 
the same extent. Thus, deleting dinP and umuDAb appears to have no further benefit with 
respect to further reducing the mutation rate of ADP1-ISx. 
Comparison to other clean-genome bacterial strains 
Several other studies have deleted selfish DNA elements and nonessential genes 
from bacterial genomes to enhance their biotechnology performance characteristics 62–
64,67,69,85,133–135. One comprehensive effort has been the development of the streamlined 
Escherichia coli strain MDS42 133. MDS42 was derived from E. coli K12 by deleting all 
active IS elements, all prophage remnants, and many nonessential genes from its 
chromosome. The rates of mutations inactivating a chromosomal reporter gene are lower 
in MDS42 than its progenitor strain 133, and these mutation rates were further reduced in 
subsequent work by deleting all three error-prone polymerases from its genome 129. 
Genetic stability is improved in MDS42 to the point that plasmids encoding highly toxic 
proteins that are rapidly inactivated in wild-type E. coli can be propagated in this strain 
58. MDS42 also exhibited an unanticipated increase in electroporation efficiency. The 
exact reason for this improvement is unknown, as many genes were deleted in this strain, 
but it is thought to result from the deletion of fimbriae that might obscure access of DNA 
to the cell surface.  
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 Pseudomonas putida EM383, a streamlined chassis strain derived from KT2440, 
also showed enhanced properties after the deletion of flagellar genes, four prophages, and 
both of its active transposons (Tn7 and Tn4652) 64. EM383 exhibits increased retention of 
functional plasmids during prolonged culture and has improved growth characteristics. 
Similarly, deleting either of two families of active IS elements from the Corynebacterium 
glutamicum ATCC 13032 genome improved its properties 134. The resulting WJ004 (with 
all four ISCg1 elements deleted) and WJ008 (with all four ISCg2 elements deleted) 
strains exhibited up to 6-fold increased electroporation efficiency and greater 
recombinant protein yields, while maintaining the same growth rates as the parental 
strain. Reduced-genome strains of Bacillus subtilis 168 can exhibit improved cell yield 
and enzyme or chemical production 62. In this species, there is typically a gradual 
decrease in transformability as large regions of the chromosome are deleted 62,136. 
However, this loss can be compensated for and transformation can even be improved 
over wild-type levels by overexpressing competence regulators 137. Overall, our results 
with ADP1-ISx are broadly similar to studies of other clean-genome bacterial strains. We 
have explicitly shown that fewer inactivating mutations occur in ADP1-ISx, and it 
exhibits an unanticipated improvement in the efficiency of natural transformation. 
CONCLUSIONS 
Directed evolution is a powerful tool for creating novel biomolecules that do not 
exist in nature and for optimizing complex cellular systems. But, when inadvertent and 
unchecked, unplanned evolution can impede progress in bioengineering by introducing 
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mutations that lead to unpredictable failures of DNA-encoded functions. Our work 
constructing ADP1-ISx further highlights the effectiveness of a rational genome 
‘cleanup’ strategy to improve a cellular chassis and the collateral benefits that often 
accompany domesticating an organism in this way. In microbial species that harbor a 
manageable number of IS elements, deleting these agents of instability may often be the 
simplest fail-safe approach for a high payoff in terms of improving genome stability and 
cell productivity. Acinetobacter baylyi ADP1-ISx is an improved chassis for synthetic 
biology and genetic studies that wish to take advantage of its natural transformability.   
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SUPPLEMENTARY INFORMATION 
Details of the mutations in ADP1-ISx-rpoD-cyoB, ADP1-ISx, and the 17 sequenced 
clones from the MA experiment are provided in Table S1 (Appl. Env. Microbiol. 83: 






















Figure 2.1. Mutations observed in Acinetobacter bayli ADP1 by whole-genome 
sequencing of 17 strains that each evolved separately for 7,500 generations under 
relaxed selection in the mutation accumulation (MA) experiment.  
 
(A) Mutations observed in each clone from the MA experiment divided into major 
categories. Overall, 26% of mutations were directly related to IS1236 element activity. 
The precise location and nature of each mutation is reported in Table S1. (B) Summed 



























Figure 2.2.  Construction of Acinetobacter bayli ADP1-ISx.  
(A) Five unmarked genomic deletions were made to remove all six IS1236 elements 
designated #1-6 found in wild-type ADP1 chromosome (shown in red) to create the 
ADP1-ISx strain. Sites 1-4 (shown in blue) were used for transformation and mutation 
assays. IS1236 elements #2 and #3 form a composite transposon (Tn5613), and element 
#6 is inactive (IS1236φ). (B) Example of qPCR data used to monitor IS element deletion 
steps. The six IS copies per genome found in wild-type ADP1 register above a given 
fluorescence threshold (ΔRn value) during early PCR cycles when amplifying a 119-bp 
fragment located within the IS1236 transposase gene. The sequential removal of IS 
elements in the deletion stains progressively increases the number of cycles necessary to 
reach this threshold from the same input quantity of genomic DNA. One example of a 
rejected candidate strain that accumulated a new IS element insertion elsewhere in the 





Figure 2.3. Repair of unintended cyoB and rpoD mutations sustained during ADP1-
ISx strain construction.  
Growth curves in LB broth (A) and MS defined medium (B) for wild-type ADP1, ADP1-
ISx with the cyoB and rpoD mutations, and ADP1-ISx with these genes repaired to the 
wild-type sequence (as verified by whole-genome sequencing) were recorded by 


























Figure 2.4. Reduced rates of inactivating mutations in ADP1-ISx.  
(A) Rates of mutations leading to loss of function of a counterselectable marker gene 
(tdk) were determined using fluctuation tests that selected for resistance to 
azidothymidine (AZTR). Error bars are 95% confidence intervals. The marker was placed 
at three different sites in the A. baylyi genome that differed in how near they were to 
IS1236 elements in the wild-type ADP1 genome (see Fig. 2A). (B) Mutation rates were 
measured for reversion of a stop codon in the leader region of an antibiotic marker gene 
that restored spectinomycin resistance (SpecR). This assay is expected to primarily reflect 
the point mutation rate. Error bars are 95% confidence intervals. (C) Spectrum of 
inactivating mutations determined by using PCR to amplify a fragment containing the tdk 
gene from the genome of one AZTR resistant mutant from each of the 24 biological 
replicates of the fluctuation tests in part A. IS1236 mutations and point mutations were 
inferred from an expected side change or no size change in this fragment, respectively. 
When no PCR product resulted and the function of the adjacent aph marker gene that was 
inserted alongside the tdk gene was also lost (yielding a KanS versus KanR phenotype), 
then the inactivating mutation was inferred to be a large deletion. If there was no PCR 
product and mutant remained KanR, then it was likely a large deletion that overlapped the 
tdk gene but not the aph gene. However, since the PCR reaction could have failed to 
amplify a band for other reasons, we conservatively classified this as an “ambiguous” 
result. This logic for classifying mutations is illustrated in the inset below the legend and 
further explained in the text (see Altered mutational spectrum in ADP1-ISx). As expected, 
no IS1236 insertions were found in ADP1-ISx. The proportion of large deletions among 




























Figure 2.5. ADP1-ISx exhibits increased transformability and reduced autolysis.  
(A) Transformation frequencies measured as transformants per colony-forming unit 
(CFU) under normal growth conditions in LB for PCR products containing the tdk-KanR 
cassette (into Site 2) or a spectinomycin resistance marker (into Site 4). (B) CFUs 
measured by plating dilutions of cultures on LB-agar after saturating growth. (C) 
Reduced settling behavior of ADP1-ISx compared to ADP1 in saturated cultures left at 
room temperature for 48 h after growth. (D) Accumulation of extracellular DNA over 
time in the supernatant of MS cultures grown under standard conditions. (E) Fraction of 




Figure 2.6. Inactivating mutation rates are unchanged in ADP1-ISx after deletion of 
error prone polymerase DinP and DNA damage response regulator UmuDAb.  
The effects of deleting each gene on the rates of mutations inactivating the tdk 
counterselectable marker gene inserted into the genome at Site 2 were measured for each 
strain. Mutation rates in ADP1-ISx and the umuDAb deletion strain were also determined 
in the presence of a subinhibitory concentration of nalidixic acid, which induces double-
















tdk/KanR amplification for deletion 





tdk/KanR amplification for deletion 





Used with P1-F to amplify just the  
tdk gene from the tdk/KanR cassette 
ACATCAGAGATTTTGAGACACAACGTG 
 
Deletion of IS1236 elements to create ISx-ADP1 
IS#1-P3-F 
 
Amplify 5′ flank for IS1236 #1 





Amplify 5′ flank with IS#1-P3-F 






Amplify 3′ flank with IS#1-P6-R 





Amplify 3′ flank for IS1236 #1 




Amplify 5′ flank with IS#1-P3-F for 





Amplify 3′ flank with IS#1-P6-R 





Amplify 5′ flank for Tn5613 deletion 




Amplify 5′ flank with IS#23-P3-F 





Amplify 3′ flank with IS#23-P6-R 





Amplify 3′ flank for Tn5613 deletion 




Amplify 5′ flank with IS#23-P3-F for 





Amplify 3′ flank with IS#23-P6-R 





Amplify 5′ flank for IS1236 #4 




Amplify 5′ flank with IS#4-P3-F 





Amplify 3′ flank with IS#4-P6-R 





Amplify 3′ flank for IS1236 #4 




Amplify 5′ flank with IS#4-P3-F for 





Amplify 3′ flank with IS#4-P6-R 





Amplify 5′ flank for IS1236 #5 
deletion and rescue cassettes 
GAATTTAAAGTTAAAGATATTTTTGCG 
Table 2.1. Primers used in this study 
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Primer Description Sequence 
IS#5-P1′P4-R 
 
Amplify 5′ flank with IS#5-P3-F 





Amplify 3′ flank with IS#5-P6-R 





Amplify 3′ flank for IS1236 #5 




Amplify 5′ flank with IS#5-P3-F for 





Amplify 3′ flank with IS#5-P6-R 





Amplify 5′ flank for IS1236 #6 




Amplify 5′ flank with IS#6-P3-F 





Amplify 3′ flank with IS#6-P6-R 





Amplify 3′ flank for IS1236 #6 




Amplify 5′ flank with IS#6-P3-F for 





Amplify 3′ flank with IS#6-P6-R 
for IS1236 #6 deletion cassette 
GGATGATACTTTCGACTAACTGAGTAG 
GTTCAAGTGGGGTTTACTGG 
qPCR to monitor IS1236 deletion 
qIS-F Amplify 119-bp fragment common to 
all IS1236 elements with qIS-R 
GTTTTCGCCAGGCATAATA 
qIS-R Amplify 119-bp fragment common to 
all IS1236 elements with qIS-F 
CAGATCATGCCAAGAAAAGTAC 
Repair of rpoD and cyoB mutations 
rpoD-F Amplify fragment containing rpoD 
mutation with rpoD-R 
GCCTTCAAACAATTCACTTAACC 
rpoD-R Amplify fragment containing rpoD 
mutation with rpoD-F 
GCAATCGAAATAACGAGACG 
rpoD-S Sequence mutation in rpoD gene GCTGAGGTTAACGATCATCT 
cyoB-F Amplify fragment containing cyoB 
mutation with cyoB-R 
GGTACGCTTTTATCTGGTGTAA 
cyoB-R Amplify fragment containing cyoB 
mutation with cyoB-F 
CAGCAGAATTATGATCATGACTC 
cyoB-S Sequence mutation in cyoB gene GACACGTCGTTTGAATACAT 
Integration of tdk/KanR cassette for measuring inactivating mutation rates and transformation 
frequency 




Site1-P1′P4-R Amplify 5′ flank with Site1-P3-F 
for integration of tdk/KanR cassette 
TGATTTGAATTGGAGGCTGGGATCTAA 
ACCTTGTGATATCAACTGTT 
Site1-P2′P5-F Amplify 3′ flank with Site1-P6-R 




Table 2.1. Primers used in this study (continued) 
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Primer Description Sequence 
Site1-P6-R Amplify 3′ flank for integration of 
tdk/KanR cassette 
TACTTCAGATTCTGGGAATTTCT 
Site2-P3-F Amplify 5′ flank for integration of 
tdk/KanR cassette 
CAAATCCATTGAAAAGAAATGC 
Site2-P1′P4-R Amplify 5′ flank with Site2-P3-F 
for integration of tdk/KanR cassette 
TGATTTGAATTGGAGGCTGGGCTGATC 
ATCATGGACAAGCT 
Site2-P2′P5-F Amplify 3′ flank with Site2-P6-R 
for integration of tdk/KanR cassette 
TTCTAAGCATGCGGAGCTGGTGTGATC 
TTTTTTTCAAATTCATT 
Site2-P6-R Amplify 3′ flank for integration of 
tdk/KanR cassette 
GGTAATGTTCTCTCCTACGAAAAG 
Site3-P3-F Amplify 5′ flank for integration of 
tdk/KanR cassette 
CCTGATCCAGAAAGATATATGACTT 
Site3-P1′P4-R Amplify 5′ flank with Site3-P3-F 
for integration of tdk/KanR cassette 
TGATTTGAATTGGAGGCTGGGTGAAAA 
GTTATCAAATATTGACGTATG 
Site3-P2′P5-F Amplify 3′ flank with Site3-P6-R 
for integration of tdk/KanR cassette 
TTCTAAGCATGCGGAGCTGGTAAAGTG 
ATCGAGCAGCCA 




Integration of SpecR genes in Region 1 for measuring point mutation rates and transformation 
frequency 
R1-P3-F Amplify R1 5′ flank for integration of 
tdk/KanR cassette 
ACGCCGAGTCCTCTTGAGTACAGG 
R1-P1′P4-R Amplify R1 5′ flank with Site1-P3-F 
for integration of tdk/KanR cassette 
TGATTTGAATTGGAGGCTGGGGATTTT 
CCGCCCATCTCAC 
R1-P2′P5-F Amplify R1 3′ flank with Site1-P6-R 
for integration of tdk/KanR cassette 
TTCTAAGCATGCGGAGCTGGCAGAAAT 
TATAAAACGCACATCA 
R1-P6-R Amplify R1 3′ flank for integration of 
tdk/KanR cassette 
ACTCGCTGCAATAGTGGCAAAAGC 




SpecR-R Amplify SpecR gene to construct 
rescue cassette 
TTATTTGCCGACTACCTTGGTGATC 
SpecR-E8*-R Amplify 5′ end of SpecR gene with 
SpecR-F to introduce stop codon 
CTGATAGTTGAGTCGATACTTAGGCGA 
SpecR-E8*-F Amplify 3′ end of SpecR gene with 
SpecR-R to introduce stop codon 
GCCTAAGTATCGACTCAACTATCAGAG 
GTA 
specR-R1-R Amplify R1 5′ flank with R1-P3-F 
to create overlap with SpecR gene 
ATGAGCGGATACATATTTGAAGATTTT 
CCGCCCATCTCAC 
specR-R1-F Amplify R1 3′ flank with R1-P6-R 
to create overlap with SpecR gene 
ACCAAGGTAGTCGGCAAATAATCTTTA 
CGAGTCATGCCAGCAC 
Deletion of dinP and umuDAb 
dinP-P3-F Amplify 5′ flank for dinP deletion and 
rescue cassettes 
CAAAGCGATAATGTAGAAAAAAC 
dinP-P1′P4-R Amplify 5′ flank with dinP-P3-F 




Table 2.1. Primers used in this study (continued) 
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Primer Description Sequence 
dinP-P2′P5-F Amplify 3′ flank with dinP-P6-R 
for dinP deletion cassette 
TTCTAAGCATGCGGAGCTGGTCATTTT 
ACTGTATTTGTGATTT 
dinP-P6-R Amplify 3′ flank for IS1236 #1 
deletion and rescue cassettes 
ATGCTCTCGATGAGTATTGG 
dinP-P5′P4-R Amplify 5′ flank with dinP-P3-F for 
dinP deletion cassette 
CTCAAATCACAAATACAGTAAAATGA 
TCGTATTTTTTTTACACAAAAATTTAA 
dinP-P4′P5-F Amplify 3′ flank with dinP-P6-R 
for dinP deletion cassette 
TTAAATTTTTGTGTAAAAAAAATACG 
ATCATTTTACTGTATTTGTGATTTGAG 
umuD-P3-F Amplify 5′ flank for umuD deletion 
and rescue cassettes 
TTGGCTCCACTACTCACAGA 
umuD-P1′P4-R Amplify 5′ flank with umuD-P3-F 
for umuD deletion cassette 
TGATTTGAATTGGAGGCTGGGTCATG 
AGTCAGAGAATCTTTGC 
umuD-P2′P5-F Amplify 3′ flank with umuD-P6-R 
for umuD deletion cassette 
TTCTAAGCATGCGGAGCTGGAATGTT 
TTCTCAAGTTAAAATAATCTAA 
umuD-P6-R Amplify 3′ flank for umuD deletion 
and rescue cassettes 
ATCTATACTAGTAGATTATACGGACGA 
TG 
umuD-P5′P4-R Amplify 5′ flank with umuD-P3-F for 
umuD deletion cassette 
TTAGATTATTTTAACTTGAGAAAACAT 
TTCATGAGTCAGAGAATCTTTGC 
umuD-P4′P5-F Amplify 3′ flank with umuD-P6-R 


















Chapter 3: Rapid and assured genetic engineering methods applied to 
Acinetobacter baylyi ADP1 genome streamlining 
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Precision engineering of bacterial genomes requires assembling DNA modules and 
integrating them at defined chromosomal sites without introducing off-target mutations. 
One goal of synthetic biology is to improve the efficiency and predictability of living 
cells by removing extraneous genes from their genomes. Here, we demonstrate improved 
methods for engineering the genome of the metabolically versatile and naturally 
transformable bacterium Acinetobacter baylyi ADP1. In Golden Transformation, linear 
DNA fragments constructed by Golden Gate Assembly are directly added to cells to 
create targeted deletions, edits, or additions to the chromosome. We tested the 
dispensability of 55 large regions of the ADP1 chromosome using Golden 
Transformation. The 19 successful multiple-gene-deletions ranged in size from 21 to 118 
kilobases and collectively accounted for 24.6% of its genome. Deletion success could not 
be predicted on the basis of essentiality predictions from a single-gene knockout 
collection or a Tn-seq experiment we conducted in rich media. We further show that the 
native CRISPR/Cas locus is active in ADP1 and that it can be retargeted using Golden 
Transformation. We reprogrammed it to demonstrate that a self-targeting CRISPR-lock 
can be used to validate that genes have been successfully removed from the chromosome 
and to prevent them from being reacquired. These methods can be used together to 
implement combinatorial routes to further genome streamlining and for more rapid and 




Biological engineering faces unique challenges that must be addressed before it will be as 
rapid, reliable, and robust as traditional engineering disciplines 45,138. On one front, 
simpler and more flexible genetic engineering tools can facilitate re-writing the genome 
sequences of living cells to speed up the design-build-test cycle. Another major challenge 
is the complexity inherent in using living cells as a starting point. Even ‘simple’ 
microbial cells maintain thousands of distinct components, from small molecules to 
proteins, but only a smaller subset of these are absolutely required for cellular replication. 
In fact, many of these functions are unnecessary or even undesirable in controlled 
laboratory and industrial settings that are not as varied as the natural challenges that 
shaped the evolution of these cells. Therefore, a major aim of the field of synthetic 
biology has been to re-factor and re-engineer genomes to create ‘chassis’ organisms with 
reduced complexity 139,140. The main approaches to genome simplification fall into two 
categories: a bottom-up approach in which DNA pieces are assembled into a minimal 
genome that is tested to see if it can successfully ‘boot up’ self-replication in a host cell 
and a top-down approach in which chromosomal regions found to be dispensable are 
removed in a step-wise fashion to create a streamlined genome. These efforts have led to 
more efficient and reliable microbial cell factories and blurred the line between chemical 
and living systems 141–144. 
 Bacterial genome streamlining efforts often begin by deleting regions of a 
chromosome that encode selfish or parasitic sequences that are obviously unnecessary 
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and may even be hazardous to a cell. Deleting transposons and prophage sequences 
reduces mutation rates and improves the fitness of cells 52,68,124,137,138. It is also relatively 
straightforward to recognize and then delete gene clusters encoding resource- or energy-
intensive functions that cells perform to survive in the wild but are not needed in 
laboratory or industrial cultures. For example, bacterial growth and productivity has been 
improved by deleting motility systems, such as flagella 148, and large genomic islands 
encoding pathways for synthesizing secondary metabolites 67,149.  
 For more extreme genome reduction, information about the conservation of genes 
within a bacterial species and what single-gene knockouts are viable can be integrated to 
predict additional genome regions to target for deletion 54,55,68. Computational tools are 
emerging that further integrate gene essentiality predictions with whole-cell metabolic 
and gene expression models to predict the viability of strains that combine multiple 
deletions 88. Still, viable routes to extreme genome reduction remain difficult to predict 
because there can be interactions between genes that make some combinations of 
deletions inviable (e.g., synthetic lethality). Even when multiple large chromosomal 
regions can be removed, significant growth defects often result from accumulating losses 
of ‘quasi-essential’ genes, defined as genes that are not needed for survival but are 
required for robust growth 79–84. Given how difficult it is to predict how gene essentiality 
and quasi-essentiality generalizes across environments 150, it is often necessary to 
empirically test the viability and performance of many different deletions and 
combinations of those deletions to create a useful minimal genome organism. 
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Acinetobacter baylyi ADP1 is a non-pathogenic soil bacterium that is notable for its 
naturally transformability under normal laboratory growth conditions 1,2. ADP1 has been 
used in fundamental studies of DNA uptake and mechanisms of bacterial genome 
evolution 16,151,152. Multiple studies have also highlighted its useful innate metabolic 
abilities, particularly related to degradation of aromatic compounds 153–157 and production 
of triacylglycerols and wax esters 30,158. ADP1’s natural transformability has been 
exploited for targeted mutagenesis and disruption of genes in its chromosome for 
metabolic engineering of these pathways 38,159, as well as to add novel genes to its 
genome and evolve them to improve these functions 30,158,160. The natural transformability 
of ADP1 makes it an especially tractable system for testing genome streamlining 
approaches and their impact on engineered functions. 
 We previously began the process of streamlining the genome of A. baylyi ADP1 by 
creating a transposon-free strain that exhibited lower mutation rates, enhanced 
transformation, and reduced autolysis 146. Here, we generated a new Tn-Seq dataset 
defining gene essentiality in rich medium and used this information to design 55 
multiple-gene-deletions covering 58.3% of its chromosome. To facilitate engineering 
these large deletions, we developed a “Golden Transformation” genome engineering 
procedure that uses Golden Gate Assembly to construct the necessary DNA modules for 
transformation 161,162. Nineteen of these large deletions, together comprising 24.6% of the 
ADP1 genome, were viable. Golden Transformation can also be used to facilitate other 
genome engineering tasks such as constructing and inserting gene expression modules 
into the chromosome sequence modules. Finally, we demonstrate that the native 
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CRISPR/Cas locus in A. baylyi ADP1 is active and show that it can be reprogrammed to 
block reacquisition of deleted genomic regions. Overall, our work demonstrates how the 
native genetic capabilities of Acinetobacter baylyi ADP1 make it an especially tractable 
system for testing combinatorial routes to more extreme genome streamlining and 
engineering. 
 
MATERIALS AND METHODS 
Culture conditions 
Acinetobacter baylyi ADP1 23 and ADP1-ISx 59 were grown at 30°C in LB-Miller 
(10 g NaCl, 10 g tryptone, 5 g yeast extract per liter). Liquid cultures were incubated in 
8×150mm test tubes with orbital shaking at 200 r.p.m. over a 1-inch diameter. Solid 
media contained 1.6% agar (w/v). Media were supplemented with 50 µg/mL kanamycin 
(Kan), 60 µg/mL spectinomycin (Spec), 20 µg/mL gentamycin (Gent), 200 µg/mL 3-
azido-2′,3′-dideoxythymidine (AZT), and 0.3 mM diaminopimelic acid  (DAP), as 
indicated. 
Golden Gate assembly 
DNA fragments for transformation were constructed using Golden Gate 
Assembly (GGA) reactions containing 1 U/µl BsaI-HF or 0.5 U/µl BsmBI and 150 U/µl 
of either T7 or T4 DNA ligase in T4 DNA ligase buffer (New England Biolabs) 163,164. 
The standard ~5-hour protocol was 31 cycles, each consisting of 37°C at 5 min and 16°C 
at 5 min, followed by one-time final incubations at 55°C for 5 min and 80°C for 5 min.  
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For the short ~1-hour protocol, the 37°C and 16°C steps were reduced to 1 min apiece. 
The pBTK622 part plasmid was constructed by adding the tdk-kanR cassette 10 to the 
pYTK001 entry vector as described elsewhere 164. Plasmid samples input into GGA 
reactions were isolated from E. coli cultures using PureLink Quick Plasmid Miniprep Kit 
(ThermoFisher). Input PCR products were purified using the GeneJet PCR purification 
kit (ThermoFisher). Concentrations of all DNA parts were determined using the Qubit 
dsDNA BR Assay Kit (Invitrogen).  
ADP1-ISx transformation 
ADP1-ISx glycerol stocks were streaked out on LB agar and incubated overnight. 
For each transformation assay replicate, a different colony was picked and inoculated 
onto LB and grown overnight to produce a culture ready for transformation. 
Transformations in liquid culture were initiated by mixing input DNA, 250 µL LB, and 
17.5 µL of the overnight ADP1-ISx culture. Puddle transformations were initiated by 
mixing input DNA with 50 µL of the overnight ADP1-ISx culture and transferring the 
complete volume onto a 13 mm diameter, 0.025 µm pore size mixed cellulose esters 
membrane (Millipore #VSWP01300) that was then placed on the surface of an LB agar 
plate. In both cases, transformations were incubated for 24 h under normal A. baylyi 
growth conditions. Then, dilutions in sterile saline were plated on LB and LB-Kan agar to 
estimate transformation frequencies or on LB-Kan or LB-AZT agar for genome 
modification steps.  
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Transformation frequency assays 
Overlap extension PCR (OE-PCR) transformations used 0.01 pmol of a 3,875-bp 
DNA product constructed by joining the tdk-kanR cassette to 1.2 kb of 5' homology and 
1.0 kb of 3'-homology to “Site 2” in the ADP1 genome as previously described 59. GGA 
DNA transformations used 10 µL assembly reactions that included 0.01 pmol of each 
DNA part: the pBTK622 plasmid and PCR amplicons that added the necessary restriction 
sites to the same two flanking genomic homology regions. Multiple GGA reactions were 
pooled and re-divided when testing the same DNA construct in multiple replicates and 
across conditions. Primer sequences for creating the PCR products used in each type of 
assembly are provided in Table 3.1.   
Transformation frequencies were determined by comparing colony-forming units 
(CFUs) on LB-Kan agar to CFUs on LB agar with 3-4 replicates for each condition. 
Puddle transformations were resuspended by carefully transferring the filter with sterile 
tweezers into 10 mL of saline and vortexing to release cells before plating dilutions. 
Negative controls without DNA yielded no colonies on LB-Kan agar. Transformation 
frequencies and confidence intervals were estimates from CFU values using Poisson 
regression models in R 165. 
Tn-Seq 
The transposon mutagenized library of A. baylyi ADP1 was constructed through 
conjugation of the mini-transposon suicide vector pBT20 166. For the conjugation, 
overnight cultures of E. coli β2163 167 carrying pBT20 and ADP1 were pelleted via 
centrifugation and resuspended together at a 3:1 ratio in 100 µL of sterile saline. This 
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mixture was then spotted onto the same type of membrane used in puddle transformations 
and placed on an LB-DAP plate. After ~24 hours at 30°C, the filter was transferred to a 
1.7 mL Eppendorf tube with 1 mL of sterile saline. After vortexing to resuspend cells, 
800 µL of this mixture was used to inoculate 50 mL of LB-Gent. After overnight growth, 
1.2 mL aliquots of this culture were stored at −80°C as glycerol stocks.  
For sequencing library preparation, genomic DNA was extracted from the frozen 
aliquots using a Purelink Genomic DNA Mini Kit (ThermoFisher) and sheared on a 
Covaris S220 to an average size of 300 bp. Poly-C tails were added to the fragmented 
DNA using terminal deoxynucleotidyl transferase (Promega). Then, the processed 
fragments were size-selected using AMPure XP beads (Beckman Coulter) and amplified 
by PCR with a biotinylated primer binding inside of the transposon and a non-
biotinylated primer binding to the poly-C tail. The amplified library fragments were then 
bound to streptatividin M-280 Dynabeads (ThermoFisher) and washed to remove 
unbound DNA.  Illumina barcodes and adaptors were added in a subsequent PCR 
reaction in which internal barcodes were introduced to allow multiple libraries to be run 
with the same external Illumina barcode. The libraries were pooled in equal ratios, 
analyzed on a BioAnalyzer 2100 (Agilent) for fragment distribution, and sequenced on an 
Illumina HiSeq 4000 at the University of Texas at Austin Genome Analysis and 
Sequencing Facility (GSAF). Tn-Seq FASTQ files are available from the NCBI Sequence 
Read Archive (PRJNA559727). 
Tn-seq reads were analyzed as previously described 168. Briefly, reads containing 
transposon sequences were quality filtered, trimmed of adapter sequences, and then 
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mapped to the A. baylyi ADP1 genome (GenBank: NC_005966.1) 23. To identify 
essential genes, we compared the observed number of insertion mutants in each gene to 
simulated null distributions based on the total number of possible insertion sites. Genes 
designated as “essential” were significantly depleted for transposon mutants when 
compared to the simulated null distributions using DESeq2 169. Scripts for performing 
this analysis are freely available online (https://github.com/spleonard1/Tn-seq). The 
functional categories of genes in the A. baylyi ADP1 genome were predicted using 
eggNOG-mapper (version 4.5.1) 170. The full output of the Tn-Seq analysis with COG 
assignments for each gene is shown in Table S1. 
Multiple-gene-deletion Strain Construction 
Large deletion variants of ADP1-ISx were generated by transforming GGA 
reactions, with the exception of MGD7 and MGD11, which were generated by 
transforming OE-PCR reactions. GGA reactions and transformations were performed as 
described above except we used 40 µL GGA reactions containing 500 ng of pBTK622 
and 600 ng of each of the ~2-kb flanking genomic homology fragments generated by 
PCR. When standard transformations of a GGA reaction for a deletion yielded no 
colonies or very few colonies on LB-Kan agar, we attempted puddle transformation of a 
new GGA reaction.   
Genome Sequencing 
Genomic DNA isolated from candidate large-scale deletion strains was prepared 
for sequencing as described previously 171. Briefly, genomic DNA was extracted from 
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overnight cultures, then fragmented, end-repaired, A-tailed, ligated to adapters, and size-
selected for library preparation. The resulting DNA libraries were sequenced to >100× 
coverage on an Illumina HiSeq 2500 platform at the UT Austin GSAF. Read files were 
analyzed with breseq (version 0.28.0) 172,173 to predict mutations, large deletions and 
other types of structural variation, relative to the A. baylyi ADP1 genome. FASTQ files 
from genome sequencing are available from the NCBI Sequence Read Archive 
(PRJNA559727). 
Growth rates 
The growth rates of ‘unrescued’ multiple-gene-deletion strains that still contained 
the tdk-kanR cassette in their genomes were compared to growth rates of ADP1-ISx. For 
each strain being tested, 2 µL of a glycerol stock was inoculated into 200 µL of LB in a 
96-well clear flat-bottom microplate (Costar). This microplate was incubated overnight at 
30°C with 250 r.p.m. orbital shaking over a diameter of 1-inch. Subsequently, 2 µL of the 
preconditioned well for each strain was used to inoculate 200 µL of fresh LB in each of 
three replicate wells in a new microplate. The optical density at 600 nm (OD600) was 
recorded every 10 minutes following a brief shaking step (15 seconds with a 6 mm 
amplitude) as these cultures were incubated at 30°C in an Infinite M200 Pro microplate 
reader (Tecan).   
OD600 values were corrected by subtracting measurements of blank wells and 
then further normalized by offsetting all measurements in each well such that the first 
three points had the same average as the grand mean of these points across all inoculated 
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wells on the entire plate. Growth rates were determined from nonlinear least squares fits 
to an exponential growth equation with lag and doubling time parameters in R 165. The 
maximum specific growth rate fit from any set of 7 consecutive points (spanning 1 h of 
measurements) that all had OD600 values between 0.01 and 0.15 was determined for 
each well. 
CRISPR assays 
The ‘CRISPR-ready’ variant of ADP1-ISx was created by replacing all but one of 
the 91 spacers of its native CRISPR array with the tdk-kanR cassette using BsaI Golden 
Transformation and selection on LB-Kan. CRISPR reprogramming was accomplished by 
transforming the CRISPR-ready strain with a rescue cassette encoding a new spacer 
sequence. To assemble each spacer cassette, two complementary oligonucleotides were 
synthesized and annealed to create a double-stranded insert flanked by restriction sites. 
The spacer was then added to the genome via BsmBI Golden Transformation using the 
same two homology flanks used in the replacement step and selection on LB-AZT agar. 
Proper insertion of each spacer into the ADP1-ISx genome was verified by PCR and 
Sanger sequencing. Transformation assays for acquisition of spectinomycin resistance 
were conducted as described above but using 100 ng of donor DNA from an ADP1 strain 
constructed by replacing bases 139832–140099 of the genome (GenBank: 
NC_005966.1), which overlap the nonessential gene ACIAD0135, by transforming an 
OE-PCR product containing the specR cassette from pIM1463 and flanking homology 
117. 
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In the CRISPR-Lock experiment, CRISPR-ready variants of the MGD2 and 
MGD18 deletion strains, a previously generated ISx-ΔdinP knockout 59, and an ADP1-
ISx strain with a suspected genome rearrangement were constructed as described above. 
Self-targeting spacer cassettes were created by BsmBI GGA as described above. AZT-
resistant colonies were further characterized for mutations in the tdk-kanR cassette versus 
spacer acquisition by patching to determine if they remained Kan resistant and by PCR 
and Sanger sequencing, if necessary. Oligonucleotides used to conduct these experiments 
are provided in Table 3.1. 
RESULTS 
Golden Transformation 
A. baylyi ADP1 is highly competent for DNA uptake during normal growth. 
Transformation frequencies of >10–2 per cell can be achieved for genomic DNA from a 
donor ADP1 strain with a genetic marker embedded in its chromosome 2, but 
transformation is less efficient for shorter DNA fragments. Successful integration of a 
foreign DNA sequence into the genome, which occurs most readily via RecA-mediated 
recombination, is generally the limiting step for transformation 174. Therefore, robust 
protocols for engineering the genome of ADP1 typically require assembling linear 
double-stranded DNA cassettes with at least 500 base pairs of flanking genomic 
homology on each end, and adding even longer flanking  homology regions further 
increases the efficiency of transformation 174,175. 
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Currently, the most common approach used for ADP1 genome engineering relies 
on PCR assembly of DNA constructs for transformation. The procedure has variously 
been called overlap extension PCR (OE-PCR), splicing PCR, fusion PCR, or other names 
1,156. In this method, one first generates a marked replacement DNA cassette containing 
dual positive and negative selection functionalities (e.g., tdk and kanR genes) flanked by 
DNA sequences matching the genomic target site. The PCR product is added to a 
growing culture of ADP1, allowing DNA uptake and homologous recombination to 
replace the native sequence between the homology regions. Successful transformants are 
isolated by plating on agar containing the positive selective agent (e.g., kanamycin). In a 
second step, an unmarked rescue cassette containing flanking homologies to the insertion 
site is added to accomplish another recombination event with the chromosome. The 
rescue cassette can be designed to precisely remove the replacement cassette and create a 
deletion or to insert new genes into the genome at that site. Successful rescue 
transformants are isolated by plating on agar containing the negative selection agent (e.g., 
AZT). 
Because it relies on multiple rounds of PCR amplification and must stitch together 
a longer assembly without giving rise to off-target amplicons, using OE-PCR to create 
DNA constructs can become cumbersome in large projects. To streamline this process, 
we tested using Golden Gate Assembly (GGA) to create the replacement and rescue 
cassettes needed for A. baylyi genome engineering more efficiently and quickly. 
Fundamentally, GGA involves the use of plasmids or PCR fragments encoding parts that 
are flanked by recognition sites for a type IIS restriction enzyme. The restriction enzyme 
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cut sites are positioned to generate compatible overhangs between fragments. Multiple 
DNA pieces can then be efficiently assembled in a designed order in a one-pot reaction 
that contains both a restriction enzyme and DNA ligase.  
For our method, which we dubbed Golden Transformation (GT), we use GGA to 
combine one or more DNA parts with the genome homology regions required for A. 
baylyi genome engineering (Fig. 3.1). In our design, just two PCR reactions that amplify 
the flanking ~1-kb homology regions from genomic DNA are needed. Each PCR 
contains a primer that adds terminal BsaI and a BsmBI restriction sites. For the first 
“replacement” step of genome modification, these flanking regions are combined with the 
tdk-KanR cassette from plasmid pBTK622 in a BsaI GGA reaction. This DNA product is 
used to transform ADP1 to insert the tdk-KanR cassette in place of any genes that are to 
be deleted. For the second "rescue" step, the same two flanking PCR fragments amplified 
from the genome are used in a GGA reaction. If a deletion is desired, the two PCR 
products can be joined together with only a 4-bp scar remaining in a BsmBI GGA 
reaction. Alternatively, since the BsaI and BsmBI overhangs can be designed to be 
compatible with GGA-based toolkits of genetic parts 164,176, one can create and insert a 
transcriptional unit or a larger construct into the genome in place of the tdk-KanR 
cassette. 
Testing Golden Transformation 
We first tested the efficiency of GT using “replacement” DNA assemblies that 
included the tdk-kanR cassette and flanking genome homology regions (Fig. 3.2). OE-
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PCR product was used as a benchmark for the expected maximum efficiency that would 
be possible with the GT procedure. It yielded transformation frequencies of 1.7 × 10–4 per 
cell, which were similar to previous tests of this construct 59. Adding GGA buffer 
containing heat-inactivated T7 ligase and BsaI to the OE-PCR product only reduced 
transformation by a factor of 1.8-fold [1.3–2.3] (95% confidence interval). Therefore, we 
concluded that it was not necessary to purify GGA reactions before they were added to 
cells for transformation.   
Golden Transformation using standard 5-hour GGA reactions with three input 
DNA pieces yielded transformation frequencies that were reduced by roughly two orders 
of magnitude relative to the OE-PCR benchmark representing the expectation for 100% 
efficient DNA assembly. Due to the high transformability of A. bayli ADP1, this still 
represents thousands of transformants per standard GT assay. There was very little 
difference in transformation frequencies whether T4 or T7 ligase was used in GGA. 
Shortening the steps in the GGA temperature cycling protocol to a shorter 1-hour 
program reduced the transformation frequency by a factor of 6.9, consistent with 
successful DNA assembly limiting GT. Interestingly, GT of a larger five-part assembly 
was roughly as efficient as GT of the three-part assembly. The ability to create this type 
of complex cassette and integrate it into the A. baylyi genome in a single step 
demonstrates a further advantage of the GT strategy over using OE-PCR for DNA 
assembly. 
We next tested whether one could compensate for the reduced efficiency of GT 
by performing “puddle” transformations. In this setup, A. baylyi and DNA are combined 
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on a filter that is transferred to an agar surface for cell growth, as opposed to the normal 
transformation procedure in which DNA is added to cells in a liquid culture. The puddle 
procedure improved the transformation frequency for each of three GGA reactions that 
were tested by a similar amount. The group-wise increase by a factor of 5.3 [4.1–6.8] 
(95% confidence interval) matched the 5-fold higher amount of DNA per cell. The 
absolute yield of successfully transformed cells is also higher in puddle transformations, 
despite a reduction in the total number of cells present after growth by a factor of 1.9, on 
average, compared to the transformation assays in liquid culture. 
Tn-Seq to determine ADP1 Gene Essentiality in LB 
To demonstrate how Golden Transformation can be used to rapidly construct 
deletions, we applied it to an A. baylyi ADP1 genome streamlining project. The ADP1 
genome sequence is annotated with 3305 protein-coding genes and 100 RNA genes 23. 
Previously, a single-gene deletion strain collection was constructed by replacing 
individual open reading frames with the tdk-kanR cassette 177. It identified 499 proteins as 
essential and 2593 as dispensable for viability in a minimal succinate growth medium. 
We used transposon sequencing (Tn-Seq) to understand which ADP1 genes are required 
for robust growth in rich medium (LB), so that we could identify regions of the genome 
that could be deleted while preserving growth under a broad range of conditions.  
Sequencing >4 million reads in the Tn-Seq library, corresponding to 59,757 
unique insertion sites, enabled us to confidently classify 2,871 proteins as either essential 
or dispensable to ADP1 fitness in LB (Fig. 3.3A, Table S1). Comparing this set to the 
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knockout collection, 238 proteins were classified as essential in both experiments, 261 
were essential for viability in minimal medium only, 108 were essential for fitness in rich 
medium only, and 2231 were dispensable in both experiments. Assigning ADP1 proteins 
to Clusters of Orthologous Groups (COGs) showed that certain functions were 
overrepresented within each of these categories (Fig. 3.3B). As expected, proteins with 
translation, ribosomal structure and biogenesis functions (J) are most common in the 
shared essential group, and proteins in the shared dispensable group commonly have an 
unknown function (S) or are not even assigned to a COG (X). Amino acid transport and 
metabolism functions (E) predominate among those proteins that are essential for growth 
in minimal medium and dispensable for maintaining fitness in rich medium, presumably 
because many biosynthesis pathways are unnecessary when amino acids are supplied as 
nutrients. Genes essential for fitness in LB yet dispensable in minimal succinate medium 
are largely involved in energy production and conversion (C). This observation is 
consistent with ADP1 needing to utilize a more diverse pool of compounds for energy 
generation in rich medium. 
Multiple-gene-deletion Strains 
We used information about gene essentiality from the knockout collection and our 
Tn-seq results to design 55 multi-gene deletions covering a total of 2.13 Mb (59.4%) of 
the 3.59 Mb ADP1-ISx genome (Fig. 3.4A, Table 3.2). In addition to spanning as many 
nonessential genes as possible, some of the regions targeted for deletion included one or a 
few genes that were predicted to be essential in one or both experiments. We expected 
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that some of these genes might be conditionally dispensable (i.e., able to be deleted if 
other nearby genes involved in the same process were removed at the same time). For 
example, the DNA methylase in a restriction-modification system is essential for cell 
viability unless its corresponding restriction enzyme is also deleted. Similar interactions 
can arise in metabolic pathways that have toxic intermediates and in other coupled 
cellular processes. 
We attempted construction of the 55 planned ADP1-ISx derivatives with multiple-
gene-deletions using Golden Transformation in rich medium (LB). Single-gene deletion 
studies commonly encounter problems with false-positives, such as integration of the 
selectable marker into one copy of a region of the genome that has been transiently 
amplified in the target cell 178–180. To detect these artifacts, we validated that the tdk-kanR 
selection cassette inserted into the genome at the expected site and replaced all copies of 
the targeted genome region in candidate deletion strains by performing several PCR 
reactions and, in some cases, by re-sequencing whole genomes (Fig. 3.7, Table 3.2). In 
total, 19 multiple-gene-deletion (MGD) strains were successfully created. Collectively, 
they dispense with 24.6% of the ADP1-ISx genome. 
For 10 of the 36 regions that we could not delete—which we designate as “retained 
genome regions” (RGRs)—we did not obtain any transformants following GT, and there 
were generally 10- to 100-fold fewer transformants in GTs for the other 26 RGRs 
compared to those that yielded successful deletions (Table 3.2). Of these 26 putative 
deletions that subsequently failed PCR verification, most appeared to have either one-
sided integrations of the tdk-kanR cassette with rearrangements or incomplete deletions 
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on the opposite side or to have large chromosomal amplifications which enabled one 
copy of the targeted genes to be replaced by the tdk-kanR cassette while leaving one or 
more other copies intact. The A. baylyi genome is known to experience gene 
amplifications at high rates 181,182, which led to false-positives during construction of the 
single-gene knockout collection 183. To check for these or other types of false-positives in 
the MGD strains, we validated a subset via whole-genome sequencing, including as 
controls two strains that failed the PCR assays. All 14 of the sequenced MGD strains 
were found to have the expected deletions. Genome sequencing corroborated that the 
other two strains, which had been transformed with DNA targeting either RGR16 or 
RGR28 for deletion, had one-sided integrations of the tdk-kanR cassette. In each case 
there was a deletion of only a few hundred bases on the opposite flank of the cassette. 
We further examined whether the presence of one or more proteins found to be 
essential in the minimal-medium single-gene knockout collection or in the rich-medium 
Tn-Seq experiment was predictive of whether a deletion was ultimately successful (Fig. 
3.4B). Deleted genome regions were roughly half as likely to contain at least one gene 
flagged as essential in the single-gene knockout collection as regions that we were unable 
to remove (p = 0.014, respectively, one-tailed Fisher’s exact test). There was also a lower 
chance of having a gene designated essential by the Tn-Seq experiment within a 
successfully deleted region, but not significantly so (p = 0.186). The worse correlation 
with the Tn-Seq experiment most likely reflects that essentiality as measured by this 
assay is for retaining high fitness rather than absolute viability for growth. 
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Growth characteristics of MGD strains 
  We next tested the viability and growth rates of the deletion strains. They were 
constructed in LB, so they are all viable in this rich medium. However, nearly all deletion 
strains had moderate 10-25% reductions in maximum specific growth rate in LB 
compared to the ancestral ADP1-ISx strain, and the MGD9, MGD14 and MGD15 strains 
exhibited larger reductions of 50% or more (Fig. 3.4C). The magnitudes of these growth 
defects were not predictable from the overall characteristics of the deletion. For example, 
there was not a significantly different growth rate depending on whether a deletion 
contained a protein classified as essential in the Tn-Seq experiment or in the deletion 
collection (p = 0.29 and p = 0.40, respectively, two-tailed t-tests). There was also no 
consistent correction between the size of the genome region deleted and the growth rate 
of a strain (p = 0.31, for a non-zero slope when bootstrap resampling by strain). Finally, 
only 2 of the 19 deletion strains (MGD9 and MGD15) showed no growth when cultured 
in minimal succinate medium for 72 hours. 
Reprogramming the native CRISPR-Cas system of A. baylyi ADP1  
  The ADP1 genome encodes a complete type I-Fa CRISPR-Cas system 184. We 
tested whether this system was functional by reprogramming it to target a foreign DNA 
sequence (Fig. 3.4A). First, we replaced the entire native CRISPR array of spacers that is 
proximal to the Cas-operon with the tdk-kanR cassette (Fig. 3.5A). We refer to an A. 
bayli strain with this modification as “CRISPR-ready” because one or more custom 
spacers can be re-inserted into the native location to reprogram the CRISPR-ready strain 
with a transformation that uses AZT counterselection against tdk (Fig. 3.5B).  
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The protospacer adjacent motif (PAM) for type I CRISPR-Cas systems has been 
reported to be a downstream GG dinucleotide 185, including for the subtype I-F system of 
Acinetobacter baumanii 186. This is equivalent to a CC located 5’ of the spacer sequence 
on the strand that it matches in the target site DNA sequence. We found that matches for 
some of the native A. bayli spacers to Acinetobacter-related phages supported this PAM 
sequence using the CRISPRTarget software 187. Therefore, we tested the ability of an A. 
bayli ADP1-ISx strain reprogrammed with a single spacer matching a site in a 
spectinomycin-resistance gene sequence (specR) with this PAM to prevent 
transformation of this genetic marker from genomic DNA isolated from a strain with the 
specR gene integrated into its genome (Fig. 3.5C). As controls, we tested the wild-type 
and CRISPR-ready derivative of this strain and also two variants in which the CRISPR 
array was re-targeted to specR gene sequences without the correct PAM. The properly re-
targeted strain reduced transformation frequency by a factor of 105, whereas the 
transformation frequency was unchanged in the other strains, indicating that the native A. 
baylyi CRISPR-Cas system is functional and highly efficient. 
Assuring and securing deletions with a CRISPR-Lock 
We next considered how CRISPR spacers targeting the chromosomal regions 
removed in the multiple-gene deletion strain could be used for two purposes to further the 
ADP1 genome streamlining project. First, we tested whether it was possible to add a 
deletion-targeting spacer to the genome for assurance: to verify whether a gene has been 
successfully eliminated from a candidate MGD strain. Second, if one has two MGD 
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strains, one with a spacer targeting its own deletion and the other that still retains the tdk-
kanR cassette replacing its deletion, then genomic DNA from the latter can be used to 
transform the former to readily combine the deletions in one strain. In this case, the 
deletion-targeting spacer serves as a “CRISPR-Lock” that prevents restoration of the 
genes originally deleted in the first strain from the genomic DNA of the second strain, 
which is expected to be strongly selected for during this transformation if it causes a large 
growth defect. 
We tested the assurance scheme by attempting to reprogram CRISPR-ready strain 
derivatives with self-targeting spacers (T2 and T18) aimed at sequences that were 
removed in two of the mutants from the deletion collection, MGD2 and MGD18, 
respectively, or with the first spacer from the native CRISPR array (N1) as an off-target 
control (Fig. 3.6). We would expect to not be able to transform a strain that does not have 
a deletion with a self-targeting spacer because this will lead to cleavage of its own 
genome and cell death. However, escape mutants can evolve that have spontaneous 
mutations inactivating the tdk gene that give them resistance to AZT without replacement 
of the tdk-kanR cassette in the step in which we add the spacer to a CRISPR-ready strain. 
The frequency of ~10–6 of background AZT-resistant (AZTR) escape mutants makes it 
difficult to determine whether the self-targeted region was present in the genome based 
on measuring differences in transformation frequencies of the different spacers alone. 
Therefore, we screened 10 colonies for whether they maintained kanamycin resistance 
(KanR) as a quick proxy for whether putative spacer transformants were actually escape 
mutants.  
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CRISPR-Ready variants of wild-type ADP1-ISx, MGD2, and MGD18 were 
constructed as detailed above (Fig. 3.5), after first removing the tdk-kanR cassette from 
the deleted regions in the latter two strains using GT with the flanking PCR homology 
segments (Fig. 3.1). Of 10 AZTR colonies isolated after transformation of each of these 
strains with the control N1 spacer construct, all 10 were all kanamycin sensitive (KanS) in 
all three cases, indicating 100% successful integration of this off-target spacer (Fig. 3.6). 
When we transformed wild-type ADP1-ISx with either of the self-targeting spacers (T2 
or T18) all 10 AZTR colonies characterized were now KanR, which the expected result 
because these spacers should be lethal in the absence of their cognate deletions. In the 
case of the T18 construct, we found that all 10 colonies had a 551-bp deletion 
inactivating the tdk gene. Most AZTR colonies isolated after transformation of MGD2 
and MGD18 with spacers targeting the regions deleted in each strain were KanS (8/10 and 
9/10, respectively). Sequencing confirmed that these isolates had proper spacer 
integration. The one exception for MGD18 contained a 1-bp deletion in the tdk gene. It is 
also possible for AZTR colonies to be KanS if they incorporate a mutated copy of the 
spacer that no longer matches the genome, but we did not observe that outcome. These 
results show that there significant difference in the chances of getting AZTR colonies that 
are sensitive or resistant to kanamycin (p = 2.6 × 10–8, Fisher’s exact test of combined T2 
and T18 results) that is enough to make this assay diagnostic for assuring that a gene has 
been successfully deleted.  
Successful MGD2+T2 and MGD18+T18 transformants from this experiment 
were used to test the CRISPR-Lock approach. We transformed these strains with 
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genomic DNA from the MGD17 strain still containing the tdk-kanR replacement cassette. 
The MGD17 deletion is separated by less than 900 bp from the one in MGD18 (Table 
3.2). In each case, 3/3 kanR colonies screened had successfully added the new deletion 
and retained the original one, as determined by PCR and Sanger sequencing.  However, 
we also were able to create the same double deletions by transforming MGD2 and 
MGD18 strains that did not have the self-targeting T2 or T18 spacers with the same 
efficiency of 3/3 kanR colonies screened having both deletions. Though it was not 
necessary to block re-incorporation of the deleted segments with the CRISPR-Lock when 
making these double deletion strains, we expect that it will be increasingly important to 
prevent re-acquisition of deleted regions as more and more deletions are combined and 
result in strains with progressively worse fitness as this genome streamlining process 
continues. 
DISCUSSION 
We developed the Golden Transformation procedure to address limitations in the 
current methods used to assemble DNA cassettes for modifying the genome of the 
naturally competent bacterium A. baylyi ADP1. The ease of Golden Gate assembly 
combined with the very high transformability of unpurified DNA from these reactions 
into A. baylyi enables a highly streamlined procedure that requires fewer steps and fewer 
oligonucleotides than PCR assembly methods. We illustrated the utility of Golden 
Transformation by generating a collection of 19 derivatives of the transposon-free A. 
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baylyi ADP1-ISx strain that each have one additional very large chromosomal deletion 
spanning 20,920 to 183,258 base pairs and 19 to 172 genes. 
Determining how removing large regions of a genome impacts viability and 
growth is a first step toward achieving a streamlined genome. The success of 19 of our 55 
attempts to erase large regions from the A. baylyi genome under rich medium conditions 
depended to some extent on whether they contained genes judged to be essential for 
viability or maintaining high fitness when they were removed or inactivated one-at-a-
time. There was a higher correlation between deletion success for genes absolutely 
required for viability in a single-gene knockout collection in minimal medium than there 
was for genes that were needed to maintain high fitness in a TnSeq library constructed in 
rich medium. These single-gene results were not able to completely predict whether a 
larger deletion containing multiple genes would be viable, and the exceptions can give 
interesting information about the overall systems-organization of the ADP1 genome. For 
example, there can be synthetic lethals in which deletion of two or more genes leads to a 
loss in viability even when none of the genes is essential on their own 188,189. Multiple-
gene deletions may also synergistically perturb gene expression and metabolic pathways 
in ways that create deleterious imbalances that are bigger than for single-gene deletions 
79,91.   
  Only 2 of the 19 A. baylyi large deletions lost their ability to grow in minimal 
media. This result was expected for one of these strains (MGD15) because it should be 
incapable of pyrimidine biosynthesis due to deletion of the pyrF gene. Supplementation 
with uracil was able to restore growth of this deletion strain in minimal succinate 
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medium, showing that pyrF could be used as an auxotrophic selection marker in ADP1 as 
it is in many other bacterial species 190. The other such deletion (MGD9) did not contain 
any genes that led to inviability in minimal medium when they were deleted one-at-a-
time in the knockout strain collection. ADP1 encodes two isocitrate dehydrogenase 
isozymes encoded by the ACIAD1187 and ACIAD1190 genes 23. Both of these genes 
were simultaneously deleted in this strain, so they likely result in synthetic lethality in the 
minimal medium that has succinate as the sole carbon source. 
  Conversely, 4 of the 19 MGD strains exhibited growth in minimal medium 
despite the removal of genes that were essential in the single-gene knockout collection. 
MGD8 included the deletion of four putative essential genes (lysS, cysD, cysN and 
ACIAD1056). MGD13 showed growth despite lacking two genes found to be essential in 
the single-gene deletion collection (terD and ACIAD1965). MGD7 deleted the ATP-
binding subunit of an iron transporter (ACIAD0969) and a protein of unknown function 
(ACIAD1000). Finally, MGD19 included a putative gene of unknown function 
(ACIAD3600) essential for growth in minimal media.  
  Many successful deletions—in 10 of the 19 MGD strains—included genes found 
to be essential for fitness in the Tn-Seq experiment that were not essential for viability in 
the deletion collection in minimal medium. These genes included several sugar 
transferases (ACIAD0084- ACIAD0091), a lipid metabolism gene (fadB), an outer 
membrane protein (ACIAD0697), an elongation factor (typA), a putative hemolysin 
(ACIAD0944), isocitrate dehydrogenase (idh), a putative transthyretin-like protein 
(ACIAD1188), a succinylglutamate desuccinylase (astE), a transcriptional regulator 
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(dcaS), an efflux pump(smvA), uridylyltransferase (glnD), and cysteine synthase A 
(cysK), another putative transcriptional regulator (ACIAD1082) and a penicillin-binding 
protein (pbpA). Loss of these genes may contribute to the reduced growth rates of the 
multiple-gene deletion strains, making them top candidates for adding back one or a few 
of the removed genes in each segment to maintain high fitness. 
The overall worse growth of the MGD strains may be the result from metabolic 
imbalances that result from genome reduction 86 or deletion of quasi-essential genes 54. 
The most growth-detrimental deletions were MGD15 and MGD9. A possible explanation 
is that among the genes deleted in MGD15 is a gene essential in succinate minimal media 
(pyrF) in addition to malate synthase G (glcB), a gene involved in the TCA cycle which 
is essential for growth in acetate and 2,3-butanediol as sole carbon sources 183. Similarly, 
two genes deleted in MGD9, ACIAD2740 and ACIAD2741, were previously determined 
to be critical for growth in acetate and quinate, respectively 183 and their loss may be 
particularly disruptive to metabolism. 
Several of the other engineered MGDs in this study have some interesting features 
and may reveal fitness-balancing effects. For instance, MGD1 may emulate the fitness-
enhancing interruptions of per and pgi genes that have been observed in an adaptive 
laboratory evolution experiment with ADP1 19. These beneficial deletions may buffer 
detrimental effects generated by the rest of the content in the deletion. In this case, the 
inclusion of galU in MGD1 could be counteracting the fitness-enhancing effects of per 
and pgi deletions, since a galU knockout shows defective growth in acetate, 2,3-
butanediol, and quinate 183. MGD1 may have benefited from the removal of an entire 
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fimbrial operon which is likely costly to express (ACIAD0119- ACIAD0123). MGD5 may 
have two potent fitness-enhancing deletions: of the type IV fimbrial biogenesis protein 
FimT) and of the small regulatory RNA AbsR28 191. Mutations in the latter gene been 
observed previously during ADP1 adaptive evolution 19.  
Other deletions may illustrate the advantages and disadvantages of concentrating 
on genome minimization in one environment while not examining robustness to other 
environments. MGD5 includes several possible detrimental deletions: a stress gene 
ACIAD0704 (mscL homolog with known functions in hypoosmotic shock and in 
mechanical, nutritional and oxidative stress), DNA repair gene mutM 
(formamidopyrimidine-DNA glycosylase) and tonB (heme/iron acquisition). It is likely 
that the genome deletion is less robust in terms of both its genome stability and its ability 
to survive nutrient and physical stresses. MGD11, one of the larger deletions (183 kb and 
167 genes), tolerates the somewhat surprising elimination of one copy of the 16S and 23S 
ribosomal genes, along with Ala and Ile tRNA copies. While it does not delete any 
essential genes deemed essential for viability in minimal media, it does remove two 
fitness-essential genes in LB, cysK and dcaS. In this case, it also seems likely that there 
could be some fitness balancing effect of removing multiple pathways involved in the 
degradation of aromatic compounds that are contained within this region (including pca-
qui-pob-hca genes) 13,15. 
Overall, our data show that the impact of single-gene deletions on growth cannot 
fully predict the results we observe with the simultaneous deletion of multiple genes and 
that complex fitness-modulating interactions may have important roles reduced-genome 
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bacteria 183. Methods that use genome-scale models may better inform the deletion 
process 192, including how one can relocate of one or a few genes that are needed for 
viability/fitness from a stretch of chromosome before it is deleted. The pyrH and icd 
genes are candidates for this approach. They could be added back to the deleted region 
during the Golden Transformation rescue step, for example. Perhaps a bigger issue for 
the genome reduction enterprise is the potential for losing robustness in other 
environments when genes are deleted from a strain. The extent of this loss of robustness 
remains to be tested for the MGD strains in future work. 
 RNA-guided nucleases have revolutionized the field of genome editing among 
many other applications. Much of this work has focused on CRISPR-Cas9, but there are a 
large diversity of CRISPR types in bacterial genomes that are less well-characterized 193. 
The type I-Fa CRISPR-Cas system of A. baylyi is analogous to the type I-Fb 
CRISPR/Cas system of A. baumanii, except the cas1 gene appears last in the Cas operon 
184,186. A. baylyi ADP1 contains three CRISPR arrays: one with 91 spacers adjacent to the 
Cas operon and two with 21 and 6 spacers located elsewhere in the genome. By using 
Golden Transformation to first replace the 91-spacer CRISPR array with the tdk-kanR 
dual selection cassette to create a “CRISPR-Ready” strain and then inserting a single 
synthetic spacer in place of this cassette, we showed that A. baylyi’s CRISPR system is 
active and readily reprogrammable.  
Novel spacers may be designed and transformed into a CRISPR-Ready A. baylyi 
strain, opening up this system for various applications. For example, we create a “self-
targeting” CRISPR-Lock that tests whether a certain gene has been successfully removed 
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from the chromosome and prevents its re-acquisition. Deletions in the strains we created 
could be combined in future work by adding genomic DNA isolated from one deletion 
strain to a locked version of another deletion strain. This strategy could be particularly 
effective if self-targeting spacers are added in place of each deleted region so that this 
protection will also accumulate during genome streamlining.  
Although orthogonal dCas9 gene repression has been applied successfully in A. 
bayli ADP1 194, there was a metabolic cost for expressing this foreign system. The ability 
to reprogram the endogenous CRISPR/Cas type I-F system opens up the possibility of 
repurposing it for programmable transcriptional repression (analogous to dCas9) via cas3 
knockout 195. These applications of the native CRISPR system broaden the opportunities 
for genome-wide screens and combinatorial pathway engineering in this strain. 
In summary, we demonstrated new methods for more facile and assured genome 
editing in Acinetobacter baylyi. We used Golden Transformation to create 19 large 
deletions that outline a future roadmap for significantly reducing its genome complexity 
to make it a simpler and more predictable metabolic and genome engineering platform. 
This method also simplifies assembling multiple DNA parts in a one-pot reaction before 
they are added to the genome, opening up new possibilities for constructing and testing 
combinatorial libraries. Additionally, by showing that the native A. baylyi CRISPR-Cas 
system is active we also open up further possibilities for restricting transformation of 
DNA that might reverse our engineered deletion and for re-purposing this system for 
genetic control. These developments leverage and further improve upon A. baylyi’s 
remarkable utility as a chassis organism that is highly naturally transformable. 
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Figure 3.1. Golden Transformation method for ADP1 genome engineering.  
Two PCR reactions are performed for upstream (U) and downstream (D) genomic target 
flanks that add terminal BsaI and BsmBI type-IIs restriction sites as depicted. The two 
PCR products can then be combined via BsaI Golden Gate assembly (GGA) with the 
selection cassette to form a replacement DNA or combined with one another and 
optionally with additional genetic parts (not shown) via BsmBI GGA to form a rescue 
cassette. The positive-negative selection cassette (tdk-kanR) is maintained on the high-
copy pBTK622 plasmid that has an origin that does not replicate in A. baylyi. The first 
GGA reaction is added to an A. baylyi culture and then plated on LB-Kan to select for 
transformants with the replacement cassette integrated into the genome. Then, 
transformation of the second assembly reaction with counterselection on LB-AZT is used 





Figure 3.2. Golden Transformation can achieve high genome editing rates.  
Transformation of two different cassettes constructed in 3-part or 5-part Golden Gate 
assembly (GGA) reactions were compared by counting colonies obtained on LB-Kan 
versus LB agar. Transformations of a purified DNA sample constructed by overlap-
extension PCR (OE-PCR) at a concentration that corresponds to 100% efficient assembly 
of the 3-part GGA reaction and this OE-PCR sample with GGA buffer added to it were 
included for comparison. The effects of “short” (1 hr) or “long” (5 hr) GGA 
thermocycling programs, using T4 versus T7 ligase in GGA reactions, and performing 
“puddle” transformations that concentrate cells and DNA by combining them on a filter 








Figure 3.3. A. bayli ADP1 protein essentiality  
(A) Comparison of the essentiality of protein-coding genes between two experiments. 
The deletion collection determined which strains lacking a single protein remained viable 
in a defined minimal succinate medium (minimal medium) 183. The Tn-Seq experiment 
from the current study examined the representation of transposon insertions in different 
genes within populations of mutants cultured in LB (rich medium), which reveals 
proteins that are essential for fitness in this environment. Colored bars correspond to the 
numbers of proteins that were judged as essential, dispensable, or uncertain (meaning 
either untested or an ambiguous). The horizontal bars are broken up to show the overlap 
of proteins classified into each category between experiments. (B) Functions of proteins 
classified as various combinations of essential or dispensable across the two experiments. 
Each column shows the breakdown of Clusters of Orthologous Groups (COG) functions 





Figure 3.4. Dispensability of A. baylyi genome regions targeted for deletion and 
growth rates of multiple-gene deletion strains. 
(A) Regions targeted for deletion from the ADP1 chromosome. Successful deletions that 
resulted in multiple-gene deletion (MGD) strains are numbered and displayed in orange. 
Deletions that could not be constructed are shown in gray. (B) Gene essentiality in 
deleted and retained regions. Histograms show the breakdown of the 19 deleted regions 
and the 36 retained regions by how many proteins they included that were classified as 
essential in the deletion collection or the Tn-Seq experiment. (C) Maximum specific 
growth rates of MGD strains in LB determined from fitting growth curves monitored by 
optical density in a microplate reader. Shapes and colors of symbols indicate whether any 
essential proteins from the Tn-Seq experiment were included in that deletion. Error bars 






















Figure 3.5. The native A. baylyi ADP1 CRISPR-Cas system is active and can be 
retargeted.  
(A) Scheme for reprogramming the A. baylyi CRISPR array. First, a “CRISPR-Ready” 
strain is created by performing a Golden Transformation that replaces the entire native 
spacer array with a tdk-kanR cassette. Then, a second Golden Transformation can be used 
to add a rescue cassette that contains one or more designed spacers under control of the 
native gene expression signals. (B) Single-spacer replacement cassette design.  Synthetic 
double-stranded DNA encoding the spacer and surrounding repeats is combined with 
PCR products corresponding to the flanking genome homology upstream (U) and 
downstream (D) using BsmBI Golden Gate assembly. The inset shows the DNA 
sequence that is targeted for cleavage with the protospacer adjacent motif (PAM) typical 
of type-I CRISPR-Cas systems. (C) Reprogrammed CRISPR-Cas system restricts 
transformation of foreign DNA. Frequencies of transformants of genomic DNA from A. 
baylyi ADP1 donor that has an integrated spectinomycin resistance gene (specR) were 
used to judge whether targeting a spacer to this sequence in a recipient strain prevented 
its acquisition. WT is wild type ADP1-ISx and CR is the CRISPR-Ready derivative of 
this strain. S1 and S2 are controls with spacers that match the specR sequence but in 
incorrect PAM contexts. S3 an on-target specR spacer with the correct PAM. Error bars 




Figure 3.6. Self-targeting spacers can be used to assure deletions and create a 
CRISPR-Lock.  
CRISPR-Ready variants of wild-type ADP1-ISx (WT) and two multiple gene deletions 
strains (MGD2 and MGD18) were transformed with different spacers to assess the 
presence of a sequence located within the putatively deleted region. N1 added back the 
first spacer sequence from the native CRISPR array. It serves as a control because it does 
not target any sequence in the A. baylyi genome. T2 and T18 are spacers that match 
sequences in the ADP1-ISx genome that are within the regions deleted in the 
corresponding MGD strains. For each strain-spacer combination tested, 10 AZTR 
colonies were isolated after transformation with the single-spacer replacement DNA. 
Successful integration of the spacer can only occur if the targeted region is not present in 
the recipient strain’s genome. It results in these AZTR colonies also becoming KanS. If 
integration of the spacer is lethal, then AZTR colonies are expected to have mutations that 
inactivate the tdk gene and remain KanR, as illustrated in the upper panel. Strains with 
successful spacer integrations from the MGD2+T2 and MGD18+T18 transformations 
have a “CRISPR-Lock” in their genomes that can prevent re-acquisition of the deleted 







Figure 3.7. Deletion mutant validation PCR reactions.  
PCR reactions A, B, C and D, were employed during deletion mutant validation. 
Successful amplification from A1 or A2 PCRs served as positive indication of integration 
of marker cassette at the correct loci, whereas amplification from B1, B2 or C reactions 



















Experiment Description Oligo Sequence 
multiple-gene deletion 
tdk-kanR primer 
for all PCR A1  A1R ACATCAGAGATTTTGAGACACAACGTG 
multiple-gene deletion 
tdk-kanR primer 
for all PCR A2 A2F GATTAAATTCCAACATGGATGC 
multiple-gene deletion RGR1 UF TCACACCGACCTTACCG 
multiple-gene deletion RGR1 UR ATGCGGTCTCACGTTCGTCTCAGACCGTACAACCCATCCAATCG 
multiple-gene deletion RGR1 DF GCATGGTCTCAGCTGCGTCTCAGGTCGTTTGTCAATTTTCAGGATCG 
multiple-gene deletion RGR1 DR CTTGCGGCATAAATAAAGC 
multiple-gene deletion DGR1 (MGD1) UF GATGGAAAACATATTTCAGATAAGC 
multiple-gene deletion DGR1 (MGD1) UR ATGCGGTCTCACGTTCGTCTCAGACCCGAATCTATATAAGAGGGATTATTTTT 
multiple-gene deletion DGR1 (MGD1) DF GCATGGTCTCAGCTGCGTCTCAGGTCATCATTGCTATATCGAACGAAC 
multiple-gene deletion DGR1 (MGD1) DR CAGGATCAACTTCACCTGC 
multiple-gene deletion DGR1 (MGD1) B1R CTCTTCAGGGCTGATCTG 
multiple-gene deletion DGR1 (MGD1) B2F GGTGCAAAGGTACGAGC 
multiple-gene deletion RGR2 UF CATTTACTGAAAGCAACAAGC 
multiple-gene deletion RGR2 UR ATGCGGTCTCACGTTCGTCTCAGACCGCTCAATCAATTTAGCAAAGC 
multiple-gene deletion RGR2 DF GCATGGTCTCAGCTGCGTCTCAGGTCTCGTCCTCTGTACTTCCG 
multiple-gene deletion RGR2 DR GCTTCAAACCCATACCG 
multiple-gene deletion DGR2 (MGD2) UF GGCTGCTTTCAAGAATATAAGC 
multiple-gene deletion DGR2 (MGD2) UR ATGCGGTCTCACGTTCGTCTCAGACCGCCTTATGATGCTGAAGC 
multiple-gene deletion DGR2 (MGD2) DF GCATGGTCTCAGCTGCGTCTCAGGTCCTTCTGCCGTTGGTCG 
multiple-gene deletion DGR2 (MGD2) DR TTTCATCAAGTACATAAACACGC 
multiple-gene deletion DGR2 (MGD2) B1R ATCGCCATTGGTTGC 
multiple-gene deletion DGR2 (MGD2) B2F GAGGACGAATTGATGAAGC 
multiple-gene deletion DGR3 (MGD3) UF CTTGGTGATTACCGAGCC 
multiple-gene deletion DGR3 (MGD3) UR ATGCGGTCTCACGTTCGTCTCAGACCCTTTCTTTCAACTCAGCATAAGC 
multiple-gene deletion DGR3 (MGD3) DF GCATGGTCTCAGCTGCGTCTCAGGTCTGCTTATGAGTTACATGATTGG 
multiple-gene deletion DGR3 (MGD3) DR GTGGTGTAATAAAATGCTTGC 
multiple-gene deletion DGR3 (MGD3) B1R CACAGATCCAATACCAGC 
multiple-gene deletion DGR3 (MGD3) B2F GAGCAGTTCTCAAGAATGC 
multiple-gene deletion RGR3 UF CTGACCAAACTGACCACG 
multiple-gene deletion RGR3 UR ATGCGGTCTCACGTTCGTCTCAGACCAGTTAAAGCAGTATCGCCG 
multiple-gene deletion RGR3 DF GCATGGTCTCAGCTGCGTCTCAGGTCCTAATTTCGATAAAAATCCACTGC 
multiple-gene deletion RGR3 DR CGATAAAATGATGCTGGC 
multiple-gene deletion RGR3 B1R CGTTTAATTGTGCATTTGC 
multiple-gene deletion RGR3 B2F CCGATCTTAAAAGGAGATGC 
multiple-gene deletion RGR3 CF AGCGTTGAATCCTGTGC 
Table 3.1. Oligonucleotides used in this study 
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Experiment Description Oligo Sequence 
multiple-gene deletion RGR3 CR CTTGCTGCGTTTGAAGC 
multiple-gene deletion RGR4 UF GACCACATTCGAGATGC 
multiple-gene deletion RGR4 UR ATGCGGTCTCACGTTCGTCTCAGACCCGCGTATAAATAATTTTGCC 
multiple-gene deletion RGR4 DF GCATGGTCTCAGCTGCGTCTCAGGTCCCAGGGTCTAACAGTGAGC 
multiple-gene deletion RGR4 DR TGTCATCAAAATCAATTCTGC 
multiple-gene deletion RGR4 B1R ATCAACCATCCTAATCATGC 
multiple-gene deletion RGR4 B2F GTCCCGGTGAGTATTTACG 
multiple-gene deletion RGR4 CF GCGAATTTGACCATCG 
multiple-gene deletion RGR4 CR GCAGGCAGTAGGTCAGC 
multiple-gene deletion DGR4 (MGD4) UF TCAATCTCAATTCATGTCGC 
multiple-gene deletion DGR4 (MGD4) UR ATGCGGTCTCACGTTCGTCTCAGACCTTCACAAAGTTGATTAAATCCG 
multiple-gene deletion DGR4 (MGD4) DF GCATGGTCTCAGCTGCGTCTCAGGTCGGTTTACATTTTTACCGTTGC 
multiple-gene deletion DGR4 (MGD4) DR CTTTGTCCATGGTAGGTGC 
multiple-gene deletion DGR4 (MGD4) B1R ACTTCGGTGGTAACTCTGC 
multiple-gene deletion DGR4 (MGD4) B2F CAATTGGATCAAGTTTAGTTGC 
multiple-gene deletion DGR5 (MGD5) UF CCTGTACAGAAGAAACATTTGC 
multiple-gene deletion DGR5 (MGD5) UR ATGCGGTCTCACGTTCGTCTCAGACCCTGCATTGTTTATTCTATCACCAG 
multiple-gene deletion DGR5 (MGD5) DF GCATGGTCTCAGCTGCGTCTCAGGTCTTCGAGCTCAATACATCATATC 
multiple-gene deletion DGR5 (MGD5) DR ATCCTGAATGTCATCATATTCG 
multiple-gene deletion DGR5 (MGD5) B1R AACCATGTGTGTTTGCG 
multiple-gene deletion DGR5 (MGD5) B2F GTTGTCGCAACATCTGC 
multiple-gene deletion RGR5 UF ACGTTGTCGAGCATACG 
multiple-gene deletion RGR5 UR ATGCGGTCTCACGTTCGTCTCAGACCGGCTCTTTGTTATGCTATGC 
multiple-gene deletion RGR5 DF GCATGGTCTCAGCTGCGTCTCAGGTCGTAGAGATTTCCAAATTGTGC 
multiple-gene deletion RGR5 DR GCGCTGAAAACAAAGTACG 
multiple-gene deletion RGR5 B1R AACTGATACATCTCGGTTGC 
multiple-gene deletion RGR5 B2F TTCAGCATTAGAAAACTGTGC 
multiple-gene deletion RGR5 CF AGCAAGTTCATCATTACGC 
multiple-gene deletion RGR5 CR TCCACATAGCATCACATGA 
multiple-gene deletion RGR6 UF GATATACTGGTTCCTGATTGGTC 
multiple-gene deletion RGR6 UR ATGCGGTCTCACGTTCGTCTCAGACCCAGAAAAGACTCAAAATAAGATGTAATTC 
multiple-gene deletion RGR6 DF GCATGGTCTCAGCTGCGTCTCAGGTCGGGCAATACTATTAGTGATGAAGC 
multiple-gene deletion RGR6 DR CGTCTGCACCAACTACAGC 
multiple-gene deletion RGR6 B1R CGCCAGTCATTGATGC 
multiple-gene deletion RGR6 B2F CGTATAGAGCAAGGCCG 
Table 3.1. Oligonucleotides used in this study (continued) 
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Experiment Description Oligo Sequence 
multiple-gene deletion DGR6 (MGD6) UF GCCATACTGGAACCGC 
multiple-gene deletion DGR6 (MGD6) UR ATGCGGTCTCACGTTCGTCTCAGACCCCAAAATCAACTTTTTCACC 
multiple-gene deletion DGR6 (MGD6) DF GCATGGTCTCAGCTGCGTCTCAGGTCTTTATCATCGCTTCCAAAATG 
multiple-gene deletion DGR6 (MGD6) DR GTTTCTGGCTGGTCTGC 
multiple-gene deletion DGR6 (MGD6) B1R TCTTGATTGCCTCTGCC 
multiple-gene deletion DGR6 (MGD6) B2F GTGTAGTTGGAGAGAAAGTTGC 
multiple-gene deletion DGR7 (MGD7) UF AAACTAATAGTCAGAGCGTGAGTTATAC 
multiple-gene deletion DGR7 (MGD7) UR TGATTTGAATTGGAGGCTGGGTATTTTTTACCTCTCTACCACCAATA 
multiple-gene deletion DGR7 (MGD7) 
UR2 
(rescue) AAGCGTGACCAGACCACTTATTTTTTACCTCTCTACCACCAATA 
multiple-gene deletion DGR7 (MGD7) DF TTCTAAGCATGCGGAGCTGGAGTGGTCTGGTCACGCTT 
multiple-gene deletion DGR7 (MGD7) 
DF2 
(rescue) TATTTTTTACCTCTCTACCACCAATAAGTGGTCTGGTCACGCTT 
multiple-gene deletion DGR7 (MGD7) DR CTCAATGAACGCTTGGAG 
multiple-gene deletion DGR8 (MGD8) UF ATGCCATAGATGTTTACCTGC 
multiple-gene deletion DGR8 (MGD8) UR ATGCGGTCTCACGTTCGTCTCAGACCGAGCACCACAACAACTGC 
multiple-gene deletion DGR8 (MGD8) DF GCATGGTCTCAGCTGCGTCTCAGGTCGATTATAAATCACGTTTTGGC 
multiple-gene deletion DGR8 (MGD8) DR GACGCTTTACAATTTCTTCG 
multiple-gene deletion DGR8 (MGD8) B1R TCCAATTGCATGACAGC 
multiple-gene deletion DGR8 (MGD8) B2F AATGGATAAAGGACTTCGC 
multiple-gene deletion DGR8 (MGD8) CF1 CACCAGTCAGATCTTATTAGCC 
multiple-gene deletion DGR8 (MGD8) CR1 GATAAAGATAATTATAGGCGAACC 
multiple-gene deletion DGR8 (MGD8) CF2 GGACTGGAAAGGAGATGC 
multiple-gene deletion DGR8 (MGD8) CR2 TGCTTGCTCAAGATTGC 
multiple-gene deletion RGR7 UF GATTGATCGAAATGCCG 
multiple-gene deletion RGR7 UR ATGCGGTCTCACGTTCGTCTCAGACCCGCTTTGAATATGGTGC 
multiple-gene deletion RGR7 DF GCATGGTCTCAGCTGCGTCTCAGGTCCATCGGATTAAATGGATCG 
multiple-gene deletion RGR7 DR GCATGTCAGATCAGATCG 
multiple-gene deletion RGR7 B1R CCAATGTTGTTCTTAATACCG 
multiple-gene deletion RGR7 B2F GCGGTATCTTATTGATCCG 
multiple-gene deletion RGR7 CF TTATTTGGCAAATAGACATGG 
multiple-gene deletion RGR7 CR ATGTCACAAACAATCACGCT 
multiple-gene deletion DGR9 (MGD9) UF GATAGGTGCATTACATGATGC 
multiple-gene deletion DGR9 (MGD9) UR ATGCGGTCTCACGTTCGTCTCAGACCCTCATTGGGAAAAACGTG 
multiple-gene deletion DGR9 (MGD9) DF GCATGGTCTCAGCTGCGTCTCAGGTCCTAAGTTCGGCTCAGATTC 
multiple-gene deletion DGR9 (MGD9) DR GCAAGATTGACTCCACG 
multiple-gene deletion DGR9 (MGD9) B1R AGTCCAACATGACCGC 
Table 3.1. Oligonucleotides used in this study (continued) 
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Experiment Description Oligo Sequence 
multiple-gene deletion DGR9 (MGD9) B2F TGGACAATGCTGATACTGC 
multiple-gene deletion RGR8 UF ATATTGCGTTGCCAGC 
multiple-gene deletion RGR8 UR ATGCGGTCTCACGTTCGTCTCAGACCGATCCAAATCATACCAATCG 
multiple-gene deletion RGR8 DF GCATGGTCTCAGCTGCGTCTCAGGTCGGTTGATTCAGCAGGC 
multiple-gene deletion RGR8 DR CATAAGCCAAAGCATTTGC 
multiple-gene deletion RGR8 B1R ATCAGCTTGGTGATATTGC 
multiple-gene deletion RGR8 B2F GCACGCTATTGTTACGC 
multiple-gene deletion RGR8 CF GCGGTAAATGCAGAATGTATC 
multiple-gene deletion RGR8 CR ATGAACATCTTCAACATTTAGATCAAG 
multiple-gene deletion DGR10 (MGD10) UF CGTGGCAATTATCAATGC 
multiple-gene deletion DGR10 (MGD10) UR ATGCGGTCTCACGTTCGTCTCAGACCAACGTTCCACTATTGTTTGTC 
multiple-gene deletion DGR10 (MGD10) DF GCATGGTCTCAGCTGCGTCTCAGGTCGATCAGAATTAGCAAAAGCAAC 
multiple-gene deletion DGR10 (MGD10) DR GTTCTGGAAATGGAAGGC 
multiple-gene deletion DGR10 (MGD10) B1R GGATTCTCTGTCAAAGTTCG 
multiple-gene deletion DGR10 (MGD10) B2F AGACAACGCGAGTCTGC 
multiple-gene deletion RGR9 UF CCTTACCCATATCTTTCATGC 
multiple-gene deletion RGR9 UR ATGCGGTCTCACGTTCGTCTCAGACCTTGATGTCGTAGATCAGAACG 
multiple-gene deletion RGR9 DF GCATGGTCTCAGCTGCGTCTCAGGTCCGTTCTTATGCAGATGCG 
multiple-gene deletion RGR9 DR GCCACCATAACTGATTGC 
multiple-gene deletion RGR10 UF AATCATGAAAACTCCATCTGG 
multiple-gene deletion RGR10 UR ATGCGGTCTCACGTTCGTCTCAGACCGGTGGTTATCATTTAGCACG 
multiple-gene deletion RGR10 DF GCATGGTCTCAGCTGCGTCTCAGGTCCTTGGCAAGGTTGTGC 
multiple-gene deletion RGR10 DR AGAGATGGTTTCAAGTGCG 
multiple-gene deletion RGR11 UF GGTATAAGGATCCCAAATGC 
multiple-gene deletion RGR11 UR ATGCGGTCTCACGTTCGTCTCAGACCAGAGATGGTTTCAAGTGCG 
multiple-gene deletion RGR11 DF GCATGGTCTCAGCTGCGTCTCAGGTCGTAGCTTTAAAAGGCAATATGC 
multiple-gene deletion RGR11 DR GAGTATGTGCTTAGCTGGTGC 
multiple-gene deletion RGR11 B1R CAAATCACCATGACCTGC 
multiple-gene deletion RGR11 B2F GCTACGAATGACCAGACG 
multiple-gene deletion RGR11 CF AACCACATTGGGACTGC 
multiple-gene deletion RGR11 CR AATGGGTTTATCAATTTGGC 
multiple-gene deletion DGR11 (MGD11) UF AAATTACCTTGATAGCCTGCA 
multiple-gene deletion DGR11 (MGD11) UR TGATTTGAATTGGAGGCTGGGAAGCTCTAAAAGGCAGCAT 
multiple-gene deletion DGR11 (MGD11) 
UR2 
(rescue) GTAAATTATTTTATAGAAATTTTAAGAGAAATATAAGCTCTAAAAGGCAGCAT 
multiple-gene deletion DGR11 (MGD11) DF TTCTAAGCATGCGGAGCTGGATATTTCTCTTAAAATTTCTATAAAATAATTTAC 
Table 3.1. Oligonucleotides used in this study (continued) 
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multiple-gene deletion DGR11 (MGD11) 
DF2 
(rescue) AAGCTCTAAAAGGCAGCATATATTTCTCTTAAAATTTCTATAAAATAATTTAC 
multiple-gene deletion DGR11 (MGD11) DR CGATCTTATGCAGGAGGTAC 
multiple-gene deletion DGR12 (MGD12) UF GCTTTGGACTTGCTCTCG 
multiple-gene deletion DGR12 (MGD12) UR ATGCGGTCTCACGTTCGTCTCAGACCCAATTGACGTATTGACGC 
multiple-gene deletion DGR12 (MGD12) DF GCATGGTCTCAGCTGCGTCTCAGGTCTCGATGATCGTTGATATAGAGG 
multiple-gene deletion DGR12 (MGD12) DR TTCGGATGAATTTTAAACGC 
multiple-gene deletion DGR12 (MGD12) B1R GCACTTCCCATGATTGC 
multiple-gene deletion DGR12 (MGD12) B2F CGTTTATCTTCAGAATGTCCG 
multiple-gene deletion RGR12 UF GCCCTGAAACATTAACATCG 
multiple-gene deletion RGR12 UR ATGCGGTCTCACGTTCGTCTCAGACCGGGACGCTTTATCATGTGC 
multiple-gene deletion RGR12 DF GCATGGTCTCAGCTGCGTCTCAGGTCGCAGGCATACGGTATTCAAC 
multiple-gene deletion RGR12 DR GCAAATACTACGGCAAATACTACG 
multiple-gene deletion RGR12 B1R CCAATGCTGAAATTATGGC 
multiple-gene deletion RGR12 B2F CACACTGATATGTTTACCTTCG 
multiple-gene deletion RGR13 UF GTCATGATCTACCCCTTGC 
multiple-gene deletion RGR13 UR ATGCGGTCTCACGTTCGTCTCAGACCTTCTTGAACTCGAATTTGAACTG 
multiple-gene deletion RGR13 DF GCATGGTCTCAGCTGCGTCTCAGGTCGCGGAATAACAGATGAAGAA 
multiple-gene deletion RGR13 DR CTTTAGCGTGGATAAGCG 
multiple-gene deletion RGR13 B1R GCGTGATTATGTTACATAGGC 
multiple-gene deletion RGR13 B2F TTGACCTTGAGCAAGTAAGC 
multiple-gene deletion RGR14 UF GCAGTTGGGAAAGAATCG 
multiple-gene deletion RGR14 UR ATGCGGTCTCACGTTCGTCTCAGACCTGGTGAGAAATCTGATGGC 
multiple-gene deletion RGR14 DF GCATGGTCTCAGCTGCGTCTCAGGTCTTACAGGCGTTGAGAATAGC 
multiple-gene deletion RGR14 DR AAGAACAACAGGCAGGC 
multiple-gene deletion RGR14 B1R AACTTAATGCTGCATCTTGC 
multiple-gene deletion RGR14 B2F AACGTTATCCCATAGGTGC 
multiple-gene deletion RGR14 CF CAATCGTGACCTGTACTGC 
multiple-gene deletion RGR14 CR GCATGGAAGACAGCGC 
multiple-gene deletion DGR13 (MGD13) UF ATGTTTGCATATAAGGGGC 
multiple-gene deletion DGR13 (MGD13) UR ATGCGGTCTCACGTTCGTCTCAGACCCGCGTACTCAATCAATGC 
multiple-gene deletion DGR13 (MGD13) DF GCATGGTCTCAGCTGCGTCTCAGGTCTGCTTGGTCGATGTCG 
multiple-gene deletion DGR13 (MGD13) DR CTTCACGAACCAAAGTCG 
multiple-gene deletion DGR13 (MGD13) B1R GTTTGGGAAACATTTGTCG 
multiple-gene deletion DGR13 (MGD13) B2F GCTTCTATAGGTTCACCATGC 
multiple-gene deletion DGR13 (MGD13) CF ATCGAAAGTGTTGTGATCG 
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multiple-gene deletion DGR13 (MGD13) CR AAGCTTGCGATGTGTGC 
multiple-gene deletion DGR14 (MGD14) UF TGGTGTACTTTCATCATCAGC 
multiple-gene deletion DGR14 (MGD14) UR ATGCGGTCTCACGTTCGTCTCAGACCGTTCTTCGGTAGGAGAGGC 
multiple-gene deletion DGR14 (MGD14) DF GCATGGTCTCAGCTGCGTCTCAGGTCGAATTTGTTTAGAGCTGGGC 
multiple-gene deletion DGR14 (MGD14) DR CTTAATGATGAACACAGCATCG 
multiple-gene deletion DGR14 (MGD14) B1R GCTGATGTGTGCTGTAAGC 
multiple-gene deletion DGR14 (MGD14) B2F CTAGCGCAGAAGACTTGC 
multiple-gene deletion RGR15 UF GACTCAAGTACATTCATTCCG 
multiple-gene deletion RGR15 UR ATGCGGTCTCACGTTCGTCTCAGACCCAAACCAGTCGCAAGC 
multiple-gene deletion RGR15 DF GCATGGTCTCAGCTGCGTCTCAGGTCTTTCATGTTGAATAGAATATCTTGC 
multiple-gene deletion RGR15 DR ACCACGACTACGATTTGC 
multiple-gene deletion RGR15 B1R GGTGTTTGCTGATTCTGC 
multiple-gene deletion RGR15 B2F ATGGGTAAAGCCTAGAGTTACG 
multiple-gene deletion RGR16 UF GTTGGAGAGTTTGAATCGC 
multiple-gene deletion RGR16 UR ATGCGGTCTCACGTTCGTCTCAGACCCATATTGTCCAAGAAGACTTTGC 
multiple-gene deletion RGR16 DF GCATGGTCTCAGCTGCGTCTCAGGTCCAAATTGATTACACGGAAAGC 
multiple-gene deletion RGR16 DR GACGAATCAAGTCATTAATCG 
multiple-gene deletion RGR16 B1R TCTAACCAACTGAGCTATAGGC 
multiple-gene deletion RGR16 B2F ATGCCAATGCTTTCTCG 
multiple-gene deletion RGR17 UF TTCAAGTAGAACAGCTAAAGGC 
multiple-gene deletion RGR17 UR ATGCGGTCTCACGTTCGTCTCAGACCTAGCGTATATGGCATGAGG 
multiple-gene deletion RGR17 DF GCATGGTCTCAGCTGCGTCTCAGGTCAAACTTTCATCTCTTTTTAATCAGG 
multiple-gene deletion RGR17 DR CTATTGGGCTGTTTAAATAGAGTATG 
multiple-gene deletion RGR18 UF GATCAAAGAGGCCATGC 
multiple-gene deletion RGR18 UR ATGCGGTCTCACGTTCGTCTCAGACCACAACCAGATACCAAGTCACC 
multiple-gene deletion RGR18 DF GCATGGTCTCAGCTGCGTCTCAGGTCTTTCTGAAAACTCTGGACG 
multiple-gene deletion RGR18 DR GTCACATTACTCTGGGTGC 
multiple-gene deletion RGR18 B1R TATCTTTGAAGCACGTAGTATGC 
multiple-gene deletion RGR18 B2F TTGATGAATACAGCCAGAGC 
multiple-gene deletion RGR18 CF CAGCCTGCTCTTAATACGC 
multiple-gene deletion RGR18 CR ACCCTCGCTAATGTTTGC 
multiple-gene deletion RGR19 UF TTGATGAATACAGCCAGAGC 
multiple-gene deletion RGR19 UR ATGCGGTCTCACGTTCGTCTCAGACCTGCTTCTGAGGCTTAATGC 
multiple-gene deletion RGR19 DF GCATGGTCTCAGCTGCGTCTCAGGTCAACTGTTGCAGAAATTCAGC 
multiple-gene deletion RGR19 DR AGAGATGCACATTAGAGATTGC 
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multiple-gene deletion DGR15 (MGD15) UF CCGAATGCGACTTATGC 
multiple-gene deletion DGR15 (MGD15) UR ATGCGGTCTCACGTTCGTCTCAGACCTTCAAATGTTAAATGGATATTCG 
multiple-gene deletion DGR15 (MGD15) DF GCATGGTCTCAGCTGCGTCTCAGGTCCGATGACCTCTTTAATTATTGC 
multiple-gene deletion DGR15 (MGD15) DR CAACTGATGGTTAATTATGTCG 
multiple-gene deletion DGR15 (MGD15) B1R CACGAGACATATAGGTTGTACG 
multiple-gene deletion DGR15 (MGD15) B2F ACGTAATGCTTTACCAGGC 
multiple-gene deletion DGR15 (MGD15) CF CATCCAACATTGCCTGC 
multiple-gene deletion DGR15 (MGD15) CR GTATTATTGTTGCCTTAGACGC 
multiple-gene deletion RGR20 UF CAACCATTTTGCTTGACG 
multiple-gene deletion RGR20 UR ATGCGGTCTCACGTTCGTCTCAGACCCTCGATTTTATGTCTACCGC 
multiple-gene deletion RGR20 DF GCATGGTCTCAGCTGCGTCTCAGGTCTGAACCTGATCAAAACATCG 
multiple-gene deletion RGR20 DR TTGCAGGTGGTTTTAATGC 
multiple-gene deletion RGR20 B1R CTGAGCGTTTTGGTGC 
multiple-gene deletion RGR20 B2F GGTATCCCACTTGCTGC 
multiple-gene deletion RGR20 CF TCATCATTCAACATAACATATTGC 
multiple-gene deletion RGR20 CR GAGAGATTGTTCTACATGCTCG 
multiple-gene deletion RGR21 UF CGAAGTAAATATCGTAATCACTGC 
multiple-gene deletion RGR21 UR ATGCGGTCTCACGTTCGTCTCAGACCCGCAAGTTGTTTGACACG 
multiple-gene deletion RGR21 DF GCATGGTCTCAGCTGCGTCTCAGGTCTGGTCAGTTGGCTTATCG 
multiple-gene deletion RGR21 DR AATATACATGCCTATTAAAGTCGC 
multiple-gene deletion RGR21 B1R TGTTGAGCGTGATGTACG 
multiple-gene deletion RGR21 B2F CACTGTAGAACAAATGCTGC 
multiple-gene deletion RGR21 CF GAAGTTTCTGAACATACTGGC 
multiple-gene deletion RGR21 CR CATTGACACGTTTGTAGTCG 
multiple-gene deletion RGR22 UF CGAACCGCTTACAGGC 
multiple-gene deletion RGR22 UR ATGCGGTCTCACGTTCGTCTCAGACCACAGGCTGTGAGTTATCCG 
multiple-gene deletion RGR22 DF GCATGGTCTCAGCTGCGTCTCAGGTCTTTAAACACAACCCATTATTCG 
multiple-gene deletion RGR22 DR AAAGAAGCCGATCTAAATGC 
multiple-gene deletion RGR22 B1R CGAACGTATTGTGCTCG 
multiple-gene deletion RGR22 B2F AACAGCACCATATCGGC 
multiple-gene deletion RGR22 CF CAGGATGACACCTATGACG 
multiple-gene deletion RGR22 CR TATGGAAAGCGTGTGAGC 
multiple-gene deletion DGR16 (MGD16) UF GATGTCAGTGATCATAATGAACG 
multiple-gene deletion DGR16 (MGD16) UR ATGCGGTCTCACGTTCGTCTCAGACCCATTTGCAGCAATGGATT 
multiple-gene deletion DGR16 (MGD16) DF GCATGGTCTCAGCTGCGTCTCAGGTCGCTATCGTCATGTTTATGCC 
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multiple-gene deletion DGR16 (MGD16) DR CGACCTTCATTCGTGC 
multiple-gene deletion DGR16 (MGD16) B1R TCTTATGGTAGTTATGATGGTGC 
multiple-gene deletion DGR16 (MGD16) B2F GCCTAAAGCTATTTGGAAGC 
multiple-gene deletion RGR23 UF AAACGCTCAGTGAAGAAGC 
multiple-gene deletion RGR23 UR ATGCGGTCTCACGTTCGTCTCAGACCTCAATGCCAGTGTCAGC 
multiple-gene deletion RGR23 DF GCATGGTCTCAGCTGCGTCTCAGGTCCATTACCACTGGAGTTATAAACG 
multiple-gene deletion RGR23 DR GACTGCCCAAGTTTATCG 
multiple-gene deletion DGR17 (MGD17) UF GTACATCTGTCACCCCTGC 
multiple-gene deletion DGR17 (MGD17) UR ATGCGGTCTCACGTTCGTCTCAGACCCTTCCTCTATCCAATCAGTGC 
multiple-gene deletion DGR17 (MGD17) DF GCATGGTCTCAGCTGCGTCTCAGGTCTACAACCATAATCTGAGCAGAG 
multiple-gene deletion DGR17 (MGD17) DR CGATTCCAATTTTACTCTGTTC 
multiple-gene deletion DGR17 (MGD17) B1R CGCCTTTACCATCACG 
multiple-gene deletion DGR17 (MGD17) B2F ACGAAAACAGTCACTTGATTG 
multiple-gene deletion DGR18 (MGD18) UF GCCGTGCTCTTATTATATCCAC 
multiple-gene deletion DGR18 (MGD18) UR ATGCGGTCTCACGTTCGTCTCAGACCATAAGTAGTGATATTTTGTATACGCAC 
multiple-gene deletion DGR18 (MGD18) DF GCATGGTCTCAGCTGCGTCTCAGGTCCGATGAGCAAATGATCAAAG 
multiple-gene deletion DGR18 (MGD18) DR GTTTCATATACTTTACGTGATGTCG 
multiple-gene deletion DGR18 (MGD18) B1R CATAGTACTGACCTCGGAAGC 
multiple-gene deletion DGR18 (MGD18) B2F TACCCTGGTCATGGACG 
multiple-gene deletion RGR24 UF TCAGAAATAATTCAATAAAACAGGG 
multiple-gene deletion RGR24 UR ATGCGGTCTCACGTTCGTCTCAGACCGTTTTATCGACAGTGTGGGC 
multiple-gene deletion RGR24 DF GCATGGTCTCAGCTGCGTCTCAGGTCGAATCTGCTCTATTTGTGAAGC 
multiple-gene deletion RGR24 DR GTGGGCAATAGTCAATGG 
multiple-gene deletion RGR24 B1R CGTTACTAGTCAAATGGATGC 
multiple-gene deletion RGR24 B2F AATTCATCTAGACGCTGTGC 
multiple-gene deletion RGR25 UF CTTCAATTCACTAATGGATTTGC 
multiple-gene deletion RGR25 UR ATGCGGTCTCACGTTCGTCTCAGACCTAAAGTCTTATCAAAGAATAGGGC 
multiple-gene deletion RGR25 DF GCATGGTCTCAGCTGCGTCTCAGGTCTCTATACTCCAAATTTTTCTATCAATGC 
multiple-gene deletion RGR25 DR GTACACTCAATGCAGTCGC 
multiple-gene deletion RGR25 B1R GTGGGCAATAGTCAATGG 
multiple-gene deletion RGR25 B2F AGCTCTTACTGCAATGTCG 
multiple-gene deletion RGR26 UF CAGTTCAAGACGGACGC 
multiple-gene deletion RGR26 UR ATGCGGTCTCACGTTCGTCTCAGACCGGATGAAGGGAAATAAAATGAC 
multiple-gene deletion RGR26 DF GCATGGTCTCAGCTGCGTCTCAGGTCGCGTCATTTATTATGCGG 
multiple-gene deletion RGR26 DR GCAGGTGAAATTGCCG 
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multiple-gene deletion RGR26 B1R AATGTTACTGATTTGGAGCG 
multiple-gene deletion RGR26 B2F CGTTACTCACCACCACG 
multiple-gene deletion RGR26 CF TGGAAGAATTAACTTTTTCGC 
multiple-gene deletion RGR26 CR CCATCTATTTCGAGGCC 
multiple-gene deletion RGR27 UF GCAATTTGAATACCTAACGG 
multiple-gene deletion RGR27 UR ATGCGGTCTCACGTTCGTCTCAGACCTCGAATAATAACTAAAGAACCGC 
multiple-gene deletion RGR27 DF GCATGGTCTCAGCTGCGTCTCAGGTCAATATCATCACATTGGAATGC 
multiple-gene deletion RGR27 DR ATATAAGGACGGGTAGGCG 
multiple-gene deletion RGR28 UF GGATTAAGTGTCGGTTTGAGC 
multiple-gene deletion RGR28 UR ATGCGGTCTCACGTTCGTCTCAGACCGTAATCCAGCAACATTGGC 
multiple-gene deletion RGR28 DF GCATGGTCTCAGCTGCGTCTCAGGTCAGCTGACTTGGAAACGC 
multiple-gene deletion RGR28 DR GCTGTATGGTTGACAACACG 
multiple-gene deletion RGR28 B1R TCGGTGACACAGGACG 
multiple-gene deletion RGR28 B2F CAACCTGAATAGCCTTGC 
multiple-gene deletion RGR29 UF ATAATCCATCACCTCGGC 
multiple-gene deletion RGR29 UR ATGCGGTCTCACGTTCGTCTCAGACCCAGCAGAGTGTTGTTTAGAGC 
multiple-gene deletion RGR29 DF GCATGGTCTCAGCTGCGTCTCAGGTCCCTTTAGGCGGATGATATGC 
multiple-gene deletion RGR29 DR GCGAGTATAAATGTGTCCTGC 
multiple-gene deletion RGR29 B1R CTAAGTTCGCTATCGAGGC 
multiple-gene deletion RGR29 B2F CTCATATCTATGGATAAATTGGC 
multiple-gene deletion RGR29 CF CAGTTGATTGGATATACAGGC 
multiple-gene deletion RGR29 CR ACATGACAATGAACATTACTGC 
multiple-gene deletion RGR30 UF TGCAGAAATTGAGATTACCG 
multiple-gene deletion RGR30 UR ATGCGGTCTCACGTTCGTCTCAGACCGCATTGGTTAATCTAATGGC 
multiple-gene deletion RGR30 DF GCATGGTCTCAGCTGCGTCTCAGGTCGCAGAAACACAAATAGCGC 
multiple-gene deletion RGR30 DR GCTGCCAATGTGATGC 
multiple-gene deletion RGR30 B1R CAAGCAAGATCATTTGGC 
multiple-gene deletion RGR30 B2F GTTGTTGGTAAGATCACTTTAGC 
multiple-gene deletion RGR31 UF AGCGGACACACAGAAGC 
multiple-gene deletion RGR31 UR ATGCGGTCTCACGTTCGTCTCAGACCCATTTCTAGAGTTACTTGAAGTATAGC 
multiple-gene deletion RGR31 DF GCATGGTCTCAGCTGCGTCTCAGGTCGTATCCATCTTTAGACAACATGC 
multiple-gene deletion RGR31 DR CTGCATAAGTTTTGTAGTAGGTAGC 
multiple-gene deletion RGR32 UF CAACACCCAAGAAACAAAGTC 
multiple-gene deletion RGR32 UR ATGCGGTCTCACGTTCGTCTCAGACCGTGACTATCATCCATCATATAGGAG 
multiple-gene deletion RGR32 DF GCATGGTCTCAGCTGCGTCTCAGGTCCTGGCTCAATAGGTAATGGC 
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multiple-gene deletion RGR32 DR CAGATGTGGAAAGCTATGC 
multiple-gene deletion RGR32 B1R CTGGATGGAATCACCG 
multiple-gene deletion RGR32 B2F TGGTGTCTGGATCAATGC 
multiple-gene deletion RGR32 CF TTCAACACTAATATAATCGCTCG 
multiple-gene deletion RGR32 CR GAAATTGGTAACTGTGACCG 
multiple-gene deletion RGR33 UF GCTGTGCTACCTGTAAACG 
multiple-gene deletion RGR33 UR ATGCGGTCTCACGTTCGTCTCAGACCGTTACCTTTACCTGCACCG 
multiple-gene deletion RGR33 DF GCATGGTCTCAGCTGCGTCTCAGGTCGTAAATATCTAAATTGGTGGGC 
multiple-gene deletion RGR33 DR GTATGGCCTCAGTCAAGC 
multiple-gene deletion RGR33 B1R AGGACGAGTGCTATGTGC 
multiple-gene deletion RGR33 B2F CCACCAATGACACCAGC 
multiple-gene deletion RGR33 CF TCCCTGTCACCACTTGC 
multiple-gene deletion RGR33 CR GATGTTAGGAGGTTTGTCTGC 
multiple-gene deletion RGR34 UF GCAACTGTGACAATTTCAGC 
multiple-gene deletion RGR34 UR ATGCGGTCTCACGTTCGTCTCAGACCTCGTGGTATTGAAGAAGTCG 
multiple-gene deletion RGR34 DF GCATGGTCTCAGCTGCGTCTCAGGTCGTCACCCGAATCTCTTGC 
multiple-gene deletion RGR34 DR AATAACGGTTAGAGATTTCACG 
multiple-gene deletion RGR34 B1R GCCTTTAATGTGATGGAAGC 
multiple-gene deletion RGR34 B2F AGGTGCAATTAGACTTGGC 
multiple-gene deletion RGR34 CF GATGGCGTTAAGGATATGC 
multiple-gene deletion RGR34 CR CCAGGTTCTGATTGGC 
multiple-gene deletion RGR35 UF CATAGGTCAGTGTTGGACG 
multiple-gene deletion RGR35 UR ATGCGGTCTCACGTTCGTCTCAGACCCCGATGCTTTATGTTGC 
multiple-gene deletion RGR35 DF GCATGGTCTCAGCTGCGTCTCAGGTCCCTTCAATTTAATGCAGATACG 
multiple-gene deletion RGR35 DR CGTCCTGGAATGTATACCG 
multiple-gene deletion RGR35 B1R GTACGTGGCAATCTGGC 
multiple-gene deletion RGR35 B2F AATAATAACGTCGGACTGAGC 
multiple-gene deletion RGR35 CF ACTCAATGCCTGTAACTTGC 
multiple-gene deletion RGR35 CR CGTGAGTGATGGTGAGC 
multiple-gene deletion DGR19 (MGD19) UF CCTCTACCAACACTATAAAGCG 
multiple-gene deletion DGR19 (MGD19) UR ATGCGGTCTCACGTTCGTCTCAGACCAATAGCTTTGGGATTGGC 
multiple-gene deletion DGR19 (MGD19) DF GCATGGTCTCAGCTGCGTCTCAGGTCCGTTACTCATCCCAATGC 
multiple-gene deletion DGR19 (MGD19) DR CGCAGTATGTATGACCGC 
multiple-gene deletion DGR19 (MGD19) B1R TTCAACATGAGAACTCCAGC 
multiple-gene deletion DGR19 (MGD19) B2F AACATCTCGATCTTTCAACG 
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multiple-gene deletion DGR19 (MGD19) CF GATTGCTAATGTCATCAGTGC 
multiple-gene deletion DGR19 (MGD19) CR GTACGTTGGATTCGTTAATCG 
multiple-gene deletion RGR36 UF CCCAAAGTGATCTGGC 
multiple-gene deletion RGR36 UR ATGCGGTCTCACGTTCGTCTCAGACCGTCAATACCGATAATTTTTGC 
multiple-gene deletion RGR36 DF GCATGGTCTCAGCTGCGTCTCAGGTCTAAATTTATTCTTATTAGGGACGC 
multiple-gene deletion RGR36 DR CCCCTTCTGCTAATGTCG 
multiple-gene deletion RGR36 B1R GTTTCACCTAAGTAGTCTTCTGC 
multiple-gene deletion RGR36 B2F TTTAGTAGCCATGCGAGC 
CRISPR ready 
CRISPR-Ready 
strain construction UF TTATCTGGAAAAAGTTCGTGTC  
CRISPR ready 
CRISPR-Ready 
strain construction UR ATGCGGTCTCACGTTCGTCTCAGAACTAGAGTTAAGTCAAAACAAAACCCT  
CRISPR ready 
CRISPR-Ready 
strain construction DF GCATGGTCTCAGCTGCGTCTCAGAAATATTAAAAGCAACATCGATAAGAT  
CRISPR ready 
CRISPR-Ready 





























































Table 3.1. Oligonucleotides used in this study 
Oligo abbreviations: U, upstream; D, downstream; F, forward; R, reverse; TS, top strand; 
BS, bottom strand. Deletion verification primers are for PCR reactions labeled A1, A2, 
B1, B2, C as shown in Figure 3.7. Bases highlighted in red serve to mark the spacer 




Strain	   Region	   Deletion	   MS	  growth	   Start	   End	   CDS	   GT	  colonies	   GT	  puddle	   PCR	  verifications	   WGS	  
NA	   RGR1	   failed	   NA	   31264	   60558	   39	   0	   0	   NA	   NA	  
MGD1	   DGR1	   successful	   Yes	   78742	   149394	   61	   >	  100	   NA	   AB	   verified	  
NA	   RGR2	   failed	   NA	   164334	   203760	   40	   0	   0	   NA	   NA	  
MGD2	   DGR2	   successful	   Yes	   208059	   233310	   19	   >	  50	   NA	   AB	   verified	  
MGD3	   DGR3	   successful	   Yes	   311062	   338405	   26	   >	  50	   NA	   AB	   verified	  
NA	   RGR3	   failed	   NA	   439602	   466208	   25	   7	   NA	   (A)(B)(C)	   NA	  
NA	   RGR4	   failed	   NA	   516394	   551625	   28	   <	  5	   NA	   (A)(B)(C)	   NA	  
MGD4	   DGR4	   successful	   Yes	   599230	   624488	   23	   >	  100	   NA	   AB	   verified	  
MGD5	   DGR5	   successful	   Yes	   676281	   701116	   23	   <	  5	   NA	   AB	   NA	  
NA	   RGR5	   failed	   NA	   710503	   752357	   38	   0	   1	   (B)(C)	   NA	  
NA	   RGR6	   failed	   NA	   783695	   810856	   29	   <	  5	   NA	   (A)(B)	   NA	  
MGD6	   DGR6	   successful	   Yes	   907554	   934015	   16	   >	  100	   NA	   (A)B	   verified	  
MGD7	   DGR7	   successful	   Yes	   934985	   1050978	   107	   NA	   NA	   CD	   verified	  
MGD8	   DGR8	   successful	   Yes	   1051557	   1093313	   43	   <	  5	   NA	   (A)(B)C	   NA	  
NA	   RGR7	   failed	   NA	   1095916	   1140655	   39	   <	  5	   1	   (A)(B)(C)	   NA	  
MGD9	   DGR9	   successful	   No	   1144054	   1200772	   45	   <	  5	   NA	   AB	   verified	  
NA	   RGR8	   failed	   NA	   1223614	   1255961	   36	   0	   1	   (B)(C)	   NA	  
MGD10	   DGR10	   successful	   Yes	   1273020	   1309698	   32	   >	  100	   NA	   AB	   verified	  
NA	   RGR9	   failed	   NA	   1329945	   1367729	   36	   0	   0	   NA	   NA	  
NA	   RGR10	   failed	   NA	   1399532	   1478908	   70	   0	   0	   NA	   NA	  
NA	   RGR11	   failed	   NA	   1480695	   1540442	   51	   <	  5	   1	   A(B)(C)	   NA	  
MGD11	   DGR11	   successful	   Yes	   1541577	   1724834	   167	   NA	   NA	   D	   verified	  
MGD12	   DGR12	   successful	   Yes	   1771365	   1818026	   43	   <	  5	   NA	   AB	   verified	  
NA	   RGR12	   failed	   NA	   1821335	   1850036	   31	   <	  5	   NA	   A(B)	   NA	  
NA	   RGR13	   failed	   NA	   1857673	   1884890	   29	   >	  100	   NA	   A(B)	   NA	  
NA	   RGR14	   failed	   NA	   1884940	   1910033	   27	   >	  100	   NA	   AB(C)	   NA	  
MGD13	   DGR13	   successful	   Yes	   1935996	   1957779	   23	   0	   1	   (B)C	   verified	  
MGD14	   DGR14	   successful	   Yes	   1960407	   1987074	   22	   >	  100	   NA	   AB	   verified	  
NA	   RGR15	   failed	   NA	   1995538	   2026373	   30	   0	   1	   (B)	   NA	  
NA	   RGR16	   failed	   NA	   2033721	   2068471	   30	   <	  5	   0	   (A)(B)	   failed	  
NA	   RGR17	   failed	   NA	   2098664	   2195479	   102	   0	   0	   NA	   NA	  
NA	   RGR18	   failed	   NA	   2215723	   2238239	   21	   <	  5	  	   0	   (A)(B)(C)	   NA	  
NA	   RGR19	   failed	   NA	   2239452	   2259450	   15	   0	   0	   NA	   NA	  
MGD15	   DGR15	   successful	   No	   2287925	   2308844	   19	   >	  50	   NA	   AB(C)	   verified	  
NA	   RGR20	   failed	   NA	   2324185	   2358277	   33	   <	  5	   NA	   (A)(B)(C)	   NA	  
NA	   RGR21	   failed	   NA	   2399337	   2418322	   19	   0	   1	   (B)(C)	   NA	  
NA	   RGR22	   failed	   NA	   2447198	   2493477	   34	   0	   1	   (B)(C)	   NA	  
MGD16	   DGR16	   successful	   Yes	   2493883	   2519587	   24	   >	  50	   NA	   AB	   verified	  
NA	   RGR23	   failed	   NA	   2560740	   2591587	   29	   0	   0	   NA	   NA	  
MGD17	   DGR17	   successful	   Yes	   2623088	   2663563	   38	   <	  5	   NA	   AB	   verified	  
MGD18	   DGR18	   successful	   Yes	   2664390	   2706074	   47	   8	   NA	   AB	   verified	  
NA	   RGR24	   failed	   NA	   2707541	   2737496	   18	   0	   1	   NA	   NA	  
NA	   RGR25	   failed	   NA	   2739309	   2776936	   40	   0	   0	   NA	   NA	  
NA	   RGR26	   failed	   NA	   2883859	   2909403	   24	   >	  100	   NA	   (A)B(C)	   NA	  
NA	   RGR27	   failed	   NA	   2918531	   2938767	   21	   0	   0	   NA	   NA	  
NA	   RGR28	   failed	   NA	   2995282	   3021943	   25	   10	   NA	   (A)B	   failed	  
NA	   RGR29	   failed	   NA	   3053283	   3077896	   22	   0	   1	   (B)(C)	   NA	  
NA	   RGR30	   failed	   NA	   3088981	   3118052	   24	   <	  5	  	   NA	   (A)(B)	   NA	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Strain	   Region	   Deletion	   MS	  growth	   Start	   End	   CDS	   GT	  colonies	   GT	  puddle	   PCR	  verifications	   WGS	  
NA	   RGR31	   failed	   NA	   3184473	   3216931	   35	   0	   0	   NA	   NA	  
NA	   RGR32	   failed	   NA	   3241618	   3264925	   16	   10	   NA	   (A)(B)(C)	   NA	  
NA	   RGR33	   failed	   NA	   3321697	   3371121	   34	   >	  100	   NA	   (A)B(C)	   NA	  
NA	   RGR34	   failed	   NA	   3372053	   3404735	   26	   >	  50	   NA	   AB(C)	   NA	  
NA	   RGR35	   failed	   No	   3446141	   3468761	   24	   >	  100	   NA	   A(B)C	   NA	  
MGD19	   DGR19	   successful	   Yes	   3506619	   3530674	   27	   >	  50	   NA	   ABC	   NA	  
NA	   RGR36	   failed	   NA	   3570486	   3598496	   27	   <	  5	  	   NA	   A(B)	   NA	  
Table 3.2. Multiple-gene deletion validation results (continued) 
Multiple-gene deletion validation results, detailing growth in minimal succinate (MS) 
media, genome coordinates (green columns), number of annotated coding sequences 
(CDS), number of colonies from Golden Transformation (GT colonies), number of 
colonies from puddle transformation (GT puddle), PCR verifications for reactions 
illustrated in Figure 3.7 with failed verifications in parenthesis and whole genome 
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One goal of synthetic biology is to define the minimal components required for cellular 
life. One way to achieve this is to target portions of an organism’s genome that are 
determined to be nonessential—via comparing genome sequences, constructing 
metabolic and regulatory networks, and testing the viability of single-gene knockouts—
for deletion. Yet, systematic disruption of many genes often impairs robust cellular 
growth. On the road towards genome minimization, this loss of fitness can severely limit 
the number and depth of design trajectories that can be explored. Adaptive laboratory 
evolution is a common strategy for improving the fitness of bacterial strains subjected to 
stresses. We hypothesized that strains with large deletions would be able to rapidly 
acquire mutations that compensated for their fitness defects through altering their 
remaining genes. We evolved 11 multiple-gene deletion strains of Acinetobacter baylyi 
for ~300 generations in either rich or minimal media and found that one or two mutations 
can completely restore fitness in many cases. The recurring appearance of ribonuclease D 
(rnd) inactivating mutations in multiple evolved lines of different reduced genome strains 
suggests regulatory changes impacting global gene expression are a dominant adaptive 
response to generic losses in fitness due to widespread gene deletion. Specific deletion 
strains also had characteristic mutations in tRNA sequences, in the AbsR28 small 
regulatory RNA, or in the csrA gene that could compensate for processes that were 
compromised or unbalanced in these strains. Our results show that compensatory 
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evolution can overcome fitness defects that accumulate during engineered genome 
reduction to re-open paths to further genome minimization.  
INTRODUCTION  
Simplifying genomes by removing unnecessary and uncharacterized genes has the 
potential to make microbes into more efficient and predictable cellular factories 50. The 
process of genome reduction can also help to better define the minimal requirements for 
cellular life 196. Several efforts in different bacterial species have shown that large-scale 
genome streamlining can result in strains with other desirable traits, including improved 
predictability 197, greater stress tolerance 52,71, lowered autolysis 62, improved plasmid 
maintenance 55, and increased competence 59,63. Notably, increased productivity (biomass 
yields) and improved expression of desired products (e.g., heterologous genes) have been 
achieved in both model and industrial organisms like Escherichia coli 56,66,68,198, Bacillus 
subtilis 62, Corynebacterium glutamicum 60 and Pseudomonas putida 64. Often, the 
improvements are the direct result of removing components—such as proteases, 
nucleases, prophages and transposons—that interfere with expression levels or genetic 
stability related to the desired product 55,56,199. Alternatively, the removal of non-essential 
gene clusters that encode particularly burdensome cellular functions (e.g., flagella or 
secondary metabolite production) may improve strain characteristics, for example, via 
upregulation of TCA cycle genes 62,64,66,200.  
Despite these advances, minimal genome construction has often reached a dead 
end when strains accumulate growth defects that make further deletions effectively 
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impossible to construct 54,69,71,79,201. In addition to losses in fitness due to deleting genes, 
genome reduction also carries the risk of inadvertently generating new sequence 
junctions that combine genetic components in ways that lead to growth defects. This was 
the case during the initial stages in the construction of the minimal Mycoplasma mycoides 
JCVI-syn1.0 genome, when colonies with severely impaired growth revealed that the 
designed deletion caused an unintended juxtaposition of a transcription terminator and an 
essential gene. However, colonies with faster-growing sectors began to appear within a 
12-day incubation, demonstrating that it is possible for fitness problems that crop up 
during genome streamlining to be fixed by spontaneous mutations 54. Evolution 
experiments also showed that Salmonella strains with large random deletions can recover 
fitness in < 100 generations 202. Just as the cost of antibiotic resistance can often be 
mitigated by compensatory mutations 203, minimized genomes appear to still have access 
to a broad adaptive landscape that can compensate for fitness lost due to gene deletion. 
Studies that examine the adaptive landscape of minimized genome strains are 
scarce and usually anecdotal. Although the most streamlined E. coli strain to date (Δ33a) 
has documented growth defects, an evolved variant (Δ33b) was later described as “fast-
growing” 204. It was reported that starvation-mediated mutagenesis and evolution 
improved growth and other phenotypic characteristics of the reduced-genome E. coli 
strain MDS42 205. Moreover, Legionella pneumophila with 18.5% of its genome deleted 
readily acquired point mutations that suppressed the deleterious effects of genome 
reduction 206. Most recently, adaptive evolution of the streamlined E. coli strain MS56 
revealed global transcriptional changes in gene expression due to mutations in the 
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housekeeping sigma factor (rpoD) that alter utilization of different promoters by RNA 
polymerase 86. These types of global changes in transcription potentially make sense in 
the context of the increased expression of genes controlled by the stationary phase sigma 
factor (rpoS) that are observed in other reduced-genome E. coli strains (MDS42 and 
MDS69) 71. Similarly, mutations in the transcriptional machinery (e.g., rpoC) are often 
observed as a means to optimize metabolism and improve growth under stressful 
conditions in many adaptive laboratory evolution (ALE) experiments with wild-type E. 
coli 207 208. Thus, it appears that re-tuning the same global regulatory processes (e.g., 
transcription) may often be the most expeditious and generalizable way for evolution to 
improve the fitnesses of both wild-type genomes and less-fit reduced genomes, though 
the knob and degree of tuning may differ. 
In some cases, loss of a specific set of genes may make it impossible for 
regulatory re-tuning to restore bacterial fitness to the same level, at least on a reasonable 
timescale. Because current evolutionary studies of minimal genomes have reported on 
fortuitous evolution experiments and/or examined only a single reduced genome, it is 
unknown how often compensatory evolution can or cannot restore fitness defects in 
minimized-genome strains. Much of our current understanding of how evolution 
compensates for the loss of different functions is derived from single-gene knockout 
studies. Some E. coli single-gene knockouts are able to restore their ability to grow in 
minimal medium after a mere ~145 generations of evolution 209. The mutations behind 
this compensatory evolution are sometimes gene amplifications but they are mostly point 
mutations and IS elements 209. Other studies have looked specifically at how 
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overexpression of a different gene can often compensate for depletion or complete loss of 
an essential gene 210. Overexpression of one gene on a plasmid can often reverse an 
auxotrophy due to loss of another gene through secondary, promiscuous, or 
uncharacterized activities of a different gene even it they may not share any sequence 
homology with the deleted one 211. Thus, there is widespread evidence that compensatory 
evolution can restore fitness after gene loss. 
We hypothesize that purposefully employing compensatory evolution before 
combining deletions can allow one to overcome the fitness constraints that are 
encountered as more and more genes are removed during minimal genome construction. 
To begin to test this hypothesis, we selected 11 reduced-genome strains of Acinetobacter 
baylyi ADP1, each with 20-57 kb of the wild-type genome removed and performed short 
adaptive laboratory evolution experiments with each one in both rich and minimal media. 
Characterization of whether fitness was restored or not during these evolution 
experiments and of the compensatory mutations that appeared in each of these reduced-
genome genetic backgrounds provides insights into the potential of utilizing evolution as 
a tool to further extreme genome reduction.  
  
METHODS 
Strains and culture conditions 
Transposon-free A. baylyi ADP1-ISx is the parental strain of all deletion mutants 
in this study 211. Liquid cultures were incubated at 30°C with orbital shaking at 200 r.p.m. 
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(1-inch diameter) in 18- by 150-mm glass test tubes in the Miller formulation of 
Lysogeny Broth (LB) or in minimal succinate (MS) medium 183. Solid media included 
1.5% (wt/vol) agar. Frozen stocks of strains and evolved populations were stored at –
80°C with 15-20% (v/v) glycerol. Where appropriate, media were supplemented with 50 
µg/ml kanamycin (Kan) or 200 µg/ml 3′-azido-2′,3′-dideoxythymidine (AZT). 
All large deletion strains used in this study underwent AZT counter-selection to 
remove the selection cassette used for their construction from their genomes. AZT is 
toxic to cells harboring the tdk gene as part of the positive-negative selection cassette 
used to replace the deleted genes. The counter-selection procedure proceeded via a 
“rescue” Golden Transformation that combined the PCR products corresponding to the 5′ 
and 3′ flanks (~2 kb each) targeting the deletion region with plating the transformation 
mix on LB-AZT plates (Chapter 3). In every case, at least 2 colonies were screened via 
PCR for successful removal of the tdk-kanR cassette and further validated by testing for 
the expected inability to grow on LB-Kan agar.  
Experimental Evolution 
A total of 11 confirmed marker-less deletion strains and a wild type ADP1-ISx 
control were subjected to a ~300 generation adaptive laboratory evolution (ALE) 
experiment. To begin the experiment, each strain was plated onto LB and MS agar to 
obtain single colonies. After growth, 6 randomly picked clones of each strain from each 
type of agar were used to initiate independent 1 mL liquid cultures in the same medium to 
grow the Day 0 populations. On each of the following days of the evolution experiment 
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cultures were diluted 1:1000 into 5 mL fresh media, left to grow for 24 h and this process 
was repeated for a total of 30 cycles of serial dilution and regrowth (~300 generations). 
An exception was made for a very unfit deletion strain (MGD8). In this case an additional 
24 h of growth was added when the cultured strain did not reach saturation in the first 24 
h early in the experiment. 
Day 0 cultures were archived as freezer stocks at −80°C. At the end of the experiment, all 
evolved populations were plated on LB or MS agar and a single large colony was 
selected in order to favor characterizing cells with compensatory mutations. Each of the 
Day 30 end-point clones was then grown overnight in 1 mL of the same medium as it was 
evolved in and stored as a freezer stock.  
Fitness assays 
Evolved population samples were competed against a GFP-tagged ADP1-ISx 
strain. This strain was constructed by inserting a tdk-kanR cassette with the T5 promoter 
from plasmid pIM1440 117 in place of IS1236#6 59. Competition experiments began by 
reviving 5 µl of glycerol stocks into 5 mL LB cultures in test tubes. After 24 h of 
preconditioning growth, 5 µL of each of these cultures were used to inoculate a test tube 
containing 5 mL of LB. After 24 h, competitions for each population (n = 6) were 
initiated by mixing 3.5 µL of each evolved line with 1.5 µL of each GFP-ADP1 culture in 
5 mL of LB; with the exception of competitions between progenitor GFP strain and 
evolved controls of ADP1-ISx, in which case 5 µL total of the two strains mixed in a 1:1 
ratio was used. Immediately after mixing and after 24 h of growth, dilutions of these 
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initial and competed co-cultures were plated on LB agar. Lastly, counts of fluorescent 
versus non-fluorescent colonies were used to compute the relative fitness as a ratio of 
Malthusian parameters as previously described 212. 
Whole genome re-sequencing 
Genomic DNA was isolated from 1-2 mL cultures of Day 0 and Day 30 clones 
from freezer stocks in the same media in which they evolved using the PureLink 
Genomic DNA Mini Kit (Invitrogen) according to the manufacturer’s instructions. DNA 
concentration was measured using a Qubit Fluorometer (ThermoFisher).  
For a first set of 56 samples analyzed in this chapter, ~500 ng of DNA was fragmented 
with NEBNext dsDNA Fragmentase (New England Biolabs) for 27 minutes to generate 
~300 bp fragments. The fragmented DNA was used as input to construct Illumina NGS-
libraries using the LTP Library Preparation Kit (Kappa Biosystems) as described by the 
manufacturer except that reaction volumes were reduced by 50% and custom adapter 
sequences were used. 7 sets of adapters were used which had 6 bp of sequence 
immediately 3' of the standard Illumina TruSeq adapter sequence such that 8 individual 
samples could be sequenced using the same external barcode sequence.  These libraries 
were sequenced on a NextSeq500 75 cycle pair-ended reaction at the University of Texas 
at Austin Genome Sequencing and Analysis Facility. Pools of 8 samples were 
demultiplexed using a custom python script based on the first 6 bases on each read. 
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Mutation analysis 
Sequencing files associated with libraries were demultiplexed based on the 6-bp 
internal barcodes introduced during library prep using a custom Python script. Adapter 
sequences were removed from all reads using Trimmomatic (version 0.36) 213 before 
being evaluated for mutations. Trimmed reads were compared to the A. baylyi ADP1 
reference genome 214 using breseq (version 0.33.2) 215 to confirm the presence of the 
expected deletions and identify additional mutations that accumulated in each strain 
during the course of the evolution experiments.to. Mutation figures were created using 
Circos 216 and R (R Core Team, 2019). 
RESULTS AND DISCUSSION 
Evolution Experiment 
We conducted a 30-day (~300-generation) adaptive laboratory evolution (ALE) 
experiment on a collection of large deletion mutants by performing 1000-fold serial-
dilution transfers in either LB or in minimal succinate (MS) media (Fig. 4.1). In total, the 
ALE experiment consisted of 144 populations: 11 large deletion mutants and their ADP1-
ISx ancestor with 6 evolved lines in LB and 6 in MS.  A. baylyi ADP1-ISx has had all 
transposable elements deleted from its genome 59 and each deletion strain has an 
additional large multiple-gene deletion of ~1% of its genome (Fig. 4.2). These strains are 
numbered according to their multiple-gene deletion (MGD) strain designation from 
Chapter 3. Strain designations are appended to the MGD number for independent 
ancestral isolates (labelled A1 and A2) and evolved isolates (labeled E1 through E6) 
followed by the medium in which they were evolved (LB or MS).    
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Fitness Evolution 
All the deletion mutants in this adaptive evolution study were found to have 
impaired growth rates relative to the ADP1-ISx progenitor when cultured in rich medium 
in previous work (Chapter 3). Here, we performed more sensitive co-culture competition 
experiments, in the same medium (LB), to assay the changes in fitness before and after 
adaptive laboratory evolution. We began by removing the tdk-kanR cassette that was 
initially present in the genomes of each of the large deletion strains prior to the ALE 
experiment to exclude fitness costs (e.g., from production of the antibiotic-resistance 
gene) other than those generated by the deletions themselves.  
The range of the growth defects in LB among the 11 deletion mutants varied from 
38% to 89% (~61% average) of the growth rate relative to the progenitor strain (Chapter 
3). We began to characterize fitness for parent and evolved strains. So far, we have 
performed fitness assays in LB with five of the deletion mutants (MGD3, MGD4, MGD6, 
MGD10 and MGD18). As expected, MGD4, MGD6, and MGD10 had reduced fitnesses 
at the start of the ALE experiment (Fig. 4.3). Unexpectedly, the MGD3 and MGD18 
unevolved parent strains exhibited nearly the same fitness as ADP1-ISx (Fig. 4.3). We 
discovered through genome sequencing that this discrepancy was due to these two strains 
having already acquired compensatory mutations, probably during the marker removal 
step in constructing these strains (described below).  
We judged whether there was a significant (p ≤ 0.01) or marginally significant 
(0.01 < p ≤ 0.05) increase in fitness in an evolved strain relative to its ancestor using two-
tailed Student’s t-tests. As mentioned, MGD3 had acquired mutations early on our 
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experiment, yet one of the evolved clones (E6) appears to have further restored fitness 
towards the ADP1-ISx baseline (Fig. 4.2). All six MGD4 LB-evolved clones have 
varying degrees of fitness recovery. In particular, four of MGD4 LB-evolved strains 
show significant—albeit partial—fitness recovery, while MGD4-E4LB shows no 
difference from wild type, and MGD4-E3LB exceeds ADP1-ISx fitness. The most 
remarkable case of fitness recovery is observed for MGD6, with stark contrast of fitness 
measurements between Day 1 and Day 30 clones. All but one of the MGD6 LB-evolved 
strains significantly recovered fitness, four partially and one (E6) with near ADP1-ISx 
fitness. One of the MGD10 LB-evolved clones (E2), marginally significantly increased 
its fitness (p=0.045), yet it remains much less fit than ADP1-ISx. No significant 
differences in fitness were observed for any of the evolved ADP1-ISx controls. 
These results highlight that even when large deletions tend to be maladaptive, at 
least partial restoration of fitness is commonly achieved if propagation is allowed to 
attain compensatory mutations 202. They are also generally consistent with the finding 
that the less-fit an initial mutation makes a strain, the greater its capacity to evolve 
increased fitness, since there are many more steep compensatory paths in the fitness 
landscape to re-ascend the same peak or access new peaks 217. This is a type of positive 
epistasis that has also been seen with adaptive mutations that compensate for deletions, 
which are generally more beneficial in less-fit genetic backgrounds 218.  
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Genome Evolution Rates  
We next examined the mutations that occurred during ALE for five of the deletion 
mutants (MGD3, MGD4, MGD6, MG10 and MGD18). Our dataset so far includes all six 
LB-evolved endpoint strains derived from each MGD ancestor, in addition to several of 
their MS-evolved counterparts. After 300 generations, we identified a total of 67 
mutations in 42 sequenced LB and MS-evolved clones. The 67 mutations (9-15 per set of 
deletion mutants) can be classified into 6 categories, including large deletions, small 
indels, intergenic SNP, non-coding SNP, non-sense SNP and non-synonymous SNP (Fig. 
4.4). Overall, we find ~1.6 mutations per evolved clone, with the number of mutations 
ranging from 1 to 3 (Fig. 4.5). Although a total of 23 genes/loci are mutated across all LB 
and MS-evolved clones, the majority (47/67) of the mutations happen within just six loci: 
ACIAD0697/lysP (AbsR28) (5 total), ACIAD2521/ACIAD2522 (11 total), 
ACIADtRNAVal_46 (6 total), csrA (5 total), pgi (4 total) and rnd (16 total) (Fig. 4.6).  
We observe a greater number of mutations in LB than in MS, with averages of 1.73 (52 
mutations in 30 clones) and 1.25 (15 mutations in 12 clones) mutations per evolved 
clone, respectively; though this difference is not significant due to the small number of 
MS-evolved clones analyzed so far. Separating these out by ancestral MGD strain, there 
are 14 mutations in MGD3, 14 mutations in MGD4, 15 mutations in MGD6, 6 mutations 
in MGD10 and 15 mutations in MGD18. The smaller number of mutations observed in 
MGD10 correlates with no significant increases in fitness for all but one of its evolved 
clones. We found no mutations in the one evolved ADP1-ISx clone sequenced so far 
(E1). This is consistent with the negligible fitness increase in the six evolved ADP1-ISx 
 114 
clones, but surprising because the first selective sweeps in ALE experiments usually 
happen within 300 or fewer generations. Since the remaining ADP1-ISx evolved clones 
did not get sequenced, it is possible these have some beneficial mutations. On the other 
hand, ADP1-ISx may evolve slowly due to a combination of its already high fitness in 
this environment (like MGD10) and its reduced mutation rate 59. 
Specificity of Genomic Evolution   
We next examined parallelism in the genes hit by mutations in different evolved 
strains and a previous 1000-generation ALE experiment with wild-type A. baylyi ADP1 
in LB 19. We found some recurring and overlapping mutations between the MGD strains 
and the prior ALE experiment (Fig. 4.7). The most frequent mutation across all evolved 
lines of different deletion strains corresponds to a 49-kb deletion of a prophage region. 
This deletion (coordinates ~2120339-2,169,692) was also previously observed in wild-
type ADP1. Its appearance across so many genetic backgrounds makes it an example of a 
universally beneficial mutation (i.e., one that is not dependent on the gene deletion 
background). Previously observed intergenic ACIAD2521-ACIAD2522 mutations 
(immediately upstream ACIAD2521) and mutations in the pgi and per genes were 
prevalent across different deletion strains and also fall into the same category. In contrast, 
recurrent mutation of rnd (RNase D) and csrA happened in multiple deletion strains but 
not in the evolved ADP1-ISx control we have sequenced or in the previous ALE 
experiment with ADP1. These mutations may be a generic adaptive response to 
compensating for some shared characteristic of deletion strains with reduced fitness (e.g., 
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growth rate). Other common mutations are specific to one MGD strain background such 
as mutations affecting the AbsR28, which are common in and only appear in the MGD6 
background. 
It has been observed that strains with deletions in the same functional module 
tend to adapt similarly 218. Other studies have repeated this observation that most 
compensatory (suppressor) mutations following gene deletion happen within the same 
functional network but also noted that they are not necessarily limited to it 219 220. 
Previous studies have also found that compensatory mutations in single-gene knockouts 
often happen in the exact same remaining gene (parallel evolution) 221 220. We also 
observe some targets for adaptive mutations that seem to be in common to all large 
deletion strains and others that are specific to MGD strains in which certain pathways or 
genes are removed that compromise fitness or constrain adaptive pathways. 
Universally beneficial mutations in extracellular polysaccharide production 
During our AE experiment, several of the LB-evolved ADP1-ISx and large 
deletion mutants acquired mutations impacting perosamine synthetase (per; ACIAD0095) 
or glucose-6-phosphate isomerase (pgi; ACIAD0101) genes (Fig. 4.6). Specifically, of the 
sequenced deletion mutants, 3/5 (MGD 3, MGD4 and MGD18) harbored pgi mutations in 
one or multiple evolved lines. Notably, mutations impacting the pgi gene are prevalent 
(3/6) in LB-evolved MGD18 (E2, E5 and E6), while only found once in MS-evolved 
MGD3 (E1), and also once in MS-evolved MGD4 (E3). Similar pgi and per mutations 
have been observed previously in ALE experiments performed in our lab and presumed 
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to be beneficial due to their high frequency 19. The pgi gene encodes phosphoglucose 
isomerase, which plays a key role in glycolysis and gluconeogenesis pathways, 
catalyzing the interconversion of glucose-6-phosphate and fructose-6-phosphate. Both 
per and pgi are known to be involved in the biosynthetic pathway of a secreted emulsifier 
in the closely related species Acinetobacter lwoffii RAG-1 222 223. Specifically, they 
belong to a large multi-gene cluster known as wee — also known as the capsule gene 
cluster — which is required for biosynthesis of emulsan polysaccharides 224 222 223.  In 
wild-type ADP1, inactivation of the pgi gene was determined to be involved in cellular 
aggregation and causes cells to settle at the bottom of liquid cultures 19, a phenotype we 
also observed in LB-evolved MGD18. Additional mutations and deletions (Δ195 bp in 
ACIAD0098 of a MGD3 line and Δ11,507 bp covering genes ACIAD0093–ACIAD0103 
of a MGD18 line) are found throughout the wee gene cluster, including mutations in 
ACIAD0085 – a glycosyl transferase – and in galU (ACIAD0099) (Fig. 4.5). Similarly, 
large IS-mediated deletions that span these same genes were observed in prior ADP1 
ALE experiments 19. Overall, due to the frequency and appearance of wee gene cluster 
mutations across multiple evolved lines regardless of the genomic context, these can be 
considered universally beneficial. They are good candidates for mutations that could be 
incorporated into any future reduced-genome strains to give them greater fitness. 
Universally beneficial mutations upstream of ACIAD2521 
In addition, several point mutations and a small deletion (deletion of one copy of 
TAAT repeat) arose upstream (98-146 bp) of the start codon of ACIAD2521, a gene of 
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unknown function (Fig. 4.8). Of these, the exact same base substitutions at 127 bp 
upstream of the start codon of this putative gene were also noted multiple times in the 
previous wild-type ADP1 ALE experiment 19. In that study, it was suspected that these 
variants emerged as a polymorphism in the parent ADP1 culture used to initiate the AE 
experiment due to their high frequency. Given the independent origins of our deletion 
mutants, our data suggest instead that mutations in this region increase in frequency 
quickly. Note that even though the small TAAT deletion seems to have been carried from 
the MGD3 parent (it is in unevolved MGD3 and all of its evolved clones), suggesting that 
it occurred during deletion construction in this lineage, this exact same mutation was only 
prevalent (9/12) in MGD4 and was seen just once in MGD6-derived strains. Also, while 
MGD10 has recurrent point mutations at 98 bp upstream of the start codon of 
ACIAD2521, a different point mutation (146 bp upstream of start codon) shows up 
exclusively in one of the MGD4 evolved lines. All of these mutations—covering a 49-bp 
region—likely affect expression of the ACIAD2521 gene by modulating its promoter. The 
lack of genetic background context-specificity of these mutations suggests they benefit 
both genome-reduced and wild-type genomes.  
RNAse D mutations specific to MGD strains 
A total of 16 rnd mutations are observed (in both LB and MS media), yet these 
are only prevalent in MGD3, MGD4 and MGD6. Of these rnd mutations, we note a 
recurring deletion (62 bp) and several premature mutations to stop codons near the end of 
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the reading frame (Fig. 4.9). The spectrum of the rnd mutations suggests that they reduce 
or eliminate rnd activity and that this change is somehow beneficial to cells.  
RNAse D is an exoribonuclease that participates in the 3’ maturation of tRNA, 5S 
rRNA, and several other small-structured (tRNA-like) RNAs 225 226. It is most active on 
tRNA molecules containing additional residues following the mature 3′ terminus or 
molecules lacking all or part of the −CCA sequence. It also has high specificity to 
denatured and damaged tRNA substrates. In E. coli, strains devoid of RNase D grow 
normally and show no defect in tRNA processing 227, while overexpression has been 
determined deleterious 228. It is only essential for viability when other nucleases (RNAse 
II, BN, T and PH) are eliminated, suggesting a role as a backup enzyme when primary 
nucleases are missing 229. This gene has a conserved DEDD catalytic motif with a fold 
that is similar to the Klenow fragment exonuclease domain, and this motif along with two 
putative nucleic acid domains come together to form a ring-shaped structure important 
for substrate specificity 226.  
Previously, rnd mutations were suspected as the possible cause behind the 
observed gene expression changes critical for pathogenesis, by way of transcriptome 
remodeling during infection 230.  This was determined by the observation that rnd gene 
inactivation (IS-element mediated) were prevalent in isolates from patients infected with 
Acinetobacter baumanii, a close relative of A. baylyi. In our study, ADP1 is responding 
similarly (rnd inactivations), yet in a very different environment (LB), and in various 
multi-gene deletion contexts. The relationship between multi-gene deletions and 
pathogenesis, although disparate, could be linked in that both may be related to the roles 
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of rnd in post-transcriptional regulation. As a global transcriptome modulator, rnd 
inactivation or modulation could cause large global changes in gene expression capable 
of leading to large fitness benefits in a single mutational step. Reduced-genome variants 
of other bacterial species have shown to have greatly perturbed gene expression patterns, 
including higher expression of stress related genes 71 53. Future transcriptome analyses of 
the effects of the rnd mutations reconstructed in wild-type and reduced genome ADP1 
variants could elucidate how it is affecting global gene expression in a beneficial manner 
and to what extent these benefits may depend on some generic feature of deletion strains 
(e.g., reduced growth rate).  
Mutations in small RNA AbsR28 specific to MGD6 strains  
Five of ten sequenced MGD6 evolved lines acquired intergenic point mutations 
(all different) between genes ACIAD0697 and ACIAD0700 (lysP). All of these mutations 
happen downstream of both these genes, rather than upstream in possible promoter 
regions, so it was unclear how they could affect these genes. This led us to looked for the 
presence of unannotated genes in this putative intergenic region. By querying the Rfam 
database, we identified an A. baylyi match to a small RNA, AbsR28 (RF02606), that had 
been experimentally validated in Acinetobacter baumanii 191 231 (Fig. 4.10). One 
predicted target of AbsR28 – from using the IntaRNA tool 232 – maps to ACIAD2197, a 
gene commonly deleted as part of the known ~ 49 kb prophage region. It may be possible 
that these sRNA mutations may regulate phage functions or prevent prophage-related 
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excision from the genome, since the aforementioned prophage region is deleted often (9 
cases) in other MGD strain backgrounds but never in MGD6. 
Carbon storage regulator csrA mutations 
Several evolved lines (4/6 LB-evolved) of MGD4 acquired csrA non-synonymous 
point mutations, and csrA was also mutated in one of the MGD6 evolved lines (Fig. 
4.11). The csrA reading frame was altered during IS1236#4 removal during construction 
of the ADP1-ISx strain that is ancestral to all MGD strains. Deletion of this IS-element 
removed 13 of the normal amino acids from the C-terminus of CsrA and added 
translation of 26 new amino acids to this protein before the new stop codon is reached. It 
is unknown how these changes to the C-terminal end of CsrA affect its function.   
The carbon storage regulator CsrA is a stress and global response gene known to 
mediate gene expression changes during shifts from rapid growth to stress survival 233 234. 
The appearance of mutations in csrA in our study could also be consistent with the 
induction of a general stress response in reduced genomes 71–provided that altering the 
function of the perturbed protein produced in the ADP1-ISx strain changes this activity, 
rather than just restoring it to its wild-type function. As a key translational regulator, 
CsrA binds its target mRNAs to regulate translation initiation and/or mRNA stability. It 
is possible that mutations in csrA result in the repression of phosphoglucose isomerase 
(pgi), since a fully functional csrA gene would be expected to positively regulate the 
activity of pgi. Thus, loss of csrA could repress pgi to phenocopy beneficial mutations in 
pgi found in other evolved strains 19,233. The lack of simultaneous pgi and csrA mutations 
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in any of our evolved strains is consistent with this possibility, though it needs to be 
tested directed by reconstructing and testing strains with combinations of these mutations. 
Since csrA has been shown affect the expression of hundreds of genes in E. coli, 
mutations in this gene may be a further indication that deletion mutants are prone to 
undergo global transcriptome remodeling to restore growth rates 235.  
 
CONCLUSION 
We sought to elucidate the genetic basis of mutations that compensate for or 
otherwise reduce the fitness defects of a panel of Acinetobacter baylyi ADP1-ISx strains 
with different multiple-gene deletions. To do so, we sequenced ancestral and end-point 
clones from a ~300 generation laboratory evolution experiment. Notably, multiple 
mutations in the rnd and csrA genes spontaneously arose in deletion mutants during ALE, 
evidence that genome-reduced strains likely undergo rapid global transcriptional changes 
to counter metabolic imbalances due to the loss of multiple genes. In addition, certain 
deletion mutants gained compensatory mutations that were unique to the specific genes 
that they were missing, possibly as mechanisms to restore fitness defects from metabolic 
or regulatory imbalances caused by the deletions. Other universally beneficial mutations 
were observed to restore fitness in several of the deletion mutants and also in the control 
strain that does not have a deletion. In most cases characterized so far, near or complete 
fitness restoration was observed. Lastly, our study reveals that, in the case of the multi-
gene deletions we have investigated so far, adaptive mutations do not seem to be 
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restricted to functional modules that are obviously related to the deleted genes in each 
deletion mutant.  
In sum, this work builds a framework to further our understanding of how 
reduced-genome variants can evolve to restore their fitness defects. If a thorough 
landscape of compensatory mechanisms can be mapped, it paves the way to superimpose 
multiple deletions and compensatory mutations to possibly achieve genome streamlining 
without compromising fitness, at least to the degree seen in most strains with severely 
reduced genomes that have been created to date. The sets of evolved A. baylyi ADP1-ISx 
multiple-gene deletion strains discovered here may also create opportunities for 
overcoming fitness constraints to explore even more extreme genome streamlining design 
trajectories than is currently possible. These insights will further the synthetic biology 


















Figure 4.1. Adaptive evolution experiment.  
A set of 11 large deletion mutants were subjected to a ~300 generation adaptive 
laboratory evolution. Starting from single colonies twelve populations of each of the 
deletion mutants were passaged with 1000-fold dilutions in 5 mL of either rich medium 
(LB) or minimal succinate medium (MS). A single large-colony clone was isolated from 
each evolved population after 30 transfers. The fitnesses of these clones were 









Figure 4.2. Large deletion mutants selected for the AE experiment.  
Regions deleted in each of 11 large deletions mutants used in this study are shown on the 
3.6 Mb A. baylyi ADP1. These are a subset of a previously generated ADP1 large 
deletion collection (Chapter 3). The deletions in the 11 MGD strains selected range in 
















Figure 4.3. Relative fitnesses of evolved and ancestral MGD strains.  
Five of the large deletion mutants tested, two control unevolved original progenitors 
(brown) and six evolved lines (blue) were competed against a GFP-marked wild-type 
ADP1-ISx strain in LB. Significance is determined by two tailed student’s t-test with 
Bonferroni correction and indicated by one (p-value <0.01) or two (p-value <0.001) 













Figure 4.4. Mutation categories by deletion mutant.  
Compensatory mutations in adaptive laboratory evolution of large deletion mutants for 
five deletion mutants (6-12 replicate lines for each in LB and minimal media) after 
experimental adaptive evolution. The sum total of mutation types found in any of the 
deletion mutants are displayed and classified into six categories represented by their 
respective color: large deletions, small indels, intergenic SNP, non-coding SNP, non-
















Figure 4.5. Distribution of mutation categories in each of the evolved large deletion 
mutants.  
The mutation categories in each of the deletion mutants are analyzed for 42 of the LB-









Figure 4.6. Mutation counts per gene/loci per deletion mutant.  
There were a total 23 mutated genes/loci found on any of 5 LB or MS-evolved deletion 
mutants. Of a total of 67 mutations, 47 happen within the six most frequently mutated 
genes/loci: ACIAD0697/lysP (AbsR28) (5 total), ACIAD2521/ACIAD2522 (11 total), 

















Figure 4.7. ADP1 chromosomal distribution of compensatory mutations of deletion 
mutants.  
View of all LB-evolved and MS-evolved compensatory mutations identified by whole 
genome sequencing throughout the 3.6 Mb chromosome of Acinetobacter baylyi ADP1, 
derived from each of the 5 large deletion mutants submitted to the ~300 generation 
adaptive laboratory evolution experiment. Sites of parallel evolution, including the rnd 








Figure 4.8. Mapped intergenic ACIAD2521-22 mutations. 
A total of 11 point mutations, between ACIAD2521 and ACIAD2522, are seen across four 
of the large deletion mutants: MGD4 (red), MGD10 (green), MGD6 (blue) and MGD18 
(purple).  The mutations span a region within 98-146 bp upstream of ACIAD2521, a gene 



















Figure 4.9. Mapped rnd mutations.  
Location and description of mutations in the rnd gene. Label/symbol colors represent any 
of the 4 evolved large deletion mutants where these were acquired: MGD3 (red; circle), 
MGD4 (blue; circle), MGD6 (green; triangle), MGD10 (purple; circle). MGD18 did not 
acquire Rnd mutations, thus is excluded. Mutation types included non-synonymous point 
mutations, stop codon mutations (TAG or TGA) or deletions (represented by gray bars at 

















Figure 4.10. Mapped csrA mutations.  
A total of 5 csrA mutations are seen across three of the large deletion mutants: MGD3 
(red; circle), MGD4 (blue; circle) and MGD6 (green; circle). It is possible these 
mutations are evolved protein adjustments resulting from deletion of last 13 amino acids 
















Figure 4.11. Mapped mutations of AbsR28 small RNA.  
Multiple lines of LB-evolved MGD6 acquired mutations downstream the lysP gene. This 
led to the identification of AbsR28 small RNA, depicted with the blue green bar 













Chapter 5: Conclusions and future directions 
 
Engineering greater A. baylyi genome stability: remaining challenges 
Several other factors that impact the genome stability of A. baylyi ADP1 as a 
platform organism remain to be explored and addressed in future work. With the IS-
element free ADP1-ISx strain created in this work, a significant portion of the mutational 
load was successfully reduced. Yet, there remain selfish genetic elements lurking in its 
genome that could be removed in future work, and there is still the potential to reduce 
mutagenic processes affecting the fidelity of DNA repair and replication to further 
improve its genome stability 236 237.  
 Importantly, clearing phage and phage-related proteins from the ADP1 genome 
remains to be addressed. These additional regions of likely genomic instability contain a 
large number of genes classified as non-essential (58 total; ~20 predicted to be phage-
related). One prophage region is located in an unstable part of the genome flanked by 
repeat sequences. It is often spontaneously lost during evolution experiments. Thus, it 
poses little problem for removal. However, another prophage, which can become 
activated during growth of ADP1 in the laboratory to produce the competence-reducing 
Acinetobacter phage (CRAφ), is more troublesome 19 238.  
CRAφ is a filamentous phage that appears to utilize the competence pilus as a 
receptor, as knockouts of competence genes provide immunity. Stochastic activation of 
phage production in some cells in A. baylyi ADP1 populations leads to strong selection 
for mutations that knock out competence during evolution experiments. Deletion of this 
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prophage would therefore stabilize maintenance of this most valuable trait for ADP1 
genome engineering. However, we have been unable to inactivate the CRAφ prophage 
after numerous attempts at replacing or inserting selection cassettes within its sequence. 
In cases where it is successfully removed from the chromosome, it persists in its episome 
form within cells, indicating that it may encode a toxin-antitoxin module or some 
essential function that leads to inviability when it is removed. In the future, it is important 
to remove this and the other prophages from the ADP1-ISx strain to achieve a fully 
clean-genome strain with even greater genomic stability. 
One can also evolve or engineer bacteria that have lower mutation rates by 
altering DNA replication and repair processes 237. For example, specific mutations in E. 
coli DNA polymerases (e.g., polA and polB) can lead to lower rates of replication errors. 
This is presumably the result of increasing nucleotide selectivity or reducing extension of 
mispaired primer termini in the case of PolA mutants 239, whereas knockout of the error-
prone polymerase PolB allows other higher-fidelity processes to be used for repair 199. 
Additionally, certain aspects of the DNA damage response can be engineered to optimize 
a cell’s capacity for preventing mutagenic damage. For example, E. coli with inactivating 
mutations in enzymes that lead to the production of reactive oxygen species have been 
shown to have lower plasmid mutation rates 240. Such mutations could potentially be 
added to ADP1-ISx to further increase the fidelity of genome replication, and this—in 
principle—would enable more stable maintenance of burdensome and complex 
biosynthetic designs over many generations of growth.  
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 In turn, it may be possible to overexpress DNA repair and other genes to reduce 
mutation rates. Candidate genes whose expression levels have been linked to mutation 
rates in E. coli include RNase H (rnhA), for its role in clearing away RNA-DNA hybrids, 
and single-stranded binding protein (SSB), for its role in protecting single-stranded DNA 
during replication and recombination. Controlled overexpression of RNAse H reduced 
amplification and point mutations by 60% on E. coli without reducing growth or cell 
viability 241. These types of genes targeted for upregulation could be tested by placing 
copies of them on a plasmid into ADP1-ISx before deciding whether it is helpful to 
engineer the native gene for overexpression to stabilize the genome. 
Development of novel engineering tools for ADP1 and other strain improvements 
Our demonstration that the native type I-Fa CRISPR-Cas locus is active in A. 
baylyi ADP1 and the method we developed to retarget it using Golden Transformation 
open new opportunities. Tools based on CRISPR-Cas systems have revolutionized the 
way we perform targeted genome manipulations 242. Yet the large diversity of CRISPR-
Cas family types still provides an ample opportunity to explore their multiple roles and 
mechanisms in bacterial adaptive immunity 193, and characterization of new varieties of 
these systems may foment the development of new and improved tools 243 244. In this 
work, we have shown that it is possible to reprogram the endogenous Cas operon and 
CRISPR array in A. baylyi. This knowledge opens up the possibility of repurposing it – 
via cas3 knockout - for transcriptional regulation, to further expand the A. baylyi toolkit 
for genetic control 195.  
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Other directed evolution approaches to minimizing genomes 
Although deletions happen spontaneously during experimental evolution, the rates 
are generally too slow (0.05 bp per chromosome per generation) to be of practical use for 
genome reduction applications 202. Tampering with DNA repair pathways (e.g., impairing 
methyl-directed DNA mismatch repair) can increase these rates ~50-fold 202, but the rate 
is still too slow to be of use. Furthermore, this strategy will also lead to the accumulation 
of deleterious mutations 245. Selection strategies can sometimes isolate spontaneous 
mutants with very large deletions (> 200 kb) in their chromosomes. These can be 
exploited to generate a new variety of reduced genomes—which may never have been 
planned because of the sets of genes they include—to expand streamlining potential even 
further 202.   
 Along these lines, some of our work that did not bear fruit in the end involved 
testing a Tn-Seq-like 246 combinatorial deletion methodology that we called rHAT for 
random Homology-Aided Targeting). rHAT aimed to exploit the natural competence of 
Acinetobacter baylyi ADP1 by feeding it an antibiotic selection marker randomly re-
ligated to ~1-kb fragments of genomic DNA to increase the rate of deletions and 
rearrangements in its genome. This method allowed for antibiotic selection of deletion 
mutants, followed by characterization at the site of cassette integration by PCR and 
sequencing. Of the 18 clones characterized, 10 (56%) had evidence of the same types of 
duplications of large genome regions that we often observed when trying to delete 
regions of the ADP1-ISx genome that contained essential genes (Chapter 4), and the 
putatively successful deletions were relatively small (Table 5.1). 
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We also tried to add the rHAT DNA to evolution experiments (without antibiotic 
selection) to uncover more-fit deletion mutants to generate a more comprehensive list of 
large sets of genes or dispensable regions for ADP1. To our disappointment, after 30 
daily transfers (300 generations of evolution) with the randomly religated DNA we found 
–via whole genome sequencing– only one large deletion (coordinates 3,240,894 - 
3,262,701) among the five replicate LB-evolved lines. This could have been the result of 
(1) low mutation rates, if there was a low frequency of integrations generating deletions 
were rare, (2) or selection effects, if most deletions were deleterious to fitness or at least 
less-beneficial than other mutations that were possible and occurred at a high frequency. 
Future work could explore combining these approaches with the CRISPR-lock strategy 
(see Chapter 3) to select for deletions in a way that prevents amplification. These 
undirected, combinatorial methods are interesting because they have the potential to 
reveal unexpected regions of genome dispensability in Acinetobacter baylyi.  
Next steps toward minimal-genome Acinetobacter baylyi strains  
While the research described here did not focus on the creation of multi-deletion 
minimal-genome strains, it did identify a path of inquiry that leads in that direction. In the 
future, solutions provided by allowing compensatory evolution after deletion of multiple 
genes can be integrated in genome streamlining designs for greater flexibility. The 
beneficial mutations identified in this work can be engineered into a multi-deletion strain 
to overcome fitness constraints that may arise due to genome reduction steps. Relocation 
of one or a few essential or quasi-essential genes from larger dispensable regions to 
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another part of the genome can also potentially be used to further minimize genomes 54 
192. 
Additionally, using RNA-seq to track gene expression levels in reduced-genome 
strains during growth would provide an ampler view of how genome reduction is 
affecting cellular systems. When combined with measuring baseline wild-type expression 
levels, RNA-seq could also be used to test the effects of fitness-compensating mutations 
that appear to direct global transcriptome changes, including rnd and csrA, on stress and 
growth-related gene expression to see which genes they control in ADP1. Once 
regulators or their important downstream targets are identified, the effects on the fitness 
of reduced genome platforms of purposefully altering their expression can be tested. 
Together, these strategies can potentially allow a researcher to explore otherwise 
unattainable genome reduction paths and open up opportunities for more ambitious 
approaches to get closer to a fully defined free-living minimal cell. 
Altogether, this work has provided a number of solutions and insights into 
improving Acinetobacter baylyi ADP1 as a platform for biological engineering. These 
developments and foundations will empower more ambitious genome editing projects 
that can be used to engineer cells that produce renewable fuels and green chemicals or 





Strain Start End Length Frequency 
ISx-rHat1 150,661 156,431 5,771 1 
ISx-rHat2 515,279 521,312 6,034 1 
ISx-rHat3 543,651 549,215 5,565 2 
ISx-rHat4 1,093,164 1,099,125 5,962 1 
ISx-rHat5 2,267,738 2,272,388 4,651 1 
ISx-rHat6 3,172,273 3,181,499 9,227 1 
ISx-rHat7 3,533,237 3,535,068 1,832 1 
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